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ABSTRACT 
 
      To determine how tetraspanin KAI1/CD82, a tumor metastasis suppressor, 
inhibits cell migration, we assessed which motility-related cellular events are 
altered by KAI1/CD82 and how KAI1/CD82 regulates these events. We found 
that KAI1/CD82-overexpressing cancer cells exhibit various morphologies but 
typically display elongated cellular extensions and a lack of lamellipodia. Live 
imaging demonstrated that the formation of lamellipodia and retraction of 
extensions were deficient upon KAI1/CD82 overexpression.  
      The deficiency in developing motility-related cellular events was 
accompanied by defects in actin cortical network and stress fiber formations. 
Notably, actin polymerization was attenuated by KAI1/CD82. Although Rac1 
activity was diminished upon KAI1/CD82 expression, Rac1 could not rescue 
lamellipodia formation because Rac1 activity is not required for this process in 
Du145 prostate cancer cells. Surprisingly, RhoA activity was upregulated upon 
KAI1/CD82 overexpression despite the loss of stress fiber and lack of cellular 
retraction, suggesting that enhanced RhoA activity is a compensatory effect 
resulting form impaired actin polymerization. Cofilin, an effector of both Rac and 
Rho, cannot translocate to the cell periphery in KAI1/CD82-overexpressing cells 
to facilitate lamellipodia formation, though the total and active cofilin proteins 
remain unchanged.  
      In summary, we demonstrate that KAI1/CD82 inhibits protrusion and 
retraction events crucial for cell movement by disrupting actin cortical network  
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and stress fiber formations. At the molecular level, KAI1/CD82 impairs actin 
polymerization by unbalancing Rac1 and RhoA activities. KAI1/CD82-induced 
disruption of actin organization likely results from the suppression of common 
signaling steps of multiple pathways but is alleviated by cell-cell adhesion. 
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CHAPTER 1.  INTRODUCTION 
 2  
1.1 Importance of cell migration in normal development and diseases 
      Cell migration is a life-long event. It accompanies us throughout our life, 
from shortly after conception to death. During embryonic development, cell 
migration is pivotal for morphogenesis (Ridley et al., 2003). For example, 
massive cell migration directly contributes to three-layer-embryo formation during 
gastrulation and subsequent tissue and organ development (Ridley et al., 2003). 
Cell migration is also actively involved in normal renewal of skin and intestine, in 
which the newly differentiated epithelial cells migrate up from the basal layer and 
the crypts, respectively. However, the detailed mechanisms of cell migration and 
its importance in a variety of biological events are still far from delineated (Ridley 
et al., 2003).  
      Cell migration is not only key for normal development and biological 
processes, but also heavily involved in a vast number of pathological processes, 
for example, vascular disease, osteoporosis, chronic inflammatory diseases 
(rheumatoid arthritis and multiple sclerosis), and cancer. During wound healing 
and immune defense processes, circulating leukocytes, which are attracted by 
the chemotactants released from the inflammatory lesion, migrate into the tissue 
surrounding the lesion to attack the pathogens, destroy infected cells, and clean 
up debris. 
     For all above pathological processes, to unveil the fundamental mechanisms 
underlying cell migration will shed light on the development of more effective 
therapeutic methods and for a variety of illnesses.  
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      In recent years, scientists have made many important progresses about how 
cancers initiate and develop. Surgery, chemotherapy and radiation can 
effectively treat the primary tumor lesion. However, relatively little is known about 
how cancers are able to metastasize to distant tissues and organs (Steeg, 2006). 
Metastasis is a multiple step process including invasion, survival and arrest of 
cancer cells in the bloodstream, and finally the formation of metastatic 
colonization to the target organs (Steeg, 2006) .  
      The metastasic cancer lesion can lead to catastrophic consequences, such 
as the functional failure of target organs due to cancer growth and infiltration. In 
fact, the local invasion and distal metastasis of the cancer are the leading cause 
of death in many common cancer cases, such as lung metastasis and 
destruction in thyroid cancer (Mazzaferri, 2006), and the bone, lungs, liver and 
brain metastasis and destruction in breast cancer (Price, 1994), et al. It is very 
important to understand the mechanisms for our body to fight against tumor 
metastasis. However, the genetic foundation of suppressing cancer metastasis 
remained unclear. It has been reported that at least three genes are involved in 
this process. They are Nm23 ( Fournier et al., 2002; Hartsough et al., 2002; 
Palacios et al., 2002; D'Angelo et al., 2004; Engel et al., 2004), 
medroxyprogesterone (MPA) (Ouatas et al., 2003; Palmieri et al., 2005), and 
KAI1 (Bandyopadhyay et al., 2006; Zijlstra and Quigley, 2006; Gellersen et al., 
2007; Iiizumi et al., 2007). Here, Iwill focus on how KAI1/CD82 inhibits cancer 
cell metastasis. 
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1.2 KAI1/CD82 is a cell motility-inhibitory tetraspanin 
 
1.2.1   The discovery of KAI1/CD82  
       KAI1/CD82 (also called R2, C33, IA4, or 4F9) was initially identified from T 
cell activation studies (Gaugitsch et al., 1991). The KAI1/CD82 gene encodes a 
267 amino acid protein that contains four putative transmembrane domains 
(Gaugitsch et al., 1991). Later studies showed that immuno-crosslinking of 
KAI1/CD82 triggered the intracellular calcium mobilization in lymphocytes and 
the T cell adhesion, the cell surface level of KAI1/CD82 was up-regulated upon 
cell activation and cytokine stimulation, and KAI1/CD82 played an accessory role 
in T cell activation (Fukudome et al., 1992; Gil et al., 1992; Nojima et al., 1993). 
Interestingly, KAI1/CD82 was also identified as a target of the monoclonal 
antibody that inhibited syncytium formation induced by human T-cell leukemia 
virus (Fukudome et al., 1992). 
      The role of KAI1/CD82 in cancer progression was discovered by a genetic 
screen attempting to identify metastasis suppressing genes (Ichikawa et al., 
1991). Using microcell-mediated chromosome transfer, human gene(s) 
responsible for suppressing metastasis of the highly metastatic rat AT6.1 
prostate cancer cells was mapped to the short arm of human chromosome 11 
(Ichikawa et al., 1992). Dong, Isaacs, and Barrett made important progress in 
1995 as they cloned the metastasis suppressor gene located at human 
chromosome 11 p11.2-13 and designated this suppressor as KAI1(Dong et al., 
1995). KAI1 is identical to CD82 (Dong et al., 1995). KAI1/CD82 expression 
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leads to a marked suppression of lung metastases of AT6.1 prostate cancer 
cells, without affecting the growth rate of the primary tumor (Dong et al., 1995).  
 
1.2.2   KAI1/CD82 as a tumor metastasis suppressor  
     Although KAI1/CD82 was initially identified as a metastasis suppressor of 
prostate cancer, a plethora of evidence supports KAI1/CD82 as a wide-spectrum 
invasion- and metastasis-suppressor during the progression of a variety of solid 
tumors (Dong et al., 1995; Hemler, 2001; Stipp et al., 2003). In the past decade, 
KAI1/CD82 expression in tumors has been thoroughly analyzed. In normal 
tissues, KAI1/CD82 is ubiquitously expressed. Its mRNA levels are high in 
spleen, placenta, lung, liver, kidney, and prostate, moderately abundant in the 
pancreas, skeletal muscle, and thymus;  and detectable at low level in brain, 
heart, ovary, stomach, and uterus (Nagira et al., 1994; Dong et al., 1995). 
KAI1/CD82 is evolutionarily conserved (Nagira et al., 1994; Dong et al., 1995) . 
For example, KAI1/CD82 protein displays 76% identity and 82% similarity 
between human and mouse (Nagira et al., 1994). Thus, although KAI1/CD82 is 
important for cancer progression, the ubiquitous tissue expression pattern and 
evolutionary conservation of KAI1/CD82 implicate that KAI1/CD82 also plays a 
significant role in development.  In malignant solid tumors, the presence of 
KAI1/CD82 expression predicts a better prognosis for cancer patients (Dong et 
al., 1996; Dong et al., 1997b; Higashiyama et al., 1998; Ow et al., 2000), 
whereas the down-regulation or loss of KAI1/CD82 expression is constantly 
found in the clinically advanced cancers (Dong et al., 1997b; Kawana et al., 
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1997; Yu et al., 1997; Uchida et al., 1999; Yang et al., 2000). Consistent with 
these observations, an inverse correlation between KAI1/CD82 expression and 
the invasive and metastatic potentials of cancer has been frequently observed in 
a wide range of malignancies such as prostate (Ueda et al., 1996; Bouras and 
Frauman, 1999; Tricoli et al., 2004), gastric (Hinoda et al., 1998), colon (Takaoka 
et al., 1998a; Lombardi et al., 1999), cervix (Liu et al., 2001; Schindl et al., 2002; 
Liu et al., 2003), breast (Yang et al., 1997; Yang et al., 2000; Yang et al., 2001), 
skin (Geradts et al., 1999), bladder (Yu et al., 1997; Jackson et al., 2000a; Ow et 
al., 2000; Jackson et al., 2002), lung (Adachi et al., 1996; Adachi et al., 1998), 
pancreas (Guo et al., 1996; Friess et al., 1998; Friess et al., 2001), liver (Guo et 
al., 1998; Sun et al., 1998), and thyroid cancers (Chen et al., 2004). KAI1/CD82 
overexpression inhibits cell migration and cancer invasion in vitro and 
suppresses cancer metastasis in animal models (Dong et al., 1995; Yang et al., 
2001). In addition to the suppression of cancer progression, it has been 
occasionally reported that KAI1/CD82 induces senescence (Bandyopadhyay et 
al., 2006) and apoptosis (Ono et al., 1999; Schoenfeld et al., 2003).      
 
1.2.3   KAI1/CD82 as a tetraspanin  
      KAI1/CD82 is a type III transmembrane protein that belongs to the 
tetraspanin superfamily (Figure 1.1). Tetraspanins are characterized by 4 
membrane-spanning domains, 4-6 well-conserved extracellular cysteine residues 
that presumably form 2-3 disulfide bonds, a Cys-Cys-Gly motif in the large  
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Figure 1.1   KAI1/CD82 is a tetraspanin  
 
KAI1/CD82 is a type III transmembrane protein and belongs to the tetraspanin 
superfamily. KAI1/CD82 is characterized by 4 membrane-spanning domains, 6 
well-conserved extracellular cysteine residues that presumably form 3 disulfide 
bonds, a Cys-Cys-Gly motif in the large extracellular loop, and polar residues 
within the transmembrane domains.  
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extracellular loop, and polar residues within the transmembrane domains (Wright 
MD & Tomlinson MG., 1994; Hakomori, 2002; Stipp et al., 2003). Tetraspanins 
participate in a wide variety of biological events such as immune response, viral 
entry, synapse formation, neurite outgrowth, and sperm-egg fusion (Maecker et 
al., 1997). Although the mechanism remains unclear, tetraspanins regulate 
migration, fusion, adhesion, and proliferation at the cellular level (Maecker et al., 
1997). Among these, regulation of cell motility stands out as a prominent feature 
for many tetraspanins. For example, tetraspanins KAI1/CD82 and CD63 inhibit 
cell motility, while tetraspanins CD151 and CO-029 promote it. The structural 
elements in KAI1/CD82 required for its function are still not well understood. 
Characterization of these elements will shed light on the mechanism that governs 
KAI1/CD82 function. In the following, Iwill discuss the biochemical and structural 
features of human KAI1/CD82 protein. (Higashiyama et al., 1995; Berditchevski, 
2001; Boucheix and Rubinstein, 2001; Levy and Shoham, 2005).  
 
1.2.3.1 Large extracellular loop (LEL) 
 
      Among tetraspanins, the LELs usually share less homology than the 
transmembrane and intracellular domains. The LELs can be further divided into 
variable and constant regions based on the sequence homology (Hemler, 2001). 
The variable region is situated in the middle and usually mediates heterogeneous 
protein-protein interactions. The constant regions are situated at N- and C-termini 
of LEL and predicted to be responsible for the dimerization (Stipp et al., 2003; 
Levy and Shoham, 2005). The variable region of the KAI1/CD82 LEL (residues 
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110-227) contains six highly conserved cysteines (Gaugitsch et al., 1991; 
Fukudome et al., 1992; Gil et al., 1992; Nojima et al., 1993). These cysteine 
residues form disulfide bonds which are critical for the correct folding of the LEL 
(Berditchevski, 2001; Hemler, 2001; Stipp et al., 2003).  Also in the LEL variable 
region, KAI1/CD82 contains 3 sites for N-glycosylation, Asn129, Asn157 and 
Asn198 (Ono et al., 1999). Although KAI1/CD82 glycosylation has been 
experimentally demonstrated (Ono et al., 2000), the contribution of each site to 
the glycosylation remains to be determined. The C-terminal constant region of 
the KAI1/CD82 LEL may contain the structural elements needed for its function 
since an alternatively spliced form of KAI1/CD82, which lacks the C-terminal part 
of LEL and a part of the 4th transmembrane region, no longer exerts the 
inhibitory activity on cell migration (Lee et al., 2003b).  
 
1.2.3.2 Small extracellular loop (SEL)  
 
      The function of KAI1/CD82 SEL has not yet been studied. The studies from 
other tetraspanins such as CD81 suggest that the SEL is involved in the optimal 
folding of the LEL (Masciopinto et al., 2001). 
 
1.2.3.3 Transmembrane (TM) domains 
      TM domains are highly conserved among tetraspanins (Levy and Shoham, 
2005). The specific hydrophobic interactions of TM domains between 
tetraspanins are important for the maintenance of Tetraspanin Web (Stipp et al., 
2003). Like other tetrapsanins, KAI1/CD82 TM1, 3, and 4 domains contain polar 
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residues Asn, Gln, and Glu, respectively. These polar residues are predicted to 
situate in the internal TM-TM interface rather than the external TM-lipid interface 
and serve as both hydrogen bond donors and recipients mediating the 
tetraspanin dimerization or polymerization (Zhou et al., 2000; Bienstock and 
Barrett, 2001; Gratkowski et al., 2001; Senes et al., 2001). Moreover, the TM 
domains are needed for KAI1/CD82 maturation. A truncated KAI1/CD82 lacking 
TM1 (TM2-4) can’t leave the endoplasmic reticulum (Cannon and Cresswell, 
2001). Co-expression of TM1 facilitates the transport of TM2-4 to the cell surface 
(Cannon and Cresswell, 2001), suggesting the TM1 may either contain a 
surface-targeting signal or be required for the proper TM domain assembly of 
KAI1/CD82.     
 
1.2.3.4 Intracellular loop (IL) 
 
      The IL only contains 4 or 5 amino acid residues including one acidic residue 
(Stipp et al., 2003; Levy and Shoham, 2005). Like tetraspanins CD9 and CD151, 
KAI1/CD82 is constitutively palmitoylated in the cysteine residues located in or 
near the interface of TM and cytoplasmic regions (Zhou et al., 2004). The Cys83 
residue at the IL and Cys74 near the IL can be palmitoylated (Zhou et al., 2004). 
 
1.2.3.5 Cytoplasmic domains 
 
      The N- and C-terminal cytoplasmic domains of KAI1/CD82 only contain 11 
and 15 residues, respectively. There are 3 cysteine residues (Cys5, Cys251, and 
Cys253) in the tails. All are adjacent to TM domains and found to be 
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palmitoylated (Zhou et al., 2004). The glycine residue (Gly2) in the N-terminal tail 
is a putative myristoylation site. Acylation likely assists the anchorage of short 
tails to membrane and the interactions between TM domains in the Tetraspanin 
Web. In addition, the Lys10 and Tyr11 residues in N-terminal tail are well 
conserved among tetraspanins (Stipp et al., 2003), but the biochemical relevance 
of these residues awaits to be addressed. The C-terminal cytoplasmic domain 
contains a tyrosine-based, functional internalization motif (Bonifacino and 
Dell'Angelica, 1999; Stipp et al., 2003). 
 
1.2.4   How KAI1/CD82 suppresses cancer invasion and metastasis  
 
1.2.4.1 KAI1/CD82 regulates the functions of its associated proteins 
      KAI1/CD82 likely suppresses cancer metastasis by primarily inhibiting cancer 
cell migration and invasion. There are two mechanisms possibly involved: one is  
that KAI1/CD82 per se directly initiates signals to diminish cell motility. This 
mechanism is less likely because the simplistic structure of KAI1/CD82 and the 
lack of enzyme motif that within its cytoplasmic domain. However, there is  
example, ligands for tetraspanins may exist (Nakamura et al., 2000; Crotta et al., 
2001; Waterhouse et al., 2002; Nakajima et al., 2005)  even though tetraspanins 
are not documented as typical receptors (Stipp et al., 2003). Also, the cross-
linking of KAI1/CD82 proteins with a monoclonal antibody produces profound 
morphological changes and signaling (Nojima et al., 1993). For example, the 
crosslinking of KAI1/CD82 with its mAb in T-cells trigger the tyrosine  
 12  
phosphorylation of Vav1 (Delaguillaumie et al., 2002), SLP76 (Delaguillaumie et 
al., 2002), and Cas-L (Delaguillaumie et al., 2002; Iwata et al., 2002). However, 
these effects could be alternatively interpreted as a result of clustering of the 
KAI1/CD82-associated tetraspanin web.  
      Alternatively, KAI1/CD82 inhibits cell motility through regulating the signaling 
initiated or mediated by KAI1/CD82 associated protein such as integrin and 
EGFR in tetraspanin web. Growing evidence supports this notion. The 
tetraspanin web components that KAI1/CD82 associates with include:  
   1. Tetraspanins such as CD9 and CD81 (Claas et al., 2001; Hemler, 2003);   
   2. Integrins such as β1 and β2 integrins (Mannion et al., 1996; Ono et al., 
1999; Shibagaki et al., 1999; Sugiura and Berditchevski, 1999; Iwata et 
al., 2002; Lee et al., 2003),  
   3. Immunoreceptors such as MHC-I and -II molecules (Szollosi et al., 1996; 
Lagaudriere-Gesbert et al., 1997; Shibagaki et al., 1999);  CD4 (Imai et 
al., 1992; Imai et al., 1995; Shibagaki et al., 1999), CD8 (Imai et al., 1992), 
EWI2/PGRL (Zhang et al., 2003), FPRP/CD9P-1 (Charrin et al., 2001), 
CD19 (Bradbury et al., 1992), and CD46 (Lozahic et al., 2000) ;   
   4. Growth factors and growth factor receptors such as heparin-binding 
epidermal growth factor (Nakamura et al., 2000), EGF receptor (Odintsova 
et al., 2000), and hepatic growth factor receptor c-Met (Sridhar and 
Miranti, 2006; Todeschini et al., 2007);   
   5. Intracellular signaling proteins such as PKC (Zhang et al., 2001), and  
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   6. Other proteins such as KITENIN (Lee et al., 2004; Rowe and Jackson, 
2006) and gamma-glutamyl transpeptidase (Nichols et al., 1998);  In the 
following, Iwill discuss the functional significance of these associations. 
 
1.2.4.1.1 Integrin   
      KAI1/CD82 associates with various integrins including α3β1, α4β1, α5β1, 
α6β1, and αLβ2 (Mannion et al., 1996; Shibagaki et al., 1999; Sugiura and 
Berditchevski, 1999; Ono et al., 2000; Iwata et al., 2002; Lee et al., 2003) (Figure 
1.2). Since integrins are indispensable for cell adhesion and migration, this 
association likely plays a role in KAI1/CD82 metastasis-suppressive function. 
Indeed, KAI1/CD82 regulates integrin-mediated signaling and -dependent 
adhesion.  
   1. KAI1/CD82 directly alters the downstream signaling events of integrin 
(Zhang et al., 2003). KAI1/CD82 has been reported to regulate the 
activities or levels of Src family kinases though Src kinases are not 
necessarily activated by integrins (Lagaudriere et al., 1998; Jee et al., 
2003; Zhang et al., 2003),. KAI1/CD82 down-regulates the formation 
p130CAS-Crk complex, a molecular switch for cell motility, leading to the 
inhibition of cell migration (Zhang et al., 2003). Rho small GTPases are 
activated by the clustering of KAI1/CD82 in T cells (Delaguillaumie et al., 
2002). The inhibition of Rho GTPases blocks the cellular protrusions 
triggered by KAI1/CD82 clustering and impairs KAI1/CD82-stimulated 
phosphorylation of Rho GTPases guanosine exchange factor Vav1 and  
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Figure 1.2   The mechanisms contributing KAI1/CD82-mediated 
suppression of cancer cell migration and invasion 
 
 A. KAI1/CD82 indirectly inhibits the uPA binding to uPAR and the pericellular 
plasminogen activation through inducing the redistribution of uPAR into focal 
adhesions and the association of uPAR with integrin α5β1. Presumably, 
pericellular ECM degradation will be consequently reduced.  B and C. 
KAI1/CD82 accelerates the internalization of both integrin α6β1 and EGFR. The 
internalized proteins might be delivered to lysosomes for degradation. Hence, the 
levels of integrin and EGFR at thecell surface are reduced, and cell adhesion and 
cell migration are impaired. D. KAI1/CD82 and other tetraspanins interact with 
each other and form tetraspanin web. KAI1/CD82 attenuates integrin signaling 
such as FAK-Src-p130CAS-Crk and Rho small GTPases signaling. The 
KAI1/CD82-containing tetraspanin web also recruits activated PKC to β1 
integrins and regulates the phosphorylation of laminin-binding integrins. As a 
consequence, cellular protrusion, possibly cellular retraction, and actin 
cytoskeleton reorganization are inhibited, and cell migration and cancer invasion 
are suppressed. E. The KAI1/CD82-EWI2/PGRL association enhances the 
motility-inhibitory activities of both molecules, while the KAI1/CD82-KITENIN 
association attenuates the motility-promoting activity of KITENIN. Modified with 
permission. Liu WM, and Zhang XA, 2006, KAI1/CD82, a tumor metastasis 
suppressor: Cancer Letters, v. 240, no. 2, p. 183-194. 
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adapter protein SLP76. However, the activity of Rho GTPases are not 
required for the inducible interaction between actin cytoskeleton and 
KAI1/CD82 (Delaguillaumie et al., 2002), suggesting a downstream role of 
Rho or other mechanisms.  
   2. KAI1/CD82 directly modulates integrin-dependent cell-extracellular matrix 
adhesion. For instance, integrin α6-dependent adhesion to laminin are 
diminished upon KAI1/CD82 overexpression and enhanced by KAI1/CD82 
knockdown (He et al., 2004). It was also reported that KAI1/CD82 
expression inhibited adhesion to fibronectin of DLD-1 and CT-26 colon 
cancer cells (Lombardi et al., 1999; Lee et al., 2003b), while KAI1/CD82 
silencing promoted the adhesion to fibronectin of BM314 colon cancer 
cells (Lombardi et al., 1999).  
 
1.2.4.1.2 Epidermal growth factor receptor (EGFR)   
      EGFR belongs to the ErbB family of receptors, and the ErbB pathway is 
frequently hyper-activated in cancer via the overproduction of ligands and 
receptors or the constitutive activation of receptors (Yarden and Sliwkowski, 
2001). KAI1/CD82 associates with EGFR, ErbB2, and ErbB3 (Odintsova et al., 
2000; Odintsova et al., 2003). Through this association, KAI1/CD82 accelerates 
the desensitization of EGF signaling and endocytosis of EGFR (Odintsova et al., 
2000) (Figure 1.2). Meanwhile, KAI1/CD82 specifically inhibits ligand-induced 
EGFR dimerization and alters the distribution of EGFR in plasma membrane 
(Odintsova et al., 2003).   
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1.2.4.1.3 EWI2/PGRL   
      EWI2/PGRL belongs to a novel Ig subfamily and associates with tetraspanins 
such as CD9, CD81, and KAI1/CD82 (Clark et al., 2001; Stipp et al., 2001) 
(Figure 1.2). KAI1/CD82 can form a complex with EWI2/PGRL in a CD9- and 
CD81-independent manner (Zhang et al., 2003b). EWI2/PGRL overexpression 
inhibits cell migration (Clark et al., 2001; Zhang et al., 2003b) and enhances the 
motility-inhibitory activity of KAI1/CD82 (Clark et al., 2001; Zhang et al., 2003b; 
Lee et al., 2004).    
 
1.2.4.1.4 KITENIN  
      KITENIN was recently found to directly bind the C-terminal cytoplasmic 
domain of KAI1/CD82 (Lee et al., 2004). KITENIN is also a transmembrane 4 
protein but does not belong to the tetraspanin superfamily. In contrast to 
KAI1/CD82, KITENIN promotes cell migration, cancer invasion, and cancer 
metastasis (Lee et al., 2004).  
 
1.2.4.1.5 Protein kinase C (PKC)  
      Among tetraspanin-associated intracellular Signaling proteins, KAI1/CD82 
interacts with the activated PKC (Zhang et al., 2001a) (Figure 1.2) but not 
phosphatidylinositol-4 kinase (PI-4K) (Zhang et al., 2001a). Upon phorbol ester 
stimulation, the activated PKC is recruited to interact with integrin-tetraspanin 
complex (Zhang et al., 2001a) and regulate integrin-dependent cell migration 
(Zhang et al., 2001a).  
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1.2.4.1.6 c-MET and GM2  
      c-MET is the cell surface receptor of HGF. HGF-cMET axis promotes 
integrin-dependent cell migration. KAI1/CD82 can attenuate this process and 
thus inhibit cell migration (Sridhar and Miranti, 2006). GM2 is a glycosphingo-
lipid (GSLs), which interacts with KAI1/CD82. GM2 is required for 
KAI1/CD82’s inhibition on cell migration through regulation of HGF-cMET axis 
(Todeschini et al., 2007).  
 
1.2.4.1.7 Duffy Antigen Receptor for Chemokines (DARC)  
     DARC can inhibit the colonization of metastasized cancer cells, probably 
through the interaction with KAI1/CD82(Bandyopadhyay et al., 2006; Rinker-
Schaeffer and Hickson, 2006). This interaction can trigger the senescene of 
cancer cell and completely abolish the lung metastasis of rat prostatic carcinoma 
cell line AT6.1, the human breast carcinoma cell line MDA-MB-435, and the 
mouse melanoma cell lines B16BL6 and B16F10 (Bandyopadhyay et al., 2006; 
Zijlstra and Quigley, 2006; Gellersen et al., 2007; Iiizumi et al., 2007). However, 
in DARC knockout mice, this inhibition of metastasis has been significantly 
impaired. 
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1.2.5   KAI1/CD82 redistributes the plasma membrane components   
      Cell surface molecules undergo dynamic redistributions during cell migration. 
KAI1/CD82 overexpression leads to the redistribution of urokinase-type 
plasminogen activator receptor (uPAR) into focal adhesions to form a stable 
complex with integrin α5β1, though no physically interaction was found between 
KAI1/CD82 and uPAR (Bass et al., 2005). The redistribution of uPAR markedly 
reduces its ability to bind the ligand uPA, and consequently to cleave and 
activate plasminogen (Bass et al., 2005) (Figure 1.2). Similarly, the redistribution 
of EGFR and gangliosides within plasma membrane were also found upon 
KAI1/CD82 overexpression (Odintsova et al., 2000; Odintsova et al., 2003).  
      Besides re-compartmentalization of plasma membrane components, 
KAI1/CD82 likely redistributes Tetraspanin Web components such as EGFR into 
distinct cellular compartments through endocytosis.  In addition, the diminished 
integrin α6-dependent cell adhesion upon KAI1/CD82 expression results from the 
decreased levels of α6 integrins at cell surface (He et al., 2004). As to the effect 
on EGFR, KAI1/CD82 accelerates the internalization of α6 integrins (Figure 1.2). 
Since the total cellular α6 integrins are not altered by KAI1/CD82, α6 integrins 
are likely redistributed into endocytic compartments. The mechanism KAI1/CD82 
use to redistribute the tetraspanin web components is obscure. The answer will 
likely rely on the identification of intrinsic trafficking motifs in KAI1/CD82.  
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1.2.6   Post-translational modifications of KAI1/CD82: the essential makeup 
for its motility-suppressive activity   
 
1.2.6.1 Palmitoylation  
       Palmitoylation is a posttranslational acylation process in which saturated 
fatty acids, predominantly palmitate, are covalently linked to the cysteine 
residues in proteins. Palmioylation contributes to membrane targeting of proteins, 
protein trafficking, localization of proteins into organized membrane 
microdomains such as lipid rafts, and regulation of functional activities of proteins 
(Dunphy and Linder, 1998; Resh, 1999; Bijlmakers and Marsh, 2003). 
Tetraspanin palmitoylation contributes to the organization of Tetraspanin Webs 
(Berditchevski et al., 2002; Charrin et al., 2002; Yang et al., 2002). KAI1/CD82 is 
palmitoylated in all 5 cysteines proximal to the plasma membrane (Cys5, Cys74 , 
Cys83 , Cys251 , and Cys253) (Zhou et al., 2004). Removal of palmitoylation 
reverses KAI1/CD82-dependent inhibition of cell migration and invasion, which is 
at least partly due to less KAI1/CD82 reaching the cell surface and joining the 
Tetraspanin Web (Zhou et al., 2004).  
 
1.2.6.2 Glycosylation   
 
      KAI1/CD82 is N-glycosylated, and the degrees of glycosylation vary among 
cells or tissues (Fukudome et al., 1992; Imai et al., 1992; White et al., 1998). The 
glycosylation appears to be important for the cell surface targeting of KAI1/CD82 
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(Fukudome et al., 1992; Imai et al., 1992), motility regulation (Ono et al., 2000), 
and integrin association (Ono et al., 1999; Ono et al., 2000).  
     These studies suggest that reaching the cell surface or the presence in 
plasma membrane is the prerequisite for KAI1/CD82 to exert its motility-inhibitory 
activity.   
 
1.2.7   KAI1/CD82 induces apoptosis: a distinctive or concurrent 
mechanism?  
      Along with several other tetraspanins, KAI1/CD82 induces apoptosis in a 
variety of cell lines upon overexpression (Ono et al., 2000; Schoenfeld et al., 
2003). Meanwhile, KAI1/CD82 sensitizes cells to the pro-apoptotic stimuli 
(Schoenfeld et al., 2003). KAI1/CD82 overexpression promotes the generation of 
intracellular reactive oxygen intermediates, which possibly result from the Cdc42-
dependent release of intracellular anti-oxidant glutathione (Schoenfeld et al., 
2003). It remains to be determined whether KAI1/CD82-induced apoptosis 
contributes to the metastasis suppression. Despite no effects on cancer cell 
proliferation in vitro and/or tumor growth in vivo for prostate, colon, and skin 
cancers (Dong et al., 1995; Takaoka et al., 1998a; Lombardi et al., 1999; Kim et 
al., 2005), KAI1/CD82 was found to decrease the size of primary tumors of 
gastric and breast cancers in animal models (Dong et al., 1995; Lee et al., 
2003a; Lee et al., 2003b).  It is therefore possible that, at least in some cancers, 
the induction of apoptosis may serve as a concurrent mechanism for KAI1/CD82.  
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1.2.8   How KAI1/CD82 expressions are diminished or lost in invasive and 
metastatic cancers 
      How KAI/CD82 gene expression is regulated becomes an increasingly 
important question. The answer will not only shed light on the mechanisms of 
cancer invasion and metastasis but also likely lead to clinical benefits. The 
regulatory mechanisms of KAI1/CD82 gene expression have started to emerge 
from recent studies and are summarized as follows and in Table 1.1.  
 
1.2.8.1 The alternative splicing of KAI1/CD82  
 
      KAI1/CD82 contains at least one alternative spliced form, in which the exon 7 
is deleted (Lee et al., 2003b). As a result, this spliced form lacks the distal part of 
the second extracellular loop and part of the fourth transmembrane region (also 
see section 1.3.1). Compared to wild type KAI1/CD82, this spliced KAI1/CD82 
cannot efficiently suppress the metastasis of gastric carcinoma (Lee et al., 2003). 
 
1.2.8.2 The transcriptional regulation of KAI1/CD82 expression 
 
      Down-regulated KAI1/CD82 expression does not result from loss of 
heterozygosity (Dong et al., 1997a; Kawana et al., 1997; Tagawa et al., 1999), 
the hyper-methylation of the CpG island within KAI1/CD82 promoter region 
(Jackson et al., 2000b), or the mutations within the KAI1/CD82 coding region 
(Dong et al., 1995; Miyazaki et al., 2000). Rather, it is likely due to increased 
transcription repressor activity and/or decreased activator activity.  
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Table 1.1 Molecules involved in KAI1/CD82 transcription regulation 
Molecules involved in activation 
Molecules involved in 
repression 
 
Transcription factors: 
 
NFκB* (Shinohara et al., 2001; Li et al., 2001; 
Baek et al., 2002; Telese et al., 2005) 
Tip60;  (Telese et al., 2005) 
Fe65;  (Telese et al., 2005) 
SET (Telese et al., 2005) 
P53;  (Dong et al., 1997a) 
AP1;  (Dong et al., 1997a) 
AP2;  (Dong et al., 1997a) 
C-Jun & JunB (Mashimo et al., 1998; 
Mashimo et al., 2000; Gao et al., 2003; 
Marreiros et al., 2005) 
 
Transcription factors: 
 
NFκB* (Baek et al., 2002; 
Telese et al., 2005; Kim et al., 
2005) 
β-Catenin (Kim et al., 2005);   
Reptin (Kim et al., 2005) 
NcoR (Baek et al., 2002);   
TAB2 (Baek et al., 2002);   
HDAC3 (Baek et al., 2002) 
 
Other molecules:  
 
Amyloid β precursor protein (APP) (Baek et 
al., 2002) 
PKC (Akita et al., 2000)  
IL-1(Baek et al., 2002)  
Nerve growth factor (Sigala et al., 1999) 
 
 
* NFκB could serve as either activator or repressor depending on whether co-
activator or co-repressor is recruited (see text for detail). 
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1.2.8.2.1 NFκB  
      NFκB P50 subunit was found to bind to a region between -6631 to -6996 bp 
upstream of the KAI1/CD82 gene transcription start site. This region contains a  
sequence homologous to the NFκB binding sequence (Baek et al., 2002; Telese 
et al., 2005). The overexpression or activation of NFκB elevates the mRNA and 
protein levels of KAI1/CD82 in murine pro-B cells (Li et al., 2001) and various 
human adenocarcinoma cell lines (Li et al., 2001; Shinohara et al., 2001), while 
specific inhibition of NFκB by IκBα down-regulates KAI1/CD82  transcription (Li et 
al., 2001). In contrast to p50, NFκB p65 subunit does not bind to the KAI1/CD82 
promoter. These observations strongly suggest that NFκB p50 subunit dimerize 
and regulate the transcription of KAI1/CD82. Whether NFκB activates or 
represses KAI1/CD82 transcription actually depends on the nature of the 
transcription co-factors recruited to NFκB p50.  Co-activator Tip60/Fe65 complex 
or co-repressor N-CoR/TAB2/HDAC3 complex could exchange with each other 
to bind NFκB p50 and turn on and off KAI1/CD82 transcription, respectively 
(Baek et al., 2002; Telese et al., 2005). 
 
1.2.8.2.2 β-Catenin and Reptin   
      A recent discovery has linked the transcription regulation of KAI1/CD82 to β-
catenin (Kim et al., 2005). β-catenin, in combination with reptin chromatin 
remodeling complex, binds directly to the p50 docked on the NFκB response 
element in the KAI1/CD82 promoter region and replaces the Tip60 co-activator 
complex (Telese et al., 2005). Consequently, the co-repressor HDACs are 
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recruited to β-catenin-reptin complex to repress KAI1/CD82 transcription. 
Therefore, the exchange of β-catenin co-repressor and Tip60 co-activator also 
regulates the KAI1/CD82 transcription. 
 
1.2.8.2.3 p53, AP-1, AP-2, JunB, and c-Jun  
       Although no typical TATA- and CAAT-binding motifs are found in KAI1/CD82 
promoter, KAI1/CD82 promoter does contain binding sites for the transcription 
factors such as p53, AP1, AP2, and Sp1 (Dong et al., 1997). Two minimal 
promoter elements have bee reported: one is located from -197 to -1 bp and 
another from +1 to +351 bp (Gao et al., 2003). Both in vitro and in vivo analyses 
indicated that p53 is able to bind the KAI1/CD82 promoter and turn on its 
expression (Mashimo et al., 2000). Furthermore, p53 is involved in etoposide-
induced KAI1/CD82 gene expression in A549 non-small cell lung cancer cells 
(Mashimo et al., 2000). Although KAI1/CD82 transcription is up-regulated by p53 
(Marreiros et al., 2003; Marreiros et al., 2005), KAI1/CD82 can still be expressed 
in cells containing p53 mutant deficient in DNA binding (Duriez et al., 2000; 
Shinohara et al., 2001). In addition, c-Jun and Jun-B was also found to 
participate in KAI1/CD82 transcription regulation (Mashimo et al., 2000; 
Marreiros et al., 2003; Marreiros et al., 2005).  
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1.2.8.2.4 Other transcription factors   
      Besides NFκB, other transcription factors in IL-1 and TNF signaling pathways  
may also regulate KAI1/CD82 transcription since IL-1 and TNF induce 
KAI1/CD82 gene expressions (Baek et al., 2002; Bao et al., 2007).  Also, a novel 
transcription co-activator, SET, can be recruited by p50-Tip60-Fe65-APP 
complex to KAI1/CD82 promoter region (Telese et al., 2005; Bao et al., 2007). 
Moreover, PKC activation promotes KAI1/CD82 gene transcription and  
expression (Akita et al., 2000), suggesting that the transcription factors 
responsive to PKC activation are involved. Finally, transcription factors 
responsive to nerve growth factor may also elevate the transcription of 
KAI1/CD82 (Sigala et al., 1999).   
      Taken together, the replacement of transcription activators from the 
KAI1/CD82 promoter by the dominant co-repressor complex may serve as one 
mechanism to repress KAI1/CD82 expression. How NFκB, N-CoR, β- catenin, 
p53, AP-1, and AP-2 coordinately regulate the transcription of KAI1/CD82 in a 
temporal-spatial manner is an interesting and important issue that remains to be 
addressed.     
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1.3 The actin cytoskeleton rearrangement, cell migration, and small Rho 
GTPases 
 
1.3.1   Cytoskeleton components, actin polymerization and cytoskeletal 
rearrangement 
      The cytoskeleton can be described as cellular "scaffolding". It provides a 
traffic track for all organelle, within the cytoplasm. It presents in all eukaryotic and 
prokaryotic cells (Albert, 1994). The cytoskeleton provides a dynamic structure to 
maintain cell shape, as well as protects the cell. Furthermore, it participates in 
cell motion. In addition to all the roles above, it plays pivotal roles in cellular 
division. Thus, the cytoskeleton functions as a bone-like structure within the 
cytoplasm (Albert, 1994). The cytoskeleton consists of three major classes of 
proteins. They are microfilaments, intermediate filaments and microtubules.  
   1. Microfilaments. The major protein residings in the microfilaments is actin.      
Actin monomer can be polymerized to form filaments, which are the major 
microfilaments. An actin filament is approximately 7 nm in diameter. It is 
composed of two actin chains oriented in a circular shape. They are 
heavily accumulated just beneath the plasma membrane, so as to keep 
cellular shape, and form cytoplasmic protuberances such as pseudopodia 
and microvilli, and mediate inter-cellular signaling transduction in some 
cell-to-cell or cell-to-matrix junctions. Moreover, they participate in 
cytokinesis and cell contraction in coordination with myosin. The 
 28  
interaction of actin and its motor, myosin, can reduce cytoplasmic 
streaming in most cells. 
   2. Intermediate filaments. The major proteins are vimentins, keratin, 
neurofilaments, and lamin. Unlike microfilaments, which only consist of 
actin, intermediate filaments consist of a variety of structural proteins. 
Different intermediate filaments and their major functions are listed as 
following: 
a. Vimentins – ubiquitously expressed as structural support of many cells. 
b. Keratin – found mostly in skin cells, hair and nails. 
c. Neurofilaments – present in neural cells. 
d. Lamin - structural support to the nuclear envelope. 
   3. Microtubules. The main cytoskeletal protein is microtubules. Microtubules 
are hollow cylinders of approximately 25 nm in diameter. They are made 
of 13 protofilaments consisting of polymers of alpha and beta tubulin. They 
constantly undergo rapid turnover as they bind GTP for polymerization or 
GDP for depolymerization. They are organized by the centrosome. The 
key functions of microtubules are listed as follows: 
a. Intracellular transport (provides track for dyneins and kinesins as that            
transport organelles such as mitochondria or vesicles). 
b. Axoneme of cilia and flagella. 
c. Mitotic spindle. 
d. Cell wall in plants. 
 29  
      As stated in the above, the major force that drives cell to migration is 
microfilaments, more specifically, actin filaments. Actin filaments are the building 
block of lamellipodia and filopodia, which play central roles in plasma membrane 
protrusion and afterwards cell migration (Albert, 1994). Understand how actin is 
polymerized is very important for understanding of cell migration and its 
regulation (Albert, 1994; Pollard and Borisy, 2003; Raftopoulou and Hall, 2004). 
The first step of locomotion, ie;  the protrusion of a leading edge is driven by the 
actin polymerization that pushes the plasma membrane outward. Types of 
protrusive structures are various in different cell types. Protrusion can be divided 
into three different catalogories, filopodia (also known as microspikes), 
lamellipodia, and pseudopodia. All of them are filled with a dense core of 
filamentous actin and contain no membrane-enclosed organelles. These three 
structures differ basically in the way at actin is organized, in two or three 
dimensions respectively. The actin associating proteins involved in the formation 
of these structures are also varied, and their interactions with actin are regulated 
in a spatial and temporal manner. These structures named above are introduced 
as follows: 
       1. Filopodia. Filopodia are growth-cone like the protrusions found commonly 
in some types of fibroblasts. They contain long, bundled actin filaments, 
similar to those in microvilli but longer, thinner, and more dynamic (Albert, 
1994; Pollard and Borisy, 2003; Raftopoulou and Hall, 2004).  
   2. Lamellipodia. Lamellipodia are more likely to be present in epithelial cells, 
although fibroblasts and some neurons may also use similar structures to 
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migrate. Unlike filopodia, lamellipodia are complicated by consisting of 
two-dimensional, sheet-like structures. They contain a dense, branched 
“dendritic” mesh network of actin filaments, lying on a plane parallel to the 
solid substratum. The geometry of lamellipodia makes it convenient to 
observe under the phase contrast light microscope. Thus, people know 
more about the dynamic organization and protrusion mechanism of 
lamellipodia than that of filopodia and pseudopodia (Albert, 1994; Pollard 
and Borisy, 2003; Raftopoulou and Hall, 2004). 
   3. Pseudopodia. Pseudopodia are stubby three-dimensional projections filled 
with an actin-filament gel. They can be found in amoebae and neutrophils 
(Albert, 1994; Pollard and Borisy, 2003; Raftopoulou and Hall, 2004).  
      Since lamellipodia is the most simplistic machinery that is required for cell 
motility, I here use them as an example to illustrate how actin undergoes 
polymerization during cell migration. 
      Actin filaments are double helical polymers of globular subunits that are 
assembled from head-to-tail to endow the filament a molecular polarity (Pollard 
and Borisy, 2003). According to the arrowhead pattern heralded by decoration 
with myosin (also see Figure 1.3), one end is called the barbed end and another 
is called the pointed end. This polarity is the core mechanism driving actin 
assembly in cells. The barbed end usually points outward towards the plasma 
membrane (Green in Figure 1.3). It is strongly oriented to favor the elongation of 
the actin filaments (Small et al., 1978). For example, when the permeabilized 
cells were fed with fluorescent dye-tagged actin, actin was found to be added to  
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Figure 1.3   Key factors participating in actin polymerization 
 
1. Extracellular stimuli activate receptors. 2. The correspondent signal 
transduction pathways activate small Rho GTPases and PIP2. 3. Activate 
WASp/Scar proteins. 4. WASp/Scar proteins recruit Arp2/3 complex and an actin 
monomer to the side of a preexisting filament to initiate a new branch. 5. Rapid 
growth at the dendritic barbed end of the new branch. 6. pushes the membrane 
outward and forms membrane protrusion and lamellipodia. 7. Capping proteins 
shut down growth within seconds. 8. Filaments aged by hydrolysis of ATP-actin 
subunit followed by dissociation of the γ phosphate (green circle turn white). 9. 
Dephosphorylated / activated ADF/cofilin induces phosphate dissociation and 
promotes disassembly of ADP-actin from pointed filament ends (during steady-
state protrusion when G-actins are depleted). Dephosphorylated / activated 
ADF/Cofilin can also sever ADP-actin filaments (during stimulated protrusion and 
lamellipodia formation when G-actins become abundant). 10. Profilin catalyzes 
the exchange of ADP for ATP (turning the white circles subunits green again), 
11. The recycling pool of ATP-actin bound to profilin can return to where 
membrane protrusion and the actin dendritic mesh network locate, ready to 
generate more barbed ends. 12. Small Rho GTPases also activate PAK and LIM 
kinase. Once LIM kinase has been acti-vated, it phosphorylates and inactivates 
ADF/cofilin. Phosphorylation or inacti-vation of ADF/cofilin slow down the 
turnover of the filaments and actin tread-milling. Modified with permission. Pollard 
TD, and Borisy GG, 2003, Cellular Motility Driven by Assembly and Disassembly 
of Actin Filaments: Cell, v. 112, no. 4, p. 453-465. 
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the barbed ends at the leading edge of the lamellum (Symons and Mitchison, 
1991; Chan et al., 2000; Pollard and Borisy, 2003). In steady state, ATP-actin 
associates at the barbed end as ADP-actin dissociates from the pointed end, 
resulting in very slow recycling and treadmilling of actin from the barbed end to 
the pointed end, which can be captured directly by fluorescence time-lapse 
microscopy (Fujiwara et al., 2002). However, in highly motile state, actin 
treadmilling at the leading edge turns faster. During the actin treadmilling, ATP  
hydrolysis in the filament also plays an essential role to maintain this process 
(Pollard and Borisy, 2003). 
      A series of questions regarding the actin cytoskeleton rearrangement during 
cell migration remains unanswered: how does the growth of actin filaments turn 
faster when cells switch from steady state to highly motile state? How is the de 
novo actin polymerization initiated and terminated? How do actin filaments form 
dendritic mesh network to push forward the membrane at the leading edge? How 
are ATP- and ADP- bound actin monomers in the barbed end and pointed end of 
the actin filament network recycled? How do environmental and internal signals 
closely govern these reactions?  
      Answers to these questions are assessed by a theory called the dendritic 
nucleation/array treadmilling (Pollard and Borisy, 2003) (Figure 1.3). In short, 
cells contain a pool of unpolymerized actin monomers bound to groups of protein 
including profilin (Vinson et al., 1998; Kaiser et al., 1999) and thymosin-β4 (Safer 
and Nachmias, 1994; De La Cruz et al., 2000). De novo actin polymerization will 
be initiated when extracellular stimuli turn on signaling pathways and sequentially 
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activate nucleation-promoting factors, primarily the WASp/Scar family of proteins 
(Takenawa and Miki, 2001; Weaver et al., 2003).  
      WASp was named after the first patient with human bleeding disorder and 
immunodeficiency, called Wiskott - Aldrich syndrome.  A mutation of the WASp 
gene has been identified as the cause of this syndrome (Rengan et al., 2000).      
      Soon after the activation of nucleation-promoting factors, Arp2/3 complex 
becomes then activated to initiate de novo polymerization of a actin filament that 
forms a branch on the side of a previously existing filament (Machesky et al., 
1994; Mullins et al., 1998) (thorough discussion of Arp2/3 can be found in section 
1.3). Fed by actin-profilin from the abundant subunit pool, newly synthesized 
branches grow rapidly and push the plasma membrane outward (Sagot et al., 
2002). The elongation of the newly synthesized actin filament is transient, as the 
capping proteins terminate growth (Cooper and Schafer, 2000). Actin subunits in 
this new dendritic network hydrolyze their bound ATP rapidly but dissociate the γ-
phosphate slowly. Dissociation of γ-phosphate triggers disassembly reactions, 
accompanying with debranching and binding of ADF/cofilin (Pollard and Borisy, 
2003).  
      Cofilin then promotes the severing and dissociation of ADP-subunits from the 
pointed ends (Pollard and Borisy, 2003) (Detailes discussion of Cofilin can be 
found in section 1.3). Profilin functions as the nucleotide exchange factor for 
actin. It catalyzes the transition of ADP-actin into ATP-actin and the recycling of 
subunits to the ATP-actin-profilin pool (Vinson et al., 1998; Kaiser et al., 1999), 
thus ready for the next round of assembly. Beside dissembling and recycling 
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actin from the pointed end during steady state movement, ADF/cofilins may also 
contribute to initiate protrusions by severing filaments to expose barbed ends for 
elongation (Zebda et al., 2000; Ghosh et al., 2004). In this case, an individual 
actin filament does not treadmill in the way of simultaneous elongating at one 
end and shortening at another. A new filament is synthesized at a branch point 
and grows towards its barbed end while its pointed end is capped at the branch;  
the filament becomes capped at its barbed end, debranches and shortens after  
being severed by cofilin (Pollard and Borisy, 2003). Thus, the actin filament 
bundle are recycling and reproducing themselves at the leading edge as a whole. 
However, actin treadmills dismantle themselves and these dismantling processes 
keep some distance from the very leading edge in the front (Figure 1.3). 
 
1.3.2   Steps in cell migration and signals that govern those steps  
   Directed cell movement is depended upon the rearrangement of cytoskeletal 
filament throughout the cytoplasm (Elson, 1988; Raftopoulou and Hall, 2004).The 
cytoskeleton consists of three distinct types of protein filaments: Actin filaments 
(Pollard and Borisy, 2003), microtubules (Watanabe et al., 2005) and 
intermediate filaments (Goldman et al., 1996). 
   Cell migration requires a highly well organized and cyclical program starting 
from transient local signaling events to initiate polarization and ending with rear 
retraction (Figure 1.4) ( Horwitz and Parsons, 1999; Parent and Devreotes, 1999; 
Horwitz and Webb, 2003; Ridley et al., 2003; Van Haastert and Devreotes, 2004;  
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Figure 1.4   Cell migration steps 
 
Cell migration can be divided into three sequential steps: A. Polarity is intrinsic to 
a migrating cell. Cdc42, as well as Par proteins and aPKC, participate in the 
initiation of polarity. Those proteins synergize to promote directed vesicle 
trafficking, such as translocation of Golgi apparatus towards the front of the 
nucleus and toward the leading edge, re-organization of microtubules , and the 
formation of the MTOC. In the presence of chemotactic agents, PIP3 start to 
accumulate at the leading edge as the result of the localized PI3K activation. 
PTEN, a PIP3 phosphatase localized to the cell margins and rear, restrict 
protrusions to the front along with mysosin II. B. Protrusion heralds the start of 
cell migration. Sequential activation of Rac and Cdc42, their down-stream 
effectors WASP/WAVE proteins, and then Arp2/3 promote the formation of actin 
branches on pre-existing actin filaments.  In the combination effect of profilin 
(control the availability of activated actin monomers), ADF/cofilin (de-branching, 
depolymerizing and severing proteins), and capping protein, promote actin 
polymerization and thus actin treadmilling. Protrusions are stabilized by the new 
adhesions formation. Integrin activation and clustering is pivotal for nascent 
adhesions. Talin binding and PKC-, Rap1-, and PI3K-mediated pathways 
activate integrins. Rac participates in Integrin clustering. C. Rear retraction and 
detachment are mediated by Src/FAK/ERK, Rho, myosin II, calcium, calcineurin, 
calpain, microtubules. Modified with permission. Ridley AJ, Schwartz MA, 
Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, and Horwitz AR, 
2003, Cell Migration: Integrating Signals from Front to Back: Science, v. 302, no. 
5651, p. 1704-1709. 
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Vicente-Manzanares et al., 2005).  Cell migration consists of several key steps 
as follows: 
   1. Polarization. When a non-migrating cell encounters chemotactic 
molecules, its cell body will transform into two distinct portions: the “front” 
portion, ie., the forward moving portion, and the”back” portion, ie., the 
retracting rear portion localizes. Small Rho GTPases family member 
Cdc42 (Stowers et al., 1995; Wedlich-Soldner et al., 2003; Watanabe et 
al., 2004; Etienne-Manneville et al., 2005), PAR proteins (PAR3 and  
PAR6) (Nagai-Tamai et al., 2002; Suzuki et al., 2002; Macara, 2004; 
Suzuki et al., 2004; Gerard et al., 2007; Totong et al., 2007), and atypical 
protein kinase C (aPKC) (Suzuki et al., 2002; Suzuki et al., 2004) are 
participating in polarization. After polarization has occurred, multiple 
overlapping signaling pathways from small RhoGTPases, PI3K, integrin,  
microtubules and vesicular transport will maintain the stability of the 
polarization.  
   2. Protrusion. Protrusion heralds the actual beginning of the migration cycle. 
The cardinal event during the formation of protrusion is the actin 
polymerization  (Pollard and Borisy, 2003). The actin cytoskeleton 
undergoes polarization, forms barbed ends and pointed ends under the 
induction of ARP2/3 complex, and thus drives the actin treadmilling and 
membrane protrusion (Bailly et al., 1999). Protrusions can be present in 
the forms of either filopodia (spike –like) or lamellipodia (large and broad). 
They provide the direction of cell migration (Pollard and Borisy, 2003). 
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Several proteins are proposed to regulate the fast-turnover actin 
cytoskeletal rearrangement. They include the following: ADF/cofilin (Kiuchi 
et al., 2007), capping proteins (Eddy et al., 1997; Miyoshi et al., 2006), 
profilin (Didry et al., 1998; Gutsche-Perelroizen et al., 1999; Blanchoin et 
al., 2000a; Battersby et al., 2004), dendritic network stabilizers within 
lamellipodia such as α-actinin (Laukaitis et al., 2001), cortactin (Weed et 
al., 2000), and filamin A (Hou et al., 1990; Flanagan et al., 2001). Cofilin 
can sever actin filaments, promote the dissociation of actin, generate more 
barbed ends for dendritic actin mesh network formation, increase actin 
turnover rate, and promote lamellipodia formation in conjunction with 
ARP2/3 complex (Svitkina and Borisy, 1999).  
   3. Traction. At this stage, the newly formed adhesions at the leading edge of 
a migrating cell are stabilized by the recycling of the integrin from the rear 
end to the front end (Pollard and Borisy, 2003; Caswell and Norman, 
2006). 
   4. Retraction. Rear retraction of the cell is the hallmark of finishing the 
migration cycle and cell translocation. During retraction, myosin II plays a 
pivotal role ( Uchida et al., 2003; Wylie and Chantler, 2003).  
 
1.3.3   Small RhoGTPases and their role in actin cytoskeleton 
rearrangement and cell migration   
      Small Rho GTPases are ubiquitously expressed in various species. So far, 
20 members have been found in mammals. Members 7, 5 and 15 were 
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uncovered in Drosophila melanogaster, Caenorhabditis elegans and 
Dictyostelium discoideum respectively (Schultz et al., 1998).  
      During cell migration, small Rho GTPases play a central role as the major 
molecular switch (Burridge and Wennerberg, 2004). They are typically activated 
by upstream signaling mechanisms such as integrin (Hood and Cheresh, 2002) 
and EGF (Ridley and Hall, 1992; Ridley et al., 1992; Nobes et al., 1995; Malliri et 
al., 1998). Rho GTPases switch the on and off downstream signal transduction 
pathways by cycling between a GDP-bound, inactivated form and a GTP-bound, 
activated form (Raftopoulou and Hall, 2004). This transition is tightly regulated by 
guanine exchange factors (GEFs), GTPase activating proteins (GAPs) and 
guanine dissociation inhibitors (GDIs) (Raftopoulou and Hall, 2004). In their GTP-
bound activated state, Rho GTPases bind and activate downstream targets 
(effectors) such as kinases and scaffold proteins. Then they trigger a series of 
intracellular responses to regulate actin dynamics, cell migration and invasion 
(Figure 1.4).  
      These small Rho GTPases coordinate with each other and play very 
distinctive but well cooperative roles to propel cell migration. For example, RhoA 
regulates the assembly of contractile and actin filament-myosin crosslinking, 
while Rac and Cdc42 promotes actin polymerization and dendritic mesh network 
to form peripheral lamellipodia and filopodia, respectively (Hood and Cheresh, 
2002; Ridley et al., 2003; Burridge and Wennerberg, 2004; Raftopoulou and Hall, 
2004). Moreover, all three GTPases also induce inside-out signaling to promote 
the assembly of integrin-based, matrix adhesion complexes (Ridley and Hall, 
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1992; Ridley et al., 1992; Nobes et al., 1995). Based on such a broad spectrum 
of functions, it is not surprising that these three regulatory proteins play such 
pivotal roles in controlling cell migration. Beside actin cytoskeleton 
rearrangement, Rho GTPases are also implicated in a variety of other 
biochemical processes, ranging from cell polarity, microtubule assembly to gene 
transcription. Most notably, Cdc42 is required for the establishment of cell 
polarity, while all three can, in distinct ways, affect the microtubule cytoskeleton 
and gene transcription (Etienne and Hall, 2002; Hood and Cheresh, 2002; Ridley  
et al., 2003; Burridge and Wennerberg, 2004; Raftopoulou and Hall, 2004). The 
functions of each Rho GTPases are listed as follows for further discussion (See 
also Figure 1.5). 
 
1.3.3.1 Upstream of Rho GTPases  
      The p130Cas/CrkII/DOCK180 pathway, as illustrated in Figure 1.5, the 
SH2/SH3 domain-containing adaptor protein Crk (Hasegawa et al., 1996; Buday 
et al., 2002) interacts with another adaptor molecule p130Cas. The presence of 
Crk/p130Cas complex activates Rac. Crk/p130Cas complex serves as a 
“molecular switch” to promote cell migration (Figure 1.5) (Klemke et al., 1998). 
DOCK180 is a downstream component of integrin signaling (Hood and Cheresh, 
2002). DOCK180 was originally portrayed as a binding partner of CrK. 
Expression of DOCK180 can enhance further p130Cas/Crk/Rac-induced cell 
migration (Cheresh et al., 1999). The mechanism of how p130Cas/Crk/DOCK180 
complex activates Rac might be as follows: DOCK180/ELMO recruits a DH- 
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Figure 1.5   Small RhoGTPases, their upstream regulators and downstream 
effectors, and their roles in actin cytoskeleton rearrangement and cell 
migration 
 
Small RhoGTPases, like Rac, can be activated by conjugation of integrin and its 
ECM ligand. After integrin activation, GEF DOCK180 form complex with CrKII 
and p130CAS and thus activates Rac. PI3-K also activates Rac. Once Rho 
GTPases are activated, they will execute distinct but well coordinated tasks to 
promote cytoskeletal rearrangement and thus cell migration. Rac and cdc42 
promote lamellipodia / new adhesion formation and filopodia / polarization 
formation respectively. Two important effectors have been identified downstream 
of Rac and cdc42. 1) Ser/Thr kinase p65PAK activates Arp2/3 and plays an 
important role in regulating actin dynamics to form lamellipodia. 2). WASp/SCAR/ 
WAVE family of scaffold proteins. Once they are activated, each of these 
proteins is able to activate the Arp2/3 complex, which in turns promotes actin 
polymerization either de novo or at the barbed end or sides of preexisting 
filaments. In this way, the dendritic morphology of lamellipodia (by Rac1) or 
filopodia (by Cdc42) is generated. Under the similar mechanism, cdc42 also 
promotes cell polarization. Rho promotes focal adhesion formation, cell body 
contraction and rear end retraction. 1) In leukocytes and macrophages, Rho 
stimulates actin-myosin filament crosslinking and in turn contractility through 
Ser/Thr kinase p160ROCK. Rock inhibits MLC phosphatase, which in turn allows 
MLC to remain phosphorylated. The overall effect is to activate MLC and induce 
actin-myosin crosslinking and thus rear contraction and tension. 2) p160ROCK, 
like p65PAK, can phosphorylate and activate LIMK, which in turn phosphorylates 
and inactivates cofilin. Cofilin temporarily lose its function to sever actin 
filaments, resulting in stabilization of actin filaments within actin:myosin filament 
bundles, as well as favoring focal adhesion formation and maintenance. Solid 
arrows symbolize direct activating signals. Modified with permission. Raftopoulou 
M, and Hall A, 2004, Cell migration: Rho GTPases lead the way: Developmental 
Biology, v. 265, no. 1, p. 23-32. 
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1.3.3.1 Upstream of Rho GTPases  
      The p130Cas/CrkII/DOCK180 pathway, as illustrated in Figure 1.5, the 
SH2/SH3 domain-containing adaptor protein Crk (Hasegawa et al., 1996; Buday 
et al., 2002) interacts with another adaptor molecule p130Cas. The presence of  
Crk/p130Cas complex activates Rac. Crk/p130Cas complex serves as a 
“molecular switch” to promote cell migration (Figure 1.5) (Klemke et al., 1998). 
DOCK180 is a downstream component of integrin signaling (Hood and Cheresh, 
2002). DOCK180 was originally portrayed as a binding partner of CrK. 
Expression of DOCK180 can enhance further p130Cas/Crk/Rac-induced cell 
migration (Cheresh et al., 1999). The mechanism of how p130Cas/Crk/DOCK180 
complex activates Rac might be as follows: DOCK180/ELMO recruits a DH- 
containing GEF to the complex, which in turn activates Rac by adding GTP 
(Raftopoulou and Hall, 2004). In lymphocytes, Vav might function as a GEF since 
it is associated with DOCK2. Other GEFs might still exist, because the blocking 
of Vav activity by dominant negative Vav is not sufficient to block activation of 
Rac by DOCK2 (Nishihara et al., 2002).  
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containing GEF to the complex, which in turn activates Rac by adding GTP 
(Raftopoulou and Hall, 2004). In lymphocytes, Vav might function as a GEF since 
it is associated with DOCK2. Other GEFs might still exist, because the blocking 
of Vav activity by dominant negative Vav is not sufficient to block activation of 
Rac by DOCK2 (Nishihara et al., 2002).  
 
 1.3.3.2 Rac signaling: lamellipodia and new adhesion in the front  
 
1.3.3.2.1 Rac1 promote actin polymerization, lamellipodia formation and cell 
migration  
      As a major downstream target of integrin and growth factor signaling 
pathways, Rac promotes actin polymerization in the leading edge to form 
membrane protrusion, lamellipodia (Nobes and Hall, 1995; Etienne and Hall, 
2002; Hood and Cheresh, 2002; Ridley et al., 2003; Burridge and Wennerberg, 
2004; Raftopoulou and Hall, 2004), and cell adhesion (Souza-Schorey et al., 
1998; Burridge and Wennerberg, 2004).  
      How does Rac promote membrane protrusion and lamellipodia formation? 
Expression of the constitutively activated Rac induces membrane ruffling. 
Furthermore, suppression of Rac activity by expressing a dominant-negative 
form of Rac, N17Rac1, impairs the ruffle formation induced by growth factors 
(Ridley et al., 1992). It is worthwhile to mention here that membrane ruffles 
closely resemble lamellipodia, and those terms are interchangeably used 
(Burridge and Wennerberg, 2004). Frequently, lamellipodia can develop into 
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membrane ruffles, especially when these membrane protrusions can’t attach to 
the matrix and thus flip backward on the dorsal surface (Burridge and 
Wennerberg, 2004). On the other hands, membrane ruffles can be induced de 
novo from the dorsal surfaces of cells. However, membrane protrusion may be 
related more to macropinocytosis than cell migration (Burridge and Wennerberg, 
2004), as the activated Rac promotes the accumulation of  large vesicles that 
contain the engulfed materials from the extracellular environment (Ridley et al., 
1992). Interestingly, macropinocytosis is also found when the activated Ras is 
introduced into cells (Bar-Sagi and Feramisco, 1986), and this Ras-induced 
membrane ruffling can be inhibited by the dominant-negative Rac (Ridley et al., 
1992; Burridge and Wennerberg, 2004). 
      Unlike the controversial role of RhoA in actin polymerization, Rac is a robust 
actin polymerization activator. Although Rac1 can activate PI 5-kinase and this 
suggests that Rac1 promotes actin polymerization by activating the uncapping 
process of actin filaments, through lipids such as PIP2 (Tolias et al., 1995). 
Arp2/3 complex, the potent actin nucleater and polymerizer, turns out to be a 
more prominent in inducing barbed ends and dendritic actin mesh network at the 
leading edge of lamellipodia. What is the linkage between Rac and Arp2/3? Does 
Rac directly or indirectly regulate actin polymerization? Why does the regulation 
of Arp2/3 by Rac1 play such an exceptionally important role in the formation of 
lamellipodia and cell migration?  
      First, WAVE/Scar protein bridges between Rac and Arp2/3 (Figure 1.5). 
WAVE/Scar protein belongs to the WASP family (Machesky and Insall, 1998; 
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Miki et al., 1998). Unlike Cdc42, which binds WASP and N-WASP and induces a 
conformational change that sequentially activates downstream effectors such as 
Arp2/3 to nucleate actin polymerization, Rac does not interact directly with the 
WAVE/Scar proteins. Instead, Rac can activate Arp2/3 through WAVE/Scar by 
two different and indirect ways, by IRSp53 (Miki et al., 2000), or alternatively by 
Rac binding proteins Nap125, PIR121, and probably HSPC300 and Abi2 (Eden 
et al., 2002). However, IRSp53 has later been found to preferentially bind Cdc42 
over Rac, indicating that IRSp53 may be the downstream of Cdc42 activation ( 
Govind et al., 2001; Krugmann et al., 2001). As for Nap125 and PIR121, along 
with HSPC300 and Abi2, they bind WAVE and restrict its activity during the 
steady state. Once activated, Rac will induce the dissociation of Nap125, 
PIR121, and Abi2 from WAVE and HSPC300, the release of WAVE to stimulate 
the actin polymerization activity of Arp2/3 (Eden et al., 2002). Interestingly, 
another adaptor protein, Nck, also binds Nap125, which similarly frees WAVE. 
Both Rac and Nck are the downstream effectors of a variety of receptors and 
provide an alternative or synergistic role in mediating extracellular signals to actin 
polymerization and cytoskeletal rearrangement (Burridge and Wennerberg, 
2004).   
      Another downstream effector of Rac that is related to cytoskeletal 
rearrangements and membrane ruffling is PAK. Both Rac and Cdc42 activate 
PAK. It then can promote lamellipodia formation (Sells et al., 1997) and disrupt 
stress fibers and focal adhesions (Manser et al., 1997).  Although the 
mutagenesis study of PAK shows that the direct binding and activation of PAK to 
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Rac or Cdc42 might not be required for its functions in promoting lamellipodia 
formation, such a physical binding and activation are indispensable for 
attenuating the formations of stress fiber and focal adhesion (Manser et al., 
1997). Besides this, PAK also affects polarization (Sells et al., 1999). PAK also 
binds to several other substrates or binding partners other than Rac, such as the 
actin binding protein filamin, LIM kinase, myosin, the paxillin/Pix/PKL complex, 
and the adaptor protein Nck (Figure 1.5) (Burridge and Wennerberg, 2004). 
      Filamin is the major actin binding protein and a substrate for PAK (Vadlamudi 
et al., 2002).  Filamin is enriched in the cell cortex where F actin is concentrated, 
especially in membrane ruffles. Filamin is essential for the growth factor- or PAK- 
induced membrane ruffling. The binding of filamin to PAK activates PAK. Filamin 
promotes lamellipodia and ruffle formation by crosslinking F actin and stabilizing 
the actin networks underneath the membrane of protrusions. Moreover, filamin 
also serves as a scaffold for PAK and other signaling proteins (Stossel et al., 
2001). Finally, filamin also binds either GTP- or GDP- loaded forms of Rho, Rac, 
and Cdc42 (Ohta et al., 1999). Since filamin is enriched in the actin cortex and is 
important for lamellipodia formation, the binding to small Rho GTPases may 
regulate the differential localization of Rac and Rho to the leading edge or rear 
contractile region (Burridge and Wennerberg, 2004). 
      As another downstream target of Pak, LIM kinase can be phosphorylated and 
activated by both PAK (Edwards and Gill, 1999; Edwards et al., 1999) and Rho-
kinase (Maekawa et al., 1999). In turn, LIM kinase phosphorylates and 
inactivates cofilin, which promotes depolymerization of F-actin (Blanchoin et al., 
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2000b; Burridge and Wennerberg, 2004). The net effect of PAK-LIM kinase 
activation is to stabilize actin filaments and filament bundles. This is somewhat 
paradoxical, as the stabilization of F-actin may slow down the turnover rate of 
actin filaments, which will to some extent impede the formation of lamellipodia or 
ruffles. During cell migration, lamellipodia formation demands active cofilin and 
rapid actin recycling between polymer and monomer to sustain the actin 
treadmilling (Figure 1.3 and 1.6) (Blanchoin et al., 2000a; Zebda et al., 2000). 
How to explain such a discrepancy? One possible explanation would be that 
cofilin activation and inactivation are under elegant spatial or temporal control. 
During the cell migration, active cofilin was found to be more concentrated at the 
leading edge to promote actin polymerization, in cooperation with Arp2/3 
complex. In contrast to the active cofilin, inactive cofilin, i.e, the one 
phosphorylated by PAK-LIM kinase may concentrate further back from the 
leading edge of lamellipodia (Burridge and Wennerberg, 2004). This subtle 
difference may allow active cofilin to promote polymerization, synergizing with the 
Arp2/3 complex at the leading edge of lamellipodia, while simultaneously the 
inactive cofilin distributes further back in the body of the lamellipodium or ruffle, 
leading to stabilization of the newly formed actin filaments in the dendritic actin 
mesh network (Burridge and Wennerberg, 2004). Furthermore, the stage of the 
cell (with or without stimulation) may also need to be included into the 
consideration. During the steady state, the need of cofilin activation at the leading 
edge is relatively low and cells may only form new actin branches by the effort of 
Arp2/3. The actin bundles are relatively stabilized under this state. However, 
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once the cell turns to the active migratory stage, the demand for active cofilin 
rises dramatically as the newly formed barbed end, actin mesh network and actin 
treadmilling will do the following: 1. Consume lots of actin monomers, which are 
generated from depolymerization of F actin by active cofilin. 2. Form new barbed 
ends severed by active cofilin to develop into dendritic mesh network and 
consequently lamellipodia (DesMarais et al., 2005).  
      The association of PAK with the Pkl/paxillin/Pix complex potentially has 
multiple effects on downstream signals. Pkl is an Arf GAP, therefore implicating a 
convergent point between Rac and Arf GTPases signaling (Burridge and 
Wennerberg, 2004). Pix is a Rac and Cdc42 GEF (Turner et al., 2001). The 
interaction of a downstream Rac effector with an upstream Rac regulator strongly 
suggests at the existance of signaling feedback loops. The pairing of 
downstream effectors with the same GEF also implies that a specific GEF may 
preferentially activate one out of the possible downstream pathways (Burridge 
and Wennerberg, 2004).  
      Another possibility for PAK to promote actin polymerization is that the adaptor 
protein Nck can recruit PAK receptor tyrosine kinases and may participate in the 
activation of both WASP and WAVE/Scar and actin polymerization (Bokoch, 
2003). As a consequence, Rac1 promotes cell migration (Hood and Cheresh, 
2002; Ridley et al., 2003; Burridge and Wennerberg, 2004; Raftopoulou and Hall, 
2004). 
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1.3.3.2.2 Rac1 promotes adhesion formation 
      Other than stimulating lamellipodia formation and cell migration, Rac1 also 
promotes cell adhesion (Burridge and Wennerberg, 2004). In lymphocytes, 
activated Rac promotes adhesion, probably through enhancing cell spreading, 
actin cytoskeleton reorganization, and inside-out signaling to the clustered 
integrin that engage with ECM (Souza-Schorey et al., 1998). Cofilin inactivation 
by Rac activation is essential for integrin mediated adhesion (Toshima et al., 
2001; Marcoux and Vuori, 2005). Other actin severing proteins such as gelsolin, 
are also the downstream effectors of Rac-phospholipase C-calcium signaling 
pathway to sever actin filaments (Snyder et al., 2003).  
      In addition to promoting adhesion, Rac1 also controlls focal adhesion 
formation within the new adhesions through the local inside-out activation of 
integrins (Kiosses et al., 2001). Active Rac may inhibit cofilin activation through 
PAK-LIM kinase pathway, to stabilize the stress fiber where focal adhesions are 
developing (Burridge and Wennerberg, 2004). Recently, this has been confirmed 
by the study using Rac1 knock out animal (Guo et al., 2006). However, Rac also 
perturbs stress fiber and focal adhesion formation via activating PAK and 
antagonizing Rho activity (Sander et al., 1999), resulting into inhibition of myosin 
light chain kinase (MLCK) activity and less MLC phosphorylation (Sander et al., 
1999).  How to explain this discrepancy? The answer may reside in the temporal 
and spatial regulation of distribution of Rac and Rho, respectively (Xu et al., 
2003). Within a cell, Rac activity dominates tje behavior at the front, while Rho 
activity is more prominent at the rear. The antagonism between Rac and Rho 
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signaling pathways determines the migration direction of the cell in response to 
chemotactic signals. The activities of Rho and myosin at the rear inhibit 
protrusive activity in this region and confine the protrusion to the front of the 
migratory cell ( Worthylake and Burridge, 2003; Xu et al., 2003) 
      Moreover, a recent study has indicated that Rac1 might also regulate the 
genomic stability and senescence (Debidda et al., 2006). 
 
1.3.3.3 RhoA signaling: stress fibers, tension and contractile at the rear 
      RhoA strengthens the formations of focal adhesions and stress fibers (Nobes 
and Hall, 1995; Etienne and Hall, 2002; Hood and Cheresh, 2002; Ridley et al., 
2003; Burridge and Wennerberg, 2004; Raftopoulou and Hall, 2004). It also 
regulates rear contraction (Nobes and Hall, 1995; Machesky and Hall, 1997; 
Etienne and Hall, 2002; Hood and Cheresh, 2002; Ridley et al., 2003; Burridge 
and Wennerberg, 2004; Raftopoulou and Hall, 2004).  
      Rho promotes actin nucleation, polymerization, and stress fibers formation in 
focal adhesions (Ridley and Hall, 1992), probably through activating of myosin 
light chain (MLC) by phosphorylation (Chrzanowska-Wodnicka and Burridge, 
1996). Situating in between Rho and MLC phosphatase is Rho-kinase (ROCK, 
ROK), a downstream Rho effector. ROCK increases MLC phosphorylation by 
inhibiting the MLC phosphatase (Kimura et al., 1996). Rho-kinase can also 
directly phosphorylate MLC and thereby activate myosin (Amano et al., 1996) 
(Figure 1.5). The important relationships among MLC, contractile tension, and 
stress fiber / focal adhesion formation are as follows: in a single cell in which 
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myosin activity was inhibited, applying extrinsically mechanical force to this single 
cell could mimic an increasing intrinsic tension, promoting the assembly of stress 
fibers and focal adhesions (Riveline et al., 2001). 
      Taken together, Rho drives the formation of stress fibers and focal 
adhesions, promotes myosin contractility, and thereby raises contractile tension 
(Nobes and Hall, 1995; Machesky and Hall, 1997; Etienne and Hall, 2002; Hood 
and Cheresh, 2002; Ridley et al., 2003; Burridge and Wennerberg, 2004; 
Raftopoulou and Hall, 2004) (Figure 1.5).  
      The next interesting question would be this: is Rho-induced actin 
polymerization relevant to stress fiber development? Surprisingly, the level of 
actin polymerization in response to Rho activation was relatively modiocre 
(Machesky and Hall, 1997). On the other hand, constitutively active form of Rho-
kinase induced robust stellate-like stress fibers. Unlike the stress fibers induced 
by active Rho, those ROCK-induced stellate-like stress fibers are much thicker 
(Watanabe et al., 1999).  
      Interestingly, activated mammalian homolog of diaphanous (mDia), another 
Rho effector, induces the formations of more stress fibers (Watanabe et al., 
1999) (Figure 1.5). As a member of the formin family proteins, mDia induces 
actin polymerization (Li and Higgs, 2003). However, how this elevated actin 
polymerization is relevant to stress fiber organization has yet to be determined. 
As mentioned above in the external force on cells study, mDia turned out to be 
an important impact factor. In the presence of Rho specific inhibitor C3 
exotransferase, external force cannot stimulate focal adhesion formation. 
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However, overexpression of active mDia, but not ROCK, could rescue this 
phenotype (Riveline et al., 2001).  
      Other targets for Rho relevant to actin cytoskeleton rearrangement (Bishop 
and Hall, 2000) include: 1) Citron kinase, a Rho-kinase like protein, which 
promotes MLC phosphorylation and myosin activation (Madaule et al., 1998; 
Fujiwara et al., 2002). 2) LIM kinase, which phosphorylates and inactivates 
cofilin/ADF, thereby leading to the inhibition of actin depolymerization and 
increasing stability of actin filament arrays including stress fibers and the cortical 
actin ring (Maekawa et al., 1999; Raftopoulou and Hall, 2004), and 3) Adducin, 
which is member of the ERM family. It is a substrate for Rho-kinase and is 
activated by phosphorylation. Once it is phosphorylated, adducin increases its 
affinity to F-actin (Kimura et al., 1998).  
      Surprisingly, when cells lose stress fibers and focal adhesions, such as cell 
rounding up during early mitosis or experimental manipulation, Rho activity is 
higher instead of lower (Ren et al., 1999; Maddox and Burridge, 2003). Based on 
Rho’s role in promoting focal adhesion and stress fiber formation, the rounded 
cells should have decreased Rho activity. Why? The answer may be that the 
presence of high Rho activity would contribute to the disassembly of stress fibers 
and the construction of more rigid cell cortex (Burridge and Wennerberg, 2004). 
The rigid cortex of a rounded cell increases the resistance to mechanical forces 
and protects the cell from damage. This may be important for leukocytes to 
survive and function in the circulation. How can high Rho activity achive this? 
The potential explanations are as follows: 1). High Rho activity promotes 
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phosphorylation and inactivation of cofilin through the ROCK / LIM kinase 
pathway (Figure 1.5);  2) High Rho activity enhances MLC phosphorylation and 
activation;  thereby promote actin-myosin crosslinking, rear contractility, and 
probably cell rounding up (Figure 1.5). On the other hand, decreased Rho activity 
can be observed when cells become adhered to ECM (Ren et al., 1999). The 
declining in Rho activity may facilitate the transition from a rigid cortex to a more 
dynamic actin cortex that allows cell spreading and cell migration (Arthur and 
Burridge, 2001). 
      Besides focal adhesion, Rho also regulates cell adhesion. Rho induces 
integrin clustering to provide firm attachment to the ends of stress fibers in focal 
adhesions (Chrzanowska-Wodnicka and Burridge, 1996). The inhibition of Rho in 
fibroblasts not only abolishes stress fibers, but also decreases adhesion, causing 
the retraction of lamellae and rounding of the cell body (Chrzanowska-Wodnicka 
and Burridge, 1996). Merely inhibiting focal adhesions cannot explain for all 
these effects, because many cells without the structures adhere and spread well 
(Burridge and Wennerberg, 2004). It is possible that the disruption of Rho 
function leads to a collapse of the cortical actin organization (Burridge and 
Wennerberg, 2004).  
      In contrast to fibroblasts, Rho inhibits the integrin clustering within leukocytes, 
which lack both stress fibers and focal adhesions. Inhibition of Rho promotes 
integrin-mediated adhesion (Worthylake et al., 2001). One explanation is that, 
during the resting / suspended state, integrins are distributed evenly on the cell 
surface. Integrin clustering has been inhibited by being tethered to the relatively 
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rigid cortical actin network. Since the stability of the cortical actin is controlled by 
Rho-ROCK-LIM kinase-cofilin pathway, active Rho may contribute to the 
maintaining of a rigid cortical actin network by inhibiting the activation of actin 
filament-severing protein, cofilin (Figure 1.5). Once Rho activity is suppressed, 
cofilin becomes activated. Activated cofilin will sever and depolymerize the 
cortical actin network, and consequently integrins are clustered by binding the 
multivalent ECM ligands or by inside-out signals (Worthylake and Burridge, 
2003).  
 
1.3.3.4 Cdc42 signaling: A master regulator of cell polarity and filopodia 
 
1.3.3.3.1 Cdc42 and cell polarity 
      Cdc42 defines cell polarity in a variety of eukaryotic organisms ranging from 
yeast to humans (Ridley et al., 2003). Despite the fact that those macrophage 
would still be able to move in a Rac-dependent manner, inhibition of Cdc42 in 
macrophage cells impairs their ability to undergo chemotaxis (Ridley, 2001). The 
mechanisms for Cdc42 to control cell polarity are the following:  
   1. Cdc42 regulates the positive feedback loop between Rac and PI (3,4,5) P3 
which is important for initiating neutrophil asymmetry and polarity when 
the external chemotactic gradient is present (Weiner et al., 2002).  
   2. Cdc42 determines where lamellipodia form, thereby regulating the direction 
of polarization (Labrousse et al., 1999; Ridley et al., 2003). Cdc42 is 
activated close to the leading edge of migrating cells (Smirnova et al., 
 56  
1998). Both inhibition and global activation of Cdc42 are able to perturb 
the directionality of migration (Etienne and Hall, 2002).  
   3. Cdc42 regulates the orientation of the microtubule-organizing center 
(MTOC) and Golgi apparatus by positioning them in front of the nucleus 
and toward the leading edge in slowly migrating cells through 
PAR6/PAR3/aPKC/APC pathway (Etienne and Hall, 2002; Rodriguez et 
al., 2003). The polarized migration of many cells is heralded by 
reorganization of the microtubule cytoskeleton and centrosome to form 
MTOC. The orientation of MTOC usually indicates the direction of 
migration. Cdc42-induced MTOC orientation is important for cell migration. 
It directs microtubule growth into the lamella as well as trafficking of Golgi-
derived vesicles to the leading edge along those growing microtubule. 
Those vesicles provide the source of membrane and associated proteins 
required for forward protrusion (Etienne and Hall, 2002; Ma and Chisholm, 
2002; Rodriguez et al., 2003). How does Cdc42 regulate MTOC? In 
astrocytes, PAR6, an effector of Cdc42, forms a complex with PAR3 and 
an atypical protein kinase C (aPKC) and mediates Cdc42 regulated of 
MTOC position (Etienne and Hall, 2003). PAR6/PAR3/aPKC complex 
orients MTOC by local capture of microtubules at the leading edge through 
a protein called APC, which binds tubulin at the ends of microtubules 
(Etienne and Hall, 2002). CLIP170 and IQGAP (Rodriguez et al., 2003) 
and/or the microtubule-based dynein/dynactin motor protein complex 
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(Etienne and Hall, 2003) might also participate in this PAR6/PAR3/aPKC 
complex-APC mediated MTOC formation. 
   4. Cdc42 crosstalks with Rac to promote and control cell polarity through the 
interaction of APC, Asef and other proteins. Interestingly, APC associates 
with Asef, a Rac-specific GEF. This interaction indicates a potential 
crosstalk between Rac and Cdc42 signalings at the leading edge 
(Kawasaki et al., 2000). APC is found to be able to move along 
microtubules, probably via binding to the microtubule-associated protein 
EB1 and the kinesin/KAP3 motor complex (Nakamura et al.2001; 
Gundersen, 2002; Jimbo et al., 2002), supporting the idea that the APC-
Asef interaction is important for polarity formation. The track by which APC 
moves towards the plus ends of microtubules in migrating cells could be 
used to track Asef down to where Rac-dependent actin polymerization is 
taking place ( Bienz, 2002; Jimbo et al., 2002).  
 
1.3.3.3.2 Cdc42 and filopodia  
      Cdc42 induces filopodia formation (Nobes and Hall, 1995; Kozma et al., 
1995), through its binding to its downstream effector WASP and N-WASP 
(Kozma et al., 1995; Nobes and Hall, 1995; Raftopoulou and Hall, 2004) (Figure 
1.5).  
      Another downstream effector of Cdc42 is PAK1. Pak1 activation induced by 
Cdc42 shares a common downstream events with the one to Rac (see above 
Rac section), i.e., activate LIMK and then inactivate cofilin, thereby stabilizing the 
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actin filament (Figure 1.5) (Arber et al., 1998; Edwards et al., 1999; Raftopoulou 
and Hall, 2004). Pak1 also interacts with downstream targets of heterotrimeric 
GTP-binding protein–coupled receptors activated by variety of chemoattractants. 
These interactions underline a positive feedback loop between Cdc42 and PAK1, 
and contribute to the high Cdc42 activity at the leading edge (Li et al., 2003). 
Similarly, integrins also maintain the local Cdc42 activity through this positive 
feedback loops (Etienne and Hall, 2001; Etienne and Hall, 2002; Raftopoulou 
and Hall, 2004). 
 
1.3.3.5 Crosstalk among Rho GTPases 
 
1.3.3.5.1. Cdc42 and Rho can be activated following the Rac activation 
      In serum-starvated fibroblasts, the activation of Rac during membrane ruffling 
usually leads to the formation of stress fibers, which is dependent on another 
member in the same Rho GTPase family, Rho (Ridley and Hall, 1992). This 
strongly indicates that Rac activation might in turn activate Rho. Moreover, 
Cdc42 is also found to be activated by a similar manner after the Rac activation 
(Kozma et al., 1995; Nobes and Hall, 1995).  
 
1.3.3.5.2. RhoA and Rac counteract with each other 
      In contrast to the early observation, activation of Rac could suppress the 
activation of RhoA and vice versa in many cell types (Sander et al., 1999) (Figure 
1.5). How does Rac suppress Rho? 1) Rac could increase the intracellular 
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reactive oxygen species (ROS) levels. Rising ROS inhibits low molecular weight 
protein tyrosine phosphatase (LMW-PTP), thereby in turns stimulates the 
phosphorylation and activation of p190RhoGAP, which inactivates RhoA 
(Nimnual et al., 2003). 2). PAK, a downstream effector of Rac1, induces the loss 
of stress fibers and focal adhesions through either inhibiting MLCK (Sander et al., 
1999) , or directly phosphorylating myosin II heavy chain (Kiosses et al., 1999; 
van Leeuwen et al., 1999).  
 
1.3.3.6 Pathogens, diseases and pharmaceutical compounds that target 
Rho GTPases 
 
1.3.3.6.1 Pathogens modulate Rho GTPases 
      Interestingly, various bacterial pathogens have developed strategies to 
escape from the host cell defense system by regulating Rho GTPases proteins. 
Those strategies include preventing phagocytosis and thus escaping from being 
uptaken and destroyed, and promoting phagocytosis to occupy the 
immunologically inaccessible locations within the host cells (Burridge and 
Wennerberg, 2004). The prototypical agent is the C3 exotransferase from 
Clostridium botulinum. It ADP-ribosylates RhoA and inhibits nucleotide exchange 
catalyzed by GEFs, and in turn immediately inactivates RhoA proteins (Barbieri 
et al., 2002).  
      Other toxins that influence Rho GTPases activity may inactivate or activate 
Rho GTPases: Clostridial toxins A and B glucosylates Rho, Rac, and Cdc42 
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proteins and thus inactivates them (Barbieri et al., 2002). Cytotoxic-necrotizing 
factor (CNF) produced from E. coli activates Rho by deamidation of Gln63 
(Barbieri et al., 2002). This blocks the GAP-activated GTPase activity, resulting in 
the constitutively active RhoA. Salmonella can also activate Rac and Cdc42 by 
injecting SopE and SopE2 proteins into host intestine epithelial cells (Stebbins 
and Galan, 2001). These toxins are such potent GEFs for Rac and Cdc42 that 
they stimulate robust membrane ruffling at the attached sites of bacteria, thereby 
facilitating the phagocytosis of the bacterium (Stebbins and Galan, 2001). After 
entry into host cells, Salmonella immediately starts to secret another protein, 
SptP, to suppress the Rac and Cdc42 activity. Inhibition of active cytoskeletal 
rearrangement by SptP will provide the bacteria more advantage to survive. 
Enteropathic Yersinia also express several proteins that can regulate Rho 
GTPase activity (Finlay and Cossart, 1997; Bliska, 2000; Burridge and 
Wennerberg, 2004).  
 
1.3.3.6.2 Cancer metastasis, Rho GTPases, their inhibitors and modulators 
      As discussed in detail above, one of the consequences of the activation of 
Rho GTPases is the elevated cell migration. For cancer, that means increased 
chance of metastasis. Compounds that inhibit Rho GTPases activity are also 
tested for their obvious clinical cancer metastasis prevention and treatment. One 
of those compounds is Rac1 specific compound, NSC23766 (Gao et al., 2004)., 
NSC23766 was identified based on a structure-based virtual screening of 
compounds that fit into a surface groove of Rac1 known to be important for GEF 
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specification. NSC23766 effectively disrupts the binding of Rac1 with its specific 
GEF, Trio or Tiam1 in a dose-dependent manner, thereby specifically inhibiting 
the Rac1 activation without interfering with other Rho GTPases such as Cdc42 or 
RhoA. In the presence of NSC23766 the Rac1-dependent lamellipodia formation 
will be blocked. It also inhibited Rac1-induced proliferation, anchorage-
independent growth, and invasion (Gao et al., 2004). 
 
1.3.3.7 Major downstream effectors of Small RhoGTPases – Cofilin, an actin 
severing and depolymerizing protein 
      During the cytoskeletal rearrangement, protrusion and cell migration, the 
most important downstream effectors of small Rho GTPases are cofilin and 
Arp2/3 (Figure 1.6).  
      Cofilin is a 19kDa protein that is ubiquitously expressed (Carlier et al., 1997; 
Maciver, 1998; Maciver et al., 1998; Bamburg et al., 1999; Wang et al., 2007). 
Cofilin can be inactivated by the phosphorylation on Ser3 position (Agnew et al., 
1995; Moriyama et al., 1996). Although cofilin binds to both G- and F-actin, it 
preferentially binds to ADP-bound actin subunits and promotes actin monomer 
disassembly from the pointed end of an actin filament. (Carlier et al., 1997; 
Maciver, 1998; Maciver et al., 1998; Bamburg et al., 1999; Wang et al., 2007).  
Thus, Cofilin plays an important role in actin cytoskeletal rearrangement, 
especially during membrane protrusion (Bamburg et al., 1999; Condeelis et al., 
2001; Ono, 2003; Pollard and Borisy, 2003; Wang et al., 2007). Active cofilin can 
also sever actin filaments and in turn generate free actin barbed ends to provide  
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Figure 1.6   Roles of Cofilin during different state protrusion 
 
A. In steady state protrusion formation, such as in keratocytes, a low G-actin 
level limits polymerization. Cofilin functions exclusively as an actin-recycling 
factor by depolymerizing filaments to generate free G-actin. In this state, cofilin 
localizes at the base of the lamellipodium to sustain steady-state actin 
polymerization at the leading edge. Meanwhile, Arp2/3 complex near the cell 
membrane is responsible for dendritic nucleation. (Loisel et al., 1999; Svitkina 
and Borisy, 1999).  B.In contrast, during the stimulated protrusion stage, such as 
in crawling cells like fibroblasts and chemotactic carcinoma cells, cofilin 
synergistically cooperates with Arp2/3 complex. Cofilin seveing is omportant r in 
initiating reassembly of actin filaments and governing the migratory direction 
during this stage (Ghosh et al., 2004) .Cofilin is found enriched within barbed 
ends at the very leading edge, but not at the base of lamellipodia (Chan et al., 
2000). Cofilin itself is sufficient to generate barbed ends, actin polymerization and 
protrusion (Ghosh et al., 2004). Actin polymerization depends on the pre-existing 
G-actin pool and is not necessarily tightly coupled to depolymerization. Cofilin 
also determines the site of activation of the Arp2/3 complex to form protrusion. 
Modified with permission. DesMarais V, Ghosh M, Eddy R, and Condeelis J, 
2005, Cofilin takes the lead: Journal of Cell Science, v. 118, no. 1, p. 19-26. 
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a platform for the later development of the dendritic network beneath the plasma 
membrane (Maciver et al., 1991; Du and Frieden, 1998; Chan et al., 2000;  
Ichetovkin et al., 2002). How does cofilin depolymerize or sever actin filaments?  
The answer is that cofilin bind to F-actin and causes a bend in the actin filament.   
This twist destabilizes the actin-actin interactions and eventually fragments the 
filament (McGough et al., 1997).  The next questions are as following: how are 
cofilin’s functions executed in vivo to contribute to cell motility and its related 
morphology? Is cofilin level positively correlated with the cell motility? In early 
studies, the activation of cofilin was thought to be required for cell motility (Carlier 
et al., 1997; Condeelis et al., 2001).  In supporting this notion, an elevated cofilin 
level or declined phosphorylated cofilin level can be detected within the cells or 
tissues from different species. Elevated total cofilin have been found in variety of 
tumor cell lines, such as highly invasive C6 rat glioblastoma cell line (Gunnersen 
et al., 2000), A549 human lung cancer cells (Keshamouni et al., 2006), and 
human pancreatic cancer cells (Sinha et al., 1999). The decreased level of 
phosphorylated / inactivated cofilin may also be an indicator of upregulated cofilin 
activity. Phosphrylated cofilin level is downregulated in T-cell lymphoma (Jurkat), 
carcinomas from the cervix (HeLa), colon (KM12), liver (HepG2) and kidney 
(COS1) (Nebl et al., 1996; Wang et al., 2007). In clinical tumor samples, the 
increased cofilin expression is detected in  oral squamous-cell carcinoma 
(Turhani et al., 2006), renal cell carcinoma (Unwin et al., 2003), and ovarian 
cancer  using both proteomic and genomic approaches (Martoglio et al., 2000). 
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      However, is cofilin always upregulated in highly motile cells, such as cancer 
cells? The answer is no. In high motility cells such as potent metastatic 
hepatocellular carcinoma (HCC) cells line MHCC97-H (Ding et al., 2004) and 
ovarian surface epithelium (OSE) cells derived from a woman with a  family 
history of ovarian and/or breast cancer and bearing BRCA1 mutation (Smith-
Beckerman et al., 2005), cofilin had been found to be downregulated instead of 
upregulated. If endogenous cofilin levels fluctuate among different cell types 
instead of positively proportional to cell motility, then what would happen if 
Iectopically overexpress cofilin into those cells? Will they have higher motility or 
less? Similar to the controversial effect of endogenous cofilin on cell motility, the 
overexpression of wild-type cofilin can either promote invasion in Melanoma cell 
(Dang et al., 2006),  or inhibit the invasiveness of human lung cancer H1299 cells 
(Lee et al., 2005). 
      Therefore, the expression level and phosphorylation level of cofilin are not 
sufficient to determine the motility and invasion status of cells (Wang et al., 
2007). What are the roles of cofilin in controling the cell motility and cytoskeletal 
rearrangement in vivo?  Without understanding the cofilin pathway in each 
individual situation, it is very hard to predict the consequence by simply altering 
the level of one component of the whole pathway, such as cofilin in those above 
cases. The well-balanced of the activity of cofilin as well as other molecules in 
the cofilin pathway are required for chemotaxis and motility in tumor cells (Wang 
et al., 2007).  
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      What are the cofilin pathways? What factors / molecules control the 
activation, inactivation and translocation of cofilin? The cofilin pathway includes 
several kinases and phosphatases that regulate cofilin phosphorylation, 
dephosphorylation, and / or translocation in response to extracellular stimuli 
(Figures 1.3; 1.6). Those stimuli include epidermal growth factor (EGF) 
(Mouneimne et al., 2004), transforming growth factor-α (TGF α) , stromal cell-
derived factor 1 (SDF1) and heregulin, which are positively correlated with 
cancer metastasis (Wang et al., 2007).  
      Cofilin is regulated in a temporal and spatial manner by the following 
processes:  
   1. Phosphorylation / inactivation. Cofilin can be phosphorylated at the serine 
3 residues by LIM kinase (LIMK1 and LIMK2) (Arber et al., 1998; Yang et 
al., 1998; Dan et al., 2001) and testicular protein kinase 1 (TESK1, 
TESK2) (Rosok et al., 1999; Toshima et al., 2001) . This phosphorylation 
inhibits the binding of cofilin to actin. LIMKs can be either activated by 
p21-activated kinase 1 (PAK1) and Rho-dependent protein kinase 
(ROCK1) (Figure 1.5) (Dan et al., 2001; Bamburg and Wiggan, 2002) 
through phosphorylation, or inhibited by SSH1 through dephosphorylation 
(Soosairajah et al., 2005).  
   2. Dephosphorylation / activation. Dephosphorylation of cofilin at Ser3 is 
achieved by phosphatase types 1, 2A (Ambach et al., 2000), phosphatase 
types 2B (Meberg et al., 1998), slingshot (SSH) (Niwa et al., 2002)  and 
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chronophin phosphatases (Gohla et al., 2005). Dephosphorylation of 
cofilin results in the activation of cofilin and its binding to actin.  
   3. Blockage of the actin-binding capability of cofilin by protein-protein 
interaction.  
 a. Phosphatidylinositol-4,5-bisphosphate (PIP2) binds to cofilin which 
blocks the binding of cofilin to actin (Yonezawa et al., 1990; Yonezawa 
et al., 1991). The binding of PIP2 to cofilin is regulated by 
phospholipase C (PLCγ). PLCγ hydrolyses PIP2 and thus releases 
cofilin to be available to bind to actin (Mouneimne et al., 2004; 
Mouneimne et al., 2006). In non-carcinoma cell type such as platelets 
and fibroblasts, PLCγ promotes the plasma membrane protrusion by 
regulating both F actin severing protein: cofilin and gelsolin (DesMarais 
et al., 2005). Like cofilin, gelsolin also severs actin filaments, but in 
Ca2+- and PIP2- dependent manners (Sun et al., 1999). In contrast to 
cofilin, the actin severing and protrusion formation rates induced by 
gelsolin are a relatively slow (the half life is of actin severing is 15 
minutes after growth factor stimulation) (Allen, 2003). In platelets and 
fibroblasts, gelsolin seems to be important for the generation of barbed 
ends (Azuma et al., 1998; Falet et al., 2002). Other actin or cofilin 
binding proteins such as tropomyosin, cyclase-associated protein, 
gelsolin, and AIP1 may also regulate cofilin’s actin severing function as 
well (DesMarais et al., 2005; Wang et al., 2007).   
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   b. Tropomysosin. The binding of tropomysosin to actin prevents actin 
filaments from being either depolymerized (Bernstein and Bamburg, 
1982) or severed (DesMarais et al., 2002) by cofilin. Within the leading 
edge of lamellipodia of carcinoma cell, tropomyosin is absent wherever 
cofilin and Arp2/3 dominate and actively promote actin polymerization 
(DesMarais et al., 2002).        
c. Cyclase-associated protein (CAP). CAP induces the release of cofilin 
from the cofilin–G-actin heterodimer (Moriyama and Yahara, 2002), 
and in turn stimulates actin depolymerization from the pointed end 
(Moriyama and Yahara, 2002; Balcer et al., 2003). CAP might also 
accelerate actin recycling and thus actin polymerization (Moriyama and 
Yahara, 2002).This may also contribute to the localization of cofilin in 
crawling cells and therefore migration direction (Bertling et al., 2004).  
d. Actin-interacting protein 1 (AIP1). AIP1 binds to cofilin (Aizawa et al., 
1999; Okada et al., 1999; Rodal et al., 1999; Ono, 2003) and this 
binding might stimulate the depolymerization activity of cofilin (Ono, 
2003).  
   4. Intracellular pH. Elevating PH by Na-H exchanger protein potentiates 
cofilin’s actin-severing efficiency (Bernstein et al., 2000; Bamburg and 
Wiggan, 2002; Patel and Barber, 2005; Srivastava et al., 2007).  
      It is worthwhile to discuss subcellular localization of cofilin specifically. The 
reason is that cofilin mediates two relatively controversial processes: barbed-end 
formation and subsequent actin polymerization (Condeelis, 2001) and actin 
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depolymerization (Carlier et al., 1997; Lappalainen and Drubin, 1997). How are 
these two opposing processes balanced during protrusion and cell motility? In 
fact, the role that cofilin plays varies from cell type and functional states of cells 
(DesMarais et al., 2005).  
   1. Cell type. In migrating chick fibroblasts, cofilin promotes depolymerization 
of actin filaments to generate more actin monomers for treadmilling 
(Cramer, 1999);  In neurons, cofilin severs actin filaments to open more 
free barbed ends for dendritic network formation which is an important 
driving force for growth cone motility (Endo et al., 2003).  
   2. Cell migration stages (Figure 1.6). In steady state protrusion formation, 
such as in keratocytes, the low G-actin level limits polymerization. Cofilin 
functions exclusively as an actin-recycling factor by depolymerizing 
filaments to generate free G-actin. Meanwhile, Arp2/3 complex near the 
cell membrane is responsible for the dendritic nucleation (Loisel et al., 
1999; Svitkina and Borisy, 1999). In contrast, during the stimulated 
protrusion stage of crawling cells like fibroblasts and chemotactic 
carcinoma cells (Figure 1.6), cofilin synergistically cooperate with Arp2/3 
complex. The severing activity of cofilin initiates reassembling of actin 
filaments and governs the migratory direction during this stage (Ghosh et 
al., 2004). Cofilin is found to be enriched at barbed ends at the very 
leading edge, but not at the base of lamellipodia (Chan et al., 2000). 
Cofilin itself is sufficient to generate barbed ends to promote actin 
polymerization and protrusion (Ghosh et al., 2004). The two models are 
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not mutually exclusive (Figure 1.6). The transition from stimulated to 
steady protrusion formation state, or vice versa, could happen if cell kept 
moving until G-actin supply become limited to support further 
polymerization. At this point, cofilin-mediated actin depolymerization and 
elevation of actin turn-over rate become critical for further polymerization.  
      Then, what is the difference between these two models? Cofilin defines the 
sites of dendritic nucleation, and in turn cell protrusion, only in the stimulated 
protrusion model (DesMarais et al., 2005; Wang et al., 2007) . 
      In addition to all these functions described above, the cofilin pathway  
contributes to morphogenesis, such as cell polarity in Drosophila (Blair et al., 
2006), and blastocyst positioning and body wall formation (Ono et al., 2003). 
      The final question: why is cofilin enriched at the leading edge of lamellipodia, 
but not at the base of the lamellipodia and other compartments of the cell during 
cell migration? Is cofilin activated in those regions or activated at other locations 
and then undergo translocation into the leading edge? If this is the case, then 
what mechanisms control cofilin translocation after activation?  
      Driven by variety of stimuli, cofilin becomes dephosphorylated or activated, 
then translocated to the plasma membrane (Suzuki et al., 1995; Nagaishi et al., 
1999; Nagata-Ohashi et al., 2004; Verdijk et al., 2004) where it interacts with the 
actin cytoskeleton and promotes actin cortical meshwork formation, actin 
recycling, and consequently lamellipodia formation (Raftopoulou and Hall, 2004). 
Translocation of cofilin to the plasma membrane constitutes a key step for cofilin 
activation (Suzuki et al., 1995; Nagaishi et al., 1999; Nagata-Ohashi et al., 2004; 
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Verdijk et al., 2004). For example, in T leukemia cells and NIH3T3 cells, 
phosphorylated cofilin undergoes the translocation to lamellipodia upon activation 
or dephosphorylation (Verdijk et al., 2004). Still, how cofilin activation couples 
with the translocation to the leading edge of lamellipodia remains largely 
unknown. In fact, the EGF stimulation of invasive mammary tumor cells doesn’t 
always result in either cofilin activation / dephosphorylation or inactivation / 
phosphorylation (Song et al., 2006c), so models of which cofilin activation 
couples with stimuli stimulation (Nishita et al., 2005b) may not always reflect the 
invasion potential in all types of tumors. Thus, one needs to be cautious in 
evaluating models.   
      The next question is this: will the level of dephosphorylated cofilin really 
portray the cofilin activity within the cells? As Ialready mentioned above, there 
are at least four mechanisms to regulate cofilin activity. Simply measuring the 
ratio of dephosphorylated cofilin to the total cofilin may not be an ideal way to 
assess the activity of cofilin in cells. Interestingly, cofilin dephosphorylation is 
uncoupled from the EGF stimulated membrane protrusion (Mouneimne et al., 
2004). In fact, the levels of phosphorylated cofilin in mammary tumor cells 
increase in response to EGF-stimulation (Mouneimne et al., 2004). However, 
EGF can activate PLCγ, which in turn hydrolyzes PIP2, releases cofilin from the 
cofilin-PIP2 complex, and thus activates cofilin (Mouneimne et al., 2004). Shortly 
after the release of cofilin, LIMK1 phosphorylates it and results in a net elevation 
of phosphorylated cofilin level. Although the total inactivated cofilin may increase 
after stimulation, the sharpening asymmetrical distribution of the cofilin activity 
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inside the tumor cell may account for the more active motility (Mouneimne et al., 
2004; Blair et al., 2006; Song et al., 2006b; Wang et al., 2007).  
 
1.4 Novelty of this study 
Overall, cell migration plays roles in a wide variety of pivotal biological 
processes ranging from embryonic development to cancer cells metastasis. 
Elucidating the mechanisms that govern cell migration will not only have a 
tremendous impact on the deciphering of those mystery biological processes, but 
will also lead to the discovery of novel and more effective treatment of many 
common diseases. KAI1/CD82 is a key suppresser of cell migration. So far, how 
KAI1/CD82 regulates cell migration is not clear, especially how KAI1/CD82 
regulates cancer cell migration. Previously, there were several studies on how 
KAI1/CD82 regulates hematopoietic cell morphology and cytoskeletal 
rearrangement (Liu and Zhang, 2006). However, those studies focused on 
suspension cells, which behave quite differently from cells with epithelial origin in 
many aspects, including cell adhesion, cytoskeletal rearrangement and cell 
migration. Instead of inhibiting migration of epithelial and fibroblast cells, 
KAI/CD82 promotes actin cytoskeleton rearrangement and cell migration in 
hematopoietic cells, probably through enhancing co-stimulation of T-cell surface 
receptors TCR (Liu and Zhang, 2006). In this dissertation, I use prostate cancer 
cell lines Du145 and PC3 cells as models to study the role of KAI1/CD82 in 
cytoskeletal rearrangement. I conclude that KAI1/CD82 inhibits cancer cell 
migration through impairing actin cytoskeletal rearrangement. 
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CHAPTER 2.  KAI1/CD82 INHIBIT CANCER CELL MIGRATION THROUGH 
ALTERING MOTILITY RELATED CELL MORPHOLOGY  
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2.1 Introduction 
      Regulation of cell motility is a common feature of many tetraspanins 
(Maecker et al., 1997; Berditchevski, 2001; Boucheix and Rubinstein, 2001 
Hemler, 2001). Although it remains largely unclear how tetraspanins modulate 
cell motility, the possible mechanisms start to emerge from recent progress 
(Higashiyama et al., 1995; Shi et al., 2000; Odintsova et al., 2003). Lines of 
evidence suggest that tetraspanins could regulate the functional status of cell 
adhesion molecules and growth factor receptors (or membrane-bound growth 
factor). They physically and/or functionally associate with each other and then 
alter cellular behaviors through these partners (Higashiyama et al., 1995;  
Maecker et al., 1997; Shi et al., 2000; Berditchevski, 2001; Boucheix and 
Rubinstein, 2001; Hemler, 2001; Odintsova et al., 2003). For example, 
KAI1/CD82 attenuates epidermal growth factor (EGF) signaling and integrin 
function by accelerating the endocytosis of its associated EGF receptor and 
integrin, respectively (Odintsova et al., 2000; Berditchevski, 2001; He et al., 
2004). In parallel, experimental data support the notion that tetraspanins per se 
solicit outside-in signals to modulate cellular functions (Maecker et al., 1997;  
Berditchevski, 2001; Hemler, 2001). Again, taking KAI1/CD82 as an example, 
immuno-crosslinking of cell surface KAI1/CD82 demonstrates that KAI1/CD82 
functions as a costimulatory molecule during the T cell activation (Nojima et al., 
1993; Lebel-Binay et al., 1995; Lagaudriere et al., 1998; Shibagaki et al., 1998; 
Delaguillaumie et al., 2002; Iwata et al., 2002), indicating that KAI1/CD82 plays a 
direct role in signal initiation and/or transduction.  
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      Regardless which of the two possible mechanisms plays a more predominant 
role, tetraspanins and/or their associated molecules must act on the cytoskeleton 
to alter cell motility and motility-related cellular events. For example, clustering 
the cell surface KAI1/CD82 proteins using immobilized KAI1/CD82 mAb induces 
profound dendritic cellular protrusions in T cells, accompanied by the 
rearrangement of the actin cytoskeleton and the connection of KAI1/CD82 to the 
actin cytoskeleton, in a protein kinase A activity-dependent but Src kinase 
activity-independent manner (Nojima et al., 1993; Lagaudriere et al., 1998). 
Further studies indicated that Rho small GTPases are required for KAI1/CD82-
induced dendritic processes in T cells (Delaguillaumie et al., 2002). 
      Cell migration requires the polarized formation and extension of cellular 
protrusions, the transmembrane connection of cytoskeleton to ECM for the 
generation of traction force to propel cell body forward, and the retraction of the 
rear cellular portion (Raftopoulou and Hall, 2004).  
      In this chapter, I will focus on how KAI1/CD82 inhibits cell migration at the 
cell morphological level, such as polarization, protrusion, lamellipodia formation, 
and random cell migration on ECM.  
      
2.2 Materials 
      The monoclonal antibodies (mAbs) used in this study were human CD81 
mAb M38 (Fukudome et al., 1992), human KAI1/CD82 mAb M104 (Fukudome et 
al., 1992), 4F9 (Schlossman et al., 1994; Iwata et al., 2002), and TS82b (Tepnel, 
Stamford, CT). A mouse monoclonal IgG2 was used as a negative control 
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antibody (Sigma). The secondary antibodies were horseradish peroxidase-
conjugated goat anti-mouse or -rabbit IgG antibody (Sigma) and rhodamine-
conjugated goat-anti-mouse IgG antibody (Biosource International, Camarillo, 
CA). 
      Cell culture medium DMEM was purchased from Invitrogen (San Diego, CA) 
Extracellular matrix (ECM) proteins used in this study were human plasma 
fibronectin (FN) (Invitrogen, San Diego, CA), mouse laminin (LN)-1 (Invitrogen, 
San Diego, CA), and rat LN-5 (Desmos Inc., San Diego, CA).  
      Growth factors or chemokine used in this study include epidermal growth 
factor (EGF) (Upstate Biotechnology, Lake Placid, NY), platelet-derived growth 
factor (PDGF) (Upstate Biotechnology), hepatocyte growth factor (HGF) (Sigma), 
and stromal cell derived factor 1 (SDF-1) (R&D, Minneapolis, MN).  
      
2.3 Methods 
 
2.3.1   Establishment of KAI1/CD82 transfectants 
      Prostate cancer cell lines Du145 and PC3 were obtained from ATCC 
(Manassas, VA) and cultured in DMEM supplemented with 10% FBS, 100 
units/ml penicillin and 100 µg/ml streptomycin. The full-length KAI1/CD82 cDNA 
was constructed in a eukaryotic expression vector pCDNA3.1 (Invitrogen). Du145 
or PC3 cells were transfected with the plasmid DNA using either Superfectin 
(Qiagen, Valencia, CA) or Lipofectamine 2000 (Invitrogen), respectively, and 
selected with 1 mg/ml geneticin (Invitrogen). The geneticin-resistant clones were 
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pooled, and the KAI1/CD82-positive cells were collected by flow cytometric cell 
sorting (Zhang et al., 2003a). 
 
2.3.2   Western blot 
      Western blot was performed as previously described (Zhang et al., 2003a). 
For of total cellular proteins, an equivalent number of cells were lysed using RIPA 
buffer, the protein concentrations of lysates were normalized, and then the 
lysates were separated by SDS-PAGE. After being transferred electrically, 
nitrocellulose membranes (Schleicher & Schuell, Keene, NH) were sequentially 
blotted with primary antibody and horseradish peroxidase conjugated anti-mouse 
or -rabbit IgG (Sigma) and then detected with chemiluminesence reagent 
(PerkinElmer Life Sciences). In some cases, membranes were stripped and 
reblotted with mAbs or pAbs according to the manufacturer's instruction. 
 
2.3.3   Flow cytometry  
      Cell surfact expression of CD82 was analyzed as discribed before (Zhang et 
al., 2001b). Du145-Mock and Du145-CD82 transfectant cells were incubated with 
either negative control mAb, integrin mAbs, or specific TM4SF mAbs M104.  In 
turns, cells were stained with FITC-conjugated goat-anti-mouse IgG. The stained 
cells were analyzed using a FACScan flow cytometer (BD Biosciences, Mountain 
View, CA). Fluorescence with negative control mAb was subtracted to give 
specific mean fluorescence intensity (MFI) units. 
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2.3.4   Cell spreading experiment 
      Du145-mock and Du145-CD82 transfectants were rinsed with PBS, then 
detached by trypsin/EDTA treatment. After centrifugation, the supernatant was 
removed and cells were resuspended in DMEM containing 10% FCS (Invitrogen, 
San Diego, CA). Cells were then plated on ECM protein (FN or LM 1)-coated 
glass bottom dishes (MatTek Corp., Ashland, MA) in DMEM medium for 3-6 h. 
Cells attached and spread for 20 min before being fixed with 3.7% formaldehyde 
in PBS with 5% sucrose and 2 mM MgCl2 for 15 min at RT. Images were taken 
with a Hamamatsu cooled CCD camera run by Metamorph (Universal Imaging, 
PA) or a Bio-Rad 1024 microscope (Bio-Rad, Hercules, CA).  Areas of cells (20–
45 cells per coverslip) were calculated using the Scion Image v1.62 program 
(Scion Corp.).  
 
2.3.5   Time-lapse video microscopy  
      The time-lapse video-microscopic experiments were performed basically as 
previously described (Hinz et al., 2004; Prass et al., 2006). The Du145- or PC3-
transfectant cells were plated on ECM protein (FN or LM 1)-coated glass bottom 
dishes (MatTek Corp., Ashland, MA) in DMEM medium for 3-6 h before the time-
lapse imaging experiment. In the imaging experiment, each transfectant cell was 
observed for 1 to 6 h on an Axiovert 135 TV microscope (Carl Zeiss, Thornwood, 
NY) using DIC optics with either an oil-immersion 40X Plan Fluar or an oil-
immersion 63X Plan Apo objective. The microscope was equipped with a heated 
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stage and the temperature was kept at 37oC.  CO2 was kept by covering the 
medium with mineral oil.  Images were taken with a Hamamatsu cooled CCD 
camera run by Metamorph (Universal Imaging, PA) in 1, 2, 5, or 10 min interval 
during the observation periods. The cellular motile behaviors and the 
translocation of cells were assessed in movies made from the saved images. 
Cellular motile behaviors were analyzed under different conditions such as 
serum-free DMEM, DMEM containing EGF, DMEM containing KAI1/CD82 mAb, 
etc. The images were analyzed by Nikon EZ-C1 FreeViewer software.  
 
2.3.6   Cell migration assay 
      Migration experiments were performed in Transwell membrane filter inserts in 
24-well tissue culture plates (BD Labware, Bedford, MA) as described previously 
(Zhou et al., 2004). The Transwell filters were 6.5 mm in diameter, and the pore 
size for polycarbonate membranes was 8 µm. Filters were spotted with FN diluted 
in 10 mM NaHCO3 or LM 1 diluted in PBS on the lower
 surface of the Transwell 
inserts at 4°C overnight and then blocked with 0.1% heat-inactivated BSA at 
37°C for 30 minutes. Cells were detached at 90% confluence with 2 mM 
EDTA/PBS, washed once in PBS, and resuspended in serum-free DMEM 
containing 0.1% BSA. A 300-µL cell suspension was added to inserts at a density 
of 3 x 104 cells/insert. DMEM containing 1% FCS was added to the lower wells. 
Migration was allowed to proceed at 37°C for 3 hours. Cells that did not migrate 
through the filters were removed using cotton swabs, and cells that migrated 
through the inserts were fixed and stained with Diff-Quick (Baxter Healthcare 
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Corp., McGraw Park, IL). The number of migrated cells per insert was counted 
under a light microscope at magnification x40. Data from several independent 
experiments were pooled and analyzed using a two-tailed, Student’s t test. 
  
2.3.7   Image analysis and MDFR measurement   
      For cell morphology evaluation, phase contrast or fluorescent digital images 
of cells were analyzed by using the Image J software from NIH image (NIH 
image, http://rsb.info.nih.gov/nih-image/ ). The margin of each individual cell was 
traced by using the software's polygon selection tool and the cell perimeter and 
cell area were automatically calculated by the software. Then, as described 
previously (Szabo et al., 1995), the morphological deviation from roundness 
(MDFR), i.e., the deviation of each cell shape from perfect roundness, was 
calculated by dividing the theoretical maximum area for a given perimeter 
(perimeter2/4π) by the observed pixel area. The value for a perfectly round cell 
equals 1.0, and larger values represent increasing levels of deviation from 
roundness. 
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2.4 Results 
 
2.4.1   Detection and comparison of CD82 expression in Du145-mock and 
Du145-CD82 stable transfectants  
       After generating Du145-mock and Du145-CD82 transfectants as described 
above in Methods 2.3.1, KAI1/CD82 expression levels were determined by both 
flow cytometry and western blot (Figure 2.1). CD82 expression is not obviously 
detected in Du145-mock cell, whereas strong signals of CD82 has been detected 
(Figure 2.1A). The CD82 expression level within Du145-CD82 is not higher than 
the endogenous level of those cells sharing similar origin as prostate epithelial, 
which naturally express CD82, such as normal prostate epithelial cell line PrEC 
(Figure 2.1A).  The expression of CD82 on the surface of Du145-CD82 
transfectants was further confirmed by FACS (Figure 2.1B).  Compared to the 
absence of CD82 expression on Du145-mock transfectants, there was a clear 
peak shift indicating successful overexpression and correct conformation of 
CD82 on the surface of Du145-CD82 transfectants, as they were able to be 
recognized by CD82 specific antibody. 
      Thus, Isuccessfully re-introduced CD82 back to Du145 cells, which lose their 
endogenous expression of CD82 due to epigenetic events which is still largely 
unknown at current stage (Liu and Zhang, 2006). As a positive control, cell 
surface β1 integrin level was also detected simultaneously. It is not a surprise to 
see that there were slightly decreasing expression levels of cell surface β1  
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Figure 2.1   Detection and comparison of CD82 expression in Du145-mock 
and Du145-CD82 stable transfectants 
 
Upon establishing stable transfectants of Du145-mock and Du145-CD82, CD82 
expression is determined by the following: A. Western blot. CD82 expression is 
barely detectable in Du145-mock cell. However, Du145-CD82 transfectants 
shows decent protein level of CD82. In order to compare how high the 
expression level of CD82 in Du145-CD82 cells, cell lysate from those cells 
sharing similar origin as prostate epithelial, which naturally express CD82, such 
as normal prostate epithelial cell line PrEC, was also collected. The ectopic 
overexpression level of CD82 within D145-CD82 was contrasted and compared 
with the endogenous expression level of that in PrEC cells in this blot. The 
bottom panel shows the actin loading control. B. FACS analysis of cell surface 
CD82 expression. Both Du145-mock and Du145-CD82 transfectants were 
detached, then blocked with 1% BSA. Cells were then stained with negative 
control mouse IgG2 mAb, specific TM4SF mAbs M104, or integrin mAbs.  In 
turns, cells were stained with FITC-conjugated goat-anti-mouse IgG as 
secondary antibody. The stained cells were analyzed using a FACScan flow 
cytometer (BD Biosciences, Mountain View, CA).  
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integrin, since CD82 may accelerate its internalization and thus reduce its cell 
surface level (Liu and Zhang, 2006).   
 
 2.4.2   KAI1/CD82 inhibits Du145 cell motility 
      Upon confirming the expression of KAI1/CD82, Du145 transfectants were in 
turn tested for their directional motility, either by transwell haptotactic migration 
on FN, or chemohaptotactic migration on FN under the stimulation of HGF, 
respectively (Figure 2.2). As shown in Figure 2.2A, the ability of Du145-CD82 
cells to migrate toward ECM was greatly reduced compared with that of the 
Du145-Mock cells. The attenuated haptotactic cell migration in Du145-
KAI1/CD82 cells could also be replicated on LN5-coated substrata in our 
previous published data (Zhang et al., 2003a). Those results indicated that 
Du145-CD82 has robust inhibitory effects on cell migration mediated by both FN- 
and LM-binding integrins such as α5β1 and α3β1, respectively.
  
      Besides inhibiting the haptotactic cell migration, CD82 expression also 
suppressed chemohaptotactic migration, i.e. cells migrated toward both the 
chemoattractant gradient and immobilized gradient (Figure 2.2B). In the 
presence of HGF, a strong cell migration promoter, the KAI1/CD82 transfectant 
still migrated significantly less on FN.  Moreover, the difference between Mock 
and CD82 cells migrating towards FCS and HGF are approximately the same, 
aound 3-4:1. This indicates that KAI1/CD82 impairs cell migration capability 
regardless the activation of c-Met. c-Met activation has been documented to be 
important for KAI1/CD82’s inhibition of cell migration in several cell types  
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Figure 2.2   KAI1/CD82 inhibits Du145 cell motility 
 
A, KAI1/CD82 inhibits haptotactic cell migration on fibronectin. Haptotactic 
migration of the Du145 transfectants was measured using the transwell inserts 
coated with FN (20 µg/ml). The migration medium in top and bottom wells was 
DMEM containing 0.1% heat-inactivated BSA and antibiotics. Cells that migrated 
onto the lower surface were fixed, stained, and photographed. In each individual 
experiment, cells that migrated through the filters were counted from at least 
three randomly selected fields. Results were obtained from at least three 
individual experiments and represented as the cell migration index, which is the 
number of cells per a high power field. The bar graph representgraph represents 
means ± S.D. p < 0.001 on FN between the Mock and KAI1/CD82 transfectants. 
B, KAI1/CD82 inhibits chemohaptotactic cell migration. Chemohaptotactic 
migration assays were carried out toward chemoattractants on FN (20 µg/ml)-
coated filters in the medium of the bottom well. The chemoattractants in the 
medium of the bottom well is HGF (100 ng/ml). The results were obtained from 
three experiments (mean ± S.D.). p < 0.001 toward HGF between the Mock and 
KAI1/CD82 transfectants. 
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including YTS1 bladder cancer cells (Todeschini et al., 2007), and metastatic 
 prostate cell line PC3 (Sridhar and Miranti, 2006). Although it has been reported 
that c-Met activation can fully overturn the motility inhibition induced by CD82  
(Todeschini et al., 2007), activation of c-Met by HGF in Du145-CD82 cells can’t 
rescue the impaired cell migration, which is previously inhibited by 
overexpression of CD82 (Figure 2.2B).   
 
2.4.3   KAI1/CD82 contributes to deficiencies in cellular extension retraction 
and lamellipodia formation  
      Cell movement on or through different ECMs is substantially diminished when 
KAI1/CD82 is forced to express in invasive or metastatic tumor cells, in which 
KAI1/CD82 expression is usually lost (Dong et al., 1995;  Hemler, 2001;  Stipp et 
al., 2003). When spread on ECM such as FN and LM, Du145-KAI1/CD82 
transfectant cells exhibited profound differences in cellular morphology from the 
Mock cells. KAI1/CD82 overexpression typically results in polygonal, dumbbell, 
liquid-drop, spindle, and arboreal cell shapes (Figures 2.3 and 2.4). In dumbbell-, 
spindle- and liquid drop-like cells, the elongated cellular extensions are probably 
caused by the deficiency in retraction of elongated cellular extensions during cell 
spreading and migration. Although the elongated cellular extensions can also be 
found in Mock cells, the occurrence frequency was much fewer than the 
KAI1/CD82-expressing cells. These cellular extensions could be observed when 
cells spread or migrate on substratum coated with FN or LN 5 (Figure. 2.4B) in 
the presence or absence of serum or growth factor. For example, extraordinarily  
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Figure 2.3   Morphological phenotypes of KAI1/CD82-overexpressing cells 
 
A. KAI1/CD82-expressing cells displayed altered morphology. Upper panel, 
Du145-Mock and -KAI1/CD82 transfectant cells were plated on either FN (10 
µg/ml)- or LM 5 (10 µg/ml)-coated glass coverslips at 37oC, 5% CO2 overnight in 
serum-free DMEM medium.  Lower panel, PC3-Mock and -CD82 transfectant 
cells were plated on tissue culture flasks at 37
o
C, 5% CO2 overnight in DMEM 
medium containing 10% FCS. B. Quantitative analysis of cell morphology. Based 
on the images of Du145-Mock and -CD82 cells on FN, the MDFR was analyzed 
as described Experimental Procedures. Asterisk stands for statis-tically 
significant difference between Mock and CD82 transfectants (p < 0.05). C. Lack 
of lamellipodia in KAI1/CD82-overexpressing cells. Upper panel, Du145-Mock 
and -CD82 cells were spread on FN (10 µg/ml)-coated plates in DMEM 
containing 1% FCS at 37
o
C for overnight. The DIC images of cells were captured 
on an Axiovert inverted microscope using DIC optics with a 40 x F Fluar oil 
immersion objective. The arrows indicate lamellipodia. Lower panel, PC3-Mock 
and -KAI1/CD82 transfectant cells were spread on FN- or LN 1-coated plates and 
stained with CD81 mAb M38 using immunofluorescence as described (Zhou et 
al., 2004) to visualize cell peripheries. D. CD82-overexpressing cells frequently 
exhibit elongated cellular extensions. Du145-Mock and -CD82 cells were spread 
on FN (10 µg/ml)-coated plates in DMEM containing 10% FCS and HGF (100 
ng/ml) at 37
o
C for 3-6 h. The DIC images of cells were captured using DIC optics 
with a 40 x F Fluar oil immersion objective. Scale bar, 50 µm.   
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Figure 2.4   KAI1/CD82 attenuates the formation of lamellipodia and      
retraction of cellular extensions 
 
A. KAI1/CD82 inhibits lamellipodia and protrusion formations. Du145-Mock and – 
KAI1/CD82 transfectant cells were plated on FN-coated glass coverslips. DIC 
images were acquired using time-laps vidoemicroscopy as described in experi-
mental procedures. Arrows indicate lamellipodia. B. KAI1/CD82 inhibits the 
retraction of rear tail. Du145-Mock and -KAI1/CD82 cells were placed on FN (10 
µg/ml)-coated coverslip for 3-6 h and treated with 100 ng/ml HGF for 4-6 h. The 
cell morphology was photographed by using time-lapse videomicroscopy for 3 h. 
Arrow heads indicate the retraction processes in Du145-Mock cells and arrows 
the rear tail in Du145-KAI1/CD82 cells. The time-lapse intervals are labeled 
inside images. Scale bar, 20 µm.  
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long cellular extensions were observed in KAI1/CD82-expressing cells treated 
with HGF (Figure 2.3D). Time-lapse video microscopy demonstrated that the 
elongated cellular extensions were generated due to the lack of contractile 
retraction (Figure. 2.3C, Figure 2.4B).  
      For KAI1/CD82-expressing cells with multilateral morphology, cell edges 
usually become flat or slightly concave, reflecting the lack of lamellipodia 
formation. Indeed, as reported earlier (Berditchevski, 2001;  Zhou et al., 2004), 
lamellipodia formation was diminished upon KAI1/CD82 overexpression (Figures 
2.3C and 2.4A).  In Du145-KAI1/CD82 cells, lamellipodia formation was 
completely lost (Figures 2.3C and 2.4A), while in PC3-KAI1/CD82 cells, localized 
lamellipodia were typically limited to one or two cellular ends (Figure 2.3C). Time-
lapse video microscopy demonstrated that the Mock cells could rapidly generate 
broad lamellipodia while the KAI1/CD82-expressing cells failed to produce 
lamellipodia (Figure 2.4A). Because of attenuated protrusive activities, some 
KAI1/CD82-expressing cells displayed more rigid edges. 
      Moreover, when spread on FN-coated plates or grow in cell culture dishes 
(Figure 1A), Du145-KAI1/CD82 cells showed significantly more MDFR, a 
parameter to describe the extent of irregularity departing from roundness in cell 
shape, than the Mock cells (Figure 2.3B). However, when spread on LN 5, 
Du145-KAI1/CD82 cells exhibited a more roundup morphology (Figure 2.3), 
reminiscent to the cell flattening process on poly-L-lysine coated plates, 
suggesting the attenuated outside-in signaling from laminin-binding integrins 
α3β1 and/or α6β4. The morphology of KAI1/CD82 transfectant cells also reflects  
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 the loss of polarization during spreading, consistent with the loss of directionality 
of these cells during cell migration (Zhang et al., 2003a). The morphological 
evidences for the loss of polarization include bipolar cellular extensions or 
lamellipodia (Figure 2.3C bottom panel), and cell flattening on LN 5 (Figure 2.3A 
top panel). The KAI1/CD82 expressionexpression level of KAI1/CD82 proteins in 
Du145-CD82 cells is slitely lower thandid not exceed the endogenous expression 
level of the endogenous protein in an immortalized human normal prostate 
epithelial cell line PERrEC (Figure 2.1). 
 
2.5 Discussion 
      Alterations in cellular morphology upon KAI1/CD82 expression reflect 
deficiencies in protrusion and retraction - could this explain the motility-inhibitory 
mechanism at the cellular level? 
      KAI1/CD82 expression alters the cellular morphology in various aspects. 
These alterations can be attributed to both diminished protrusive activities such 
as the lack of formation of lamellipodia and cellular protrusion and attenuated 
retraction of cellular extension and trailing edge. Since migrating cells typically 
display these motility-related morphological events, loss and disruption of these 
events are therefore predicted to be important for the cell movement-inhibitory 
activity of KAI1/CD82.   
      In Du145 prostate cancer cells, KAI1/CD82 expression abolishes the 
lamellipodia formation on fibronectin-coated, laminin-coated, or regular cell 
culture flask surface. Only on laminin 5-coated substratum did KAI1/CD82-
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expressing cells undergo cell flattening, a symmetric cell spreading process. In 
PC3 prostate cancer cells, KAI1/CD82 grossly inhibits the lamellipodia formation 
on fibronectin but partially inhibits it on laminin. Because PC3 cells could form 
fan-like, well-developed lamellipodia on laminin, KAI1/CD82 more likely inhibits 
the development or prevailence of fan-like lamellipodia. Of note, the definition of 
lamellipodia referrenced herein covers both subdomains of recently designated 
lamellipodia and lamella (Ponti et al., 2004). Since both Du145 and PC3 cells 
form lamellipodia during cell migration, the lack or disruption of lamellipodia 
formation or development is very likely to be crucial for the motility-inhibitory 
activity of KAI1/CD82, though some PC3-KAI1/CD82 cells can still form 
incomplete lamellipodia on laminin.  
      The presence of elongated cellular extensions is another genuine effect of 
KAI1/CD82 overexpression in Du145 and PC3 cells. The elongated cellular 
extensions could be the consequence of excessive protrusive activity, but they 
could also reflect the retraction deficiency. Our study clearly demonstrated that 
various cellular extensions in KAI1/CD82-expressing Du145 and PC3 cells are 
caused by deficiency in the retraction process. Earlier studies showed that the 
immobilized-KAI1/CD82 mAbs induce profound dendritic extensions in 
hematopoetic cells (Nojima et al., 1993;  Lagaudriere et al., 1998), 
morphologically reminiscent of some types of cellular extensions seen in 
KAI1/CD82-expressing Du145 and PC3 cells. Despite the differences between 
overexpression and Ab engagement and between adherent and suspension 
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cells, these dendritic extensions more likely represent the phenotype of less 
retraction if the motility-inhibitory activity of KAI1/CD82 is considered. 
      KAI1/CD82 not only blocked the cellular protrusion and retraction processes 
that were induced by the integrin-ECM engagement, but also blocked these 
events stimulated by growth factors or serum (Figure 1), For example,  
KAI1/CD82-caused deficiency in rear tail retraction is manifested in the presence  
of HGF. These observations indicate that KAI1/CD82 inhibits both integrin and 
growth factor signaling. Another novel observation in this study is that the effect 
of KAI1/CD82 on these motility-required cellular processes appears to be 
independent of cell-cell contacts. In other words, KAI1/CD82 can induce these 
morphological changes without directly engaging a cellular receptor from 
adjacent cells because those morphological effects are pronounced when cells 
do not form cell-cell contacts. On the contrary, the cell-cell contacts alleviate 
KAI1/CD82 effects on the actin cytoskeleton: the foundation of morphological 
changes and this will be shown in Chapter 3. 
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CHAPTER 3.  KAI1/CD82 DISRUPTS ACTIN CYTOSKELETON 
REARRANGEMENT THROUGH REGULATION OF THE SMALL-RHO 
GTPASES SIGNALING PATHWAY 
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3.1 Introduction 
      Cell migration consists of several critical steps: polarization formation, 
extension of cellular protrusions, the transmembrane connection of cytoskeleton 
to ECM for the generation of traction force to propel the cell body forward, and 
the retraction of the rear cellular portion (Horwitz and Parsons, 1999; Parent and 
Devreotes, 1999; Horwitz and Webb, 2003; Ridley et al., 2003; Raftopoulou and 
Hall, 2004;  Van Haastert and Devreotes, 2004;  Vicente-Manzanares et al., 
2005). Thus, by nature, cell migration is a process of global reorganization of 
thecytoskeleton. For example, actin polymerization drives the formation and 
extension of the protrusions such as lamellipodia at the leading edge (Condeelis, 
1993; Small et al., 1993; Mitchison and Cramer, 1996; Mogilner and Oster, 1996;  
), while the asymmetric distribution and crossing linking of myosin and actin 
produce the force for cellular contractility and lead to the retraction of the trailing 
edge (Kolega, 2003;  Kolega, 2006;  Sato et al., 2007). Rho small GTPases are 
clearly pivotal in all of these cytoskeletal rearrangement processes (Raftopoulou 
and Hall, 2004). For example, Rac is primarily responsible for generating a 
protrusive force through localized actin polymerization, while Rho is responsible 
for the contraction of the cell body and the retraction of the rear end (Jaffe and 
Hall, 2005). As a downstream effector of Rho GTPases (Raftopoulou and Hall, 
2004), cofilin severs actin filaments to generate barbed ends and thus facilitates 
the actin treadmilling (Bamburg and Wiggan, 2002;  Raftopoulou and Hall, 2004). 
Arp2/3, an effector complex, nucleates new actin filaments from the sides of 
preexisting filaments (Weaver et al., 2003;  Raftopoulou and Hall, 2004). The 
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severing activity of cofilin and branching activity of Arp2/3 function coordinately to 
promote the formation of branched actin network or cortical actin meshwork at 
the leading edge and generate propulsive force for migrating cells (Blanchoin et 
al., 2000a).       
      Tetraspanin KAI1/CD82 is an inhibitor of cell movement (Dong et al., 1995;  
Guo et al., 1996; Higashiyama et al., 1998; Takaoka et al., 1998a; Takaoka et al., 
1998b; Miyake et al., 1999; Ono et al., 1999; Uchida et al., 1999; Yang et al., 
2001; Delaguillaumie et al., 2002; Zhang et al., 2003a; Zhang et al., 2003b). 
Previous studies have shown that KAI1/CD82 suppresses cancer metastasis by 
inhibiting cell migration. Mechanisms may include the following: 1) Inhibiting EGF 
and integrin signaling by accelerating their endocytosis (Berditchevski, 2001;  
Odintsova et al., 2003;  He et al., 2004;  Liu and Zhang, 2006). In turns 
KAI1/CD82 attenuates outside-in signals and thus modulates cellular functions 
(Maecker et al., 1997;  Berditchevski, 2001;  Hemler, 2001). 2) Regulating 
cytoskeletal rearrangement.  In T cells, CD82 clustering promotes cellular 
protrusions and actin cytoskeleton rearrangement. This activity may depend on 
protein kinase A (Nojima et al., 1993;  Lagaudriere et al., 1998). Rho small 
GTPases are also important for KAI1/CD82-induced dendritic protrusion in T 
cells (Delaguillaumie et al., 2002).      
      Recent studies revealed that, in solid tumor cells, KAI1/CD82 attenuates the 
signaling derived from integrin (Ridley et al., 2003), EGFR (Yarden and 
Sliwkowski, 2001), and c-Met  (Dugina et al., 1995;  Sridhar and Miranti, 2006;  
Todeschini et al., 2007) and that FAK-Src-p130CAS-Crk pathway is a major 
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downstream signaling pathway affected by KAI1/CD82 (Zhang et al., 2003a;  
Sridhar and Miranti, 2006). At the cellular level, besides the aforementioned 
induction of cellular protrusions via immobilized KAI1/CD82 mAbs, earlier studies 
showed KAI1/CD82 inhibits lamellipodia formation (Odintsova et al., 2000). The 
cellular and molecular events critical for the function of KAI1/CD82 and the 
signaling altered by KAI1/CD82, however, have not been elucidated in depth and 
details. The goal of this study is to determine the subcellular event and 
cytoskeletal events crucial for the motility-inhibitory activity of KAI1/CD82. In this 
study, Ifound that KAI1/CD82 inhibits the formation of lamellipodia and the 
retraction of cellular extension, which result from deficient development of actin 
cortical meshwork and stress fibers. Not surprisingly, actin polymerization 
becomes attenuated upon KAI1/CD82 overexpression, due to the deregulation of 
Rho small GTPase activities and aberrant functions of Rho GTPase effectors.  
 
3.2 Materials 
      The monoclonal antibodies (mAbs) used in this study were human integrin α3 
mAb X8 (Sauer et al., 2003), human integrin α5 mAb PUJ-2 (Pujades C, 1996), 
human integrin β1 mAb A1A5 and TS2/16 (Hemler et al., 1984), human CD81 
mAb M38 (Fukudome et al., 1992), human KAI1/CD82 mAb M104 (Fukudome et 
al., 1992), 4F9 (Schlossman et al., 1994;  Iwata et al., 2002), and TS82b (Tepnel, 
Stamford, CT), Rac1 mAb (BD Pharmingen, San Jose, CA), and β-tubulin mAb 
(Sigma, St. Louis, MI). A mouse monoclonal IgG2 was used as a negative control 
antibody (Sigma). The polyclonal Ab (pAb) for cofilin was purchased from 
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Cytoskeleton (Denver, CO). The pAb for phosphorylated cofilin were either the 
gift from Dr. Bombarg of University of Colorado or purchased from Cell Signalling 
(Danvers, MA). The pAb for p34 of Arp2/3 complex was purchased from Upstate 
Biotechnology (Lake Placid, NY). Polyclonal Abs for RhoA, Cdc42, and Rac1 
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The 
secondary antibodies were horseradish peroxidase-conjugated goat anti-mouse 
or -rabbit IgG antibody (Sigma) and rhodamine-conjugated goat-anti-mouse IgG 
antibody (Biosource International, Camarillo, CA). 
      Extracellular matrix (ECM) proteins used in this study were human plasma 
fibronectin (FN) (Invitrogen, San Diego, CA), mouse laminin (LN)-1 (Invitrogen, 
San Diego, CA), and rat LN-5 (Desmos Inc., San Diego, CA).  
      Growth factors or chemokine used in this study include epidermal growth 
factor (EGF) (Upstate Biotechnology, Lake Placid, NY), platelet-derived growth 
factor (PDGF) (Upstate Biotechnology), hepatocyte growth factor (HGF) (Sigma), 
and stromal cell derived factor 1 (SDF-1) (R&D, Minneapolis, MN).  
      Other reagents include cell permeable C3 transferase (Cytoskeleton), Texas 
Red- or Alexa 488-conjugated α-phallodin (Molecular Probe, Eugene, OR), Rac1 
inhibitor 23766 and its negative control 23767 (NIH, Bethesda, MD), and actin 
polymerization enhancer jasplakinolide (J7473) (Molecular Probe).  
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3.3 Methods 
 
3.3.1   Transfectants 
      Retrovirus containing the Rac1 dominant negative mutants Rac1N17, and 
constitutively active mutants Rac1L61 were kindly provided by Dr. Yi Zheng of 
University of Cincinnati. Those constructs were ligated in frame with the 
nucleotides encoding a three-hemagglutinin (HA3) tag at the 5′ end of the 
retroviral vector MIEG3 that expresses enhanced green fluorescent protein 
bicistronically. Recombinant retroviruses were produced using the Phoenix cell 
packaging system as described before (Guo and Zheng, 2004). Du145-mock and 
Du145-CD82 were infected with the respective retroviruses and harvested 48 to 
72 h postinfection. The enhanced green fluorescent protein-positive cells were 
isolated by fluorescence-activated cell sorting (FACS). pEGFP, pEGFP-actin , 
pEGFP-N-WASp (kindly provided by Dr. A. Weaver of Vanderbilt University), 
pEGFP-Cofilin (kindly provided by Dr. J Vandekerckhove of University Ghent)and 
pEGFP-PLCδ PH domain (kindly provided by Dr. John Cox of University of 
Tennessee) were transiently transfected into Du145-KAI1/CD82 and -Mock cells 
using Lipofectamine 2000 by following the manufacturer’s protocol. 
 
 3.3.2   Time-lapse video microscopy  
      The time-lapse video-microscopic experiments were performed as previously 
described in Chapter 2 method 2.3.5. For intracellular GFP-actin polymerization 
study, GFP-actin was transfected 48 h prior to experiment, then plated on FN-
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coated glass bottom plates (MatTek Corp., Ashland, MA). Images were taken 
with a C1Si confocal system mounted on an Eclipse TE2000-E microscope 
(Nikon, Melville, NY), using a Plan Fluor oil-immersion 40X objective (N.A. 1.3), 
or an oil-immersion Plan Apo 60X objective (N.A. 1.45).  The system is equipped 
with an environmental-control chamber (InVivo Scientific, St Louis, MO).  
Temperature was kept at 37oC and 5% CO2.  DIC and fluorescent images were 
recorded every 1-2 minute. Polymerization of GFP-actin was assessed in movies 
made from the saved images 
 
3.3.3   Fluorescent and confocal microscopy  
            The immunofluorescence staining was carried out as described (Zhang et 
al., 2001b). In brief, glass coverslips were coated with either FN (50 µg/ml) in 10 
mM NaHCO3 or LM 1 (50 µg/ml) in phosphate buffer saline (PBS) at 4
oC 
overnight, and then blocked with 0.1% heat-inactivated bovine serum albumin 
(BSA) at 37oC 45 min.  Du145 transfectants were harvested in PBS containing 2 
mM EDTA, washed once, and plated on the ECM-coated coverslips in serum-
free or serum DMEM for 4 to 6 h at 37oC.  Then the cells were fixed with 3% 
paraformaldehyde (Sigma) and permeated with 0.1% Brij99 (Sigma).  
Nonspecific binding sites were blocked with 20% goat serum in PBS for 1 h at 
room temperature.  The cells were incubated sequentially with primary mAbs (~1 
µg/ml) and with Rhodamine-conjugated secondary antibody. For F-actin staining, 
cells were incubated with Texas Red-conjugated phalloidin. Each incubation 
lasted 30 min at RT in 20% goat serum/PBS and followed by 4 washes with PBS. 
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Finally the coverslips were mounted on glass slides in FluroSave reagent 
(Calbiochem-Novabiochem, San Diego, CA), analyzed using an Axiophot 
fluorescent microscope (Carl Zeiss) or a Bio-Rad 1024 confocal microscope (Bio-
Rad, Hercules, CA) and photographed with Optronics digital camera (Southern 
Micro Instrument, Marietta, GA) at 40X or 63X magnification.   
 
3.3.4   Rac1, Cdc42 and RhoA effector pull-down assay   
      The cellular Rho GTPase activities were measured by an effector domain 
pull-down assay  as described (Gao et al., 2004). Du145 transfectant cells were 
washed with PBS buffer once and lysed in RIPA buffer (1% NP40, 0.2% SDS, 
150 mM NaCl, 25 mM HEPES, 2 mM phenylmethylsulfonyl-fluoride, 20 µg/ml 
leupeptin, 20 µg/ml aprotinin, 2 mM sodium vanadate, and 2 mM sodium fluoride) 
on ice. Cell lysates were clarified by centrifugation at 14, 000 g at 4oC for 5 min, 
and equal amounts of lysate were incubated with GST fusion beads at 4oC for 45 
min. The beads were washed three times with ice-cold RIPA buffer. To assay the 
activity of Cdc42, cell lysate was affinity-precipitated with the beads adsorbed 
with the WASP Cdc42 binding domain-GST fusion that only binds to the active, 
GTP-bound form of Cdc42. With the same principle, Rac1 or RhoA activity was 
pulled down with PAK Rac1 binding domain-GST fusion or Rhotekin RhoA 
binding domain-GST fusion beads, respectively. The total cell lysates and the 
affinity-precipitated products were run on a SDS-PAGE gel, transferred to 
nitrocellulose membrane, and then immunoblotted for Cdc42, Rac1, or RhoA, 
respectively. The blots were detected with chemiluminesence reagent (Perkin-
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Elmer, Boston, MA). The intensities of the bands from four separate experiments 
were measured by NIH Scion Image program (Kroczynska et al., 2006). 
 
3.3.5   Cell motility assay 
      Different Rac1 mutants within either Du145-mock or Du145-CD82 were 
tested by the transwell migration described as above in Chapter 2 method 2.3.6.  
 
3.3.6   Actin polymerization analysis 
      As described above, intracellular GFP-actin polymerization was analyzed 
using live fluorescent imaging under a time-lapse confocal microscope. In 
addition, intracellular F-actin level was measured by using flow cytometry 
(Miyake et al., 2001). Briefly, Du145 transfectant cells at the confluent culture 
stage were detached with trypsin and washed once with sterile PBS. The cells 
were permeabilized with 0.01% Triton X-100 in PBS at 4ºC for 1 min and then 
washed 3 times with PBS. The permeabilized cells were fixed with 3.7% 
formaldehyde at RT for 5 min and subsequently washed 3 times with PBS. For F-
actin staining, the cells were incubated with 66 nM Alexa 488-conjugated 
phalloidin in PBS containing 1 % BSA at 37ºC for 1 h.  The stained cells were 
washed 3 times with PBS and analyzed in BD LSR II flow cytometer. The flow 
cytometry data were analyzed by using FlowJo 7.1 or FCS express V3 software. 
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3.3.7   Rac1 inhibitor assay 
      To evaluate whether Rac1 specific inhibitor, NSC23766, can inhibit 
lamellipodia formation in Du145 cell, Du145 cells grown in 10% calf serum were 
treated with 100 µM NSC23766 or DMSO overnight according to previous 
description (Gao et al., 2004), and then the cell were detached. Cell spreading 
experiment were then done as described in Chapter 2 method 2.3.4.  
 
3.3.8   Cytokine stimulation assay  
      Du145-Mock or -KAI1/CD82 transfectant cells were spread on FN-coated 
plates in complete DMEM and treated with integrin β1 activating mAb A1A5 (8 
µg/ml), EGF (100 ng/ml), HGF (100 ng/ml), or SDF-1 (100 ng/ml) at 37oC for 4-6 
h. Cells were then fixed, permeabilized, and incubated with Texas Red-
conjugated α-phalloidin. Digital images were captured under a fluorescent 
microscope. Scale bar, 20 µM. 
 
3.3.9   RhoA inhibition assay  
      Du145 cells were plated on coverslips overnight in DMEM full medium 
containing 10% FBS, then were untreated or treated with 2.0 µg/ml of C3 
Transferase (Cytoskeleton) for 4-6h at 37°C.  Cell were then fixed, stained with 
Rhodamine-labeled Phalloidin, and visualized by fluorescence 
microscopy.  Images were taken at a magnification of 60X.  
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3.3.10 Jasplakinolide inducing actin polymerization   
      It has been reported that Jasplakinolide  (Molecular probe, J7473) can induce 
actin polymerization (Bubb et al., 1994c). Effect of Jasplakinolide on actin 
polymerization of Du145-Mock and Du145-CD82 were then determined. Cells 
were treated with 50nM Jasplakinolide in full DMEM containing 10% FCS for 24 
hours, Cell were then fixed, stained with Rhodamine-labeled Phalloidin, and 
visualized by fluorescence microscopy.  Images were taken at a magnification of 
60X.  
 
3.3.11 Image analysis  
      For quantitation of F-actin intensity, the cell perimeters were outlined as 
described above in chapter 2 method 2.3.7. fluorescent digital images of cells 
were analyzed by using the Image J software from NIH image (NIH image, 
http://rsb.info.nih.gov/nih-image/). The margin of each individual cell was traced 
by using the software's polygon selection tool and the cell perimeter and cell area 
were automatically calculated by the software.Then, based on the fluorescent 
digital images of α-phalloidin staining, the total cellular F-actin intensity, F-actin 
intensity inside the inner edge of cortical actin ring, and F-actin intensity of 
membrane protrusion or outside the inner edge of cortical actin ring were 
measured using the “analyze” function in Image J software. Theoretically, total 
cellular F-actin intensity = F-actin intensity inside the inner edge of cortical actin 
ring + F-actin intensity of membrane protrusion. Relative F-actin intensity of 
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membrane protrusion = F-actin intensity of membrane protrusion / total cellular F-
actin intensity (Figure 3.1). 
 
3.4 Results 
 
3.4.1   KAI1/CD82 inhibits the formations of actin cortical network and 
stress fibers  
      Dynamic actin reorganization is the hallmark of a motile cell (Steinmetz et al., 
1997). Usually, the loss of stress fibers and formation of extensive cortical 
meshwork accompany the enhanced cell migration (Steinmetz et al., 1997). It 
was reported that KAI1/CD82 could induce F-actin rearrangement either by the 
immobilized KAI1/CD82 mAb (Delaguillaumie et al., 2002) or in response to EGF 
stimulation (Lagaudriere et al., 1998). In Du145-Mock cells, actin was extensively 
polymerized into continuous fibers when cells were spread on both FN- and LM1-
coated substrata (Figure 3.2A). The actin fibers distributed in the cell peripheral 
areas were assembled into cortical actin ring or meshwork, while the ones in cell 
central areas are the stress fibers (Figure 3.2A). In contrast, the F-actin in 
Du145-KAI1/CD82 cell was either stained as patches or formed discontinuous 
fibers (Figure 3.2A), suggesting a defect in actin polymerization. In some cells,  
F-actin was concentrated in cell periphery to form dense actin bundles (Figure 
3.2A), which were found much more frequently in KAI1/CD82-expressing cells 
than in the Mock cells. Similar abnormality of actin organization was also found in 
PC3-KAI1/CD82 cells (data not shown).  
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Figure 3.1   Illustration of the calculation of F-actin intensity quantification 
and membrane protrusions 
 
For quantitationquantization of F-actin intensity, the cell perimeters were outlined 
by image J software as described above. Then, based on the fluorescent digital 
images of α-phalloidin staining, the total cellular F-actin intensity, F-actin intensity 
inside the inner edge of cortical actin ring, and F-actin intensity of membrane 
protrusion or outside the inner edge of cortical actin ring were measured using 
the “analyze” function in Image J software. Theoretically, total cellular F-actin 
intensity = F-actin intensity inside the inner edge of cortical actin ring + F-actin 
intensity of membrane protrusion, so F-actin intensity inside the inner edge of 
cortical actin ring = total cellular F-actin intensity - F-actin intensity of membrane 
protrusion . Finally, Relative F-actin intensity of membrane protrusion = F-actin 
intensity of membrane protrusion / total cellular F-actin intensity.  
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Figure 3.2   KAI1/CD82 regulates the activities of Rho GTPases  
 
A. After being spread on FN (50 µg/ml)- or LM1 (50 µg/ml)-coated coverslips at 
37oC, 5% CO2 for 6 h, Du145 transfectant cells were fixed, permeabilized, and 
then stained with TRITC-conjugated α-phalloidin. The fluorescent images were 
captured under an Axiophot fluorescent microscope equipped with an Optronics 
digital camera at magnification 63X. B. Kymography of actin polymerization in 
Du145-Mock and -KAI1/CD82 cells. The cells were transiently transfected with 
pEGFP-actin construct. They were spread on FN-coated coverslip in complete 
DMEM and photographed using time-lapse confocal videomicroscopy. 
Arrowheads and arrows indicate actin polymerization during the development of 
mini-protrusion and stress fiber, respectively. C. Less F-actin in Du145-
KAI1/CD82 cells. Top panel, Du145-Mock and -KAI1/CD82 cells were fixed, 
permeabilized, incubated with Alexa 488-conjugated phalloidin or IgG2b, and 
then analyzed using flow cytometry. Bottom panel, Quantization of the mean 
fluorescence intensity (MFI) of F actin shown in the top panel. Data are 
expressed as the mean MFI of three independent experiments (p < 0.05 between 
Mock and KAI1/CD82 cells). Right bottom panel, the cell lysates from the 
experiment were analyzed in Western blot for total cellular actin proteins. Cofilin 
blot was used as the protein loading control. 
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      Since microtubules also play an important role in cell movement and 
morphogenesis (Wittmann and Waterman-Storer, 2001), Ianalyzed the effect of 
KAI1/CD82 expression on microtubule organization. As showed in Figure 3.2A, 
no apparent difference was found in microtubule number, length, and distribution 
between Du145-Mock and -KAI1/CD82 cells, indicating that KAI1/CD82 
specifically affects the actin cytoskeleton. In contrast to the pronounced defect in 
actin cytoskeletal rearrangement, microtubule cytoskeletal structure remained 
less affected in terms of length, continuity, and number in Du145-CD82 cells, 
though microtubule organization centers in these cells become less profound 
than those in Mock cells (Figure 3.2A).  
 
3.4.2   Actin polymerization is impaired upon KAI1/CD82 overexpression  
      To determine the biochemical nature of the aberrant actin organization in 
KAI1/CD82-expressing cells, Ianalyzed actin polymerization. Consistent with the 
F-actin staining at steady state under immunoflurescence microscopy, Ifound that 
actin polymerization was impaired in Du145-KAI1/CD82 cells under live imaging 
using GFP-actin as a tracer (Figure 3.2B). Actin polymerization in stress fibers 
(Figure 3.2B, arrow), cortical ring, and peripheral bundles (Figure 3.2B, arrow 
head) in the membrane protrusions occurred in Mock cells, but they are 
significantly attenuated in KAI1/CD82 cells (Figure 3.1B). In KAI1/CD82 cells, 
actin polymerization could still be found at the end of cellular extensions, and 
were sometimes accompanied by the formation of large endocytic or exocytic 
vesicles. 
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      To confirm this observation, Idirectly measured and compared the 
intracellular quantity of F-actin using fluorescent phalloidin in permeabilized 
Du145 transfectant cells. As shown in Figure 3.2C, the F-actin level, reflected by 
the mean fluorescent intensity of intracellular phalloidin staining, was significantly 
decreased in KAI1/CD82-expressing cells, compared with the one in Mock cells. 
The levels of total actin protein or G-actin were equal between Du145-Mock and -
KAI1/CD82 cells (Figure 3.2C bottom panel).   
      Thus, the results from the qualitative live imaging and quantitative flow 
cytometry experiments agree with each other and indicate impaired actin 
polymerization within KAI1/CD82 cells.  
 
3.4.3   The roles of cell adhesion- and growth factor-signaling in 
KAI1/CD82-induced morphological and cytoskeletal changes   
      It has been reported that signaling initiated by integrin-ECM adhesion and 
growth factors is diminished by KAI1/CD82 and these diminutions correlate 
KAI1/CD82-induced inhibition of cell movement (Dong et al., 1995;  Hemler, 
2001;  Stipp et al., 2003). Inext investigated if increased input of the signaling 
from cell adhesion, growth factor, and chemokine could reverse KAI1/CD82-
induced morphological and cytoskeletal changes. For example, growth factors  
such as EGF and HGF were reported to promote actin cortical meshwork and 
stress fiber formation or development (Gohla et al., 1999;  Kodama et al., 2000;  
Liu et al., 2002;  Marcoux and Vuori, 2005). By evaluating the quantity and 
distribution of F-actin in Du145-KAI1/CD82 cells, Ifound that KAI1/CD82-induced 
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changes such as the loss of actin cortical meshwork or less F-actin in protrusions 
could not be rescued by the activation of following signaling either alone (Figure 
3.3A) or in combination (data not shown): β1 integrins, EGFR, c-Met, and 
CXCR4. Thus, KAI1/CD82 affects actin reorganization likely through inhibiting 
either multiple signaling pathways or the signaling step after the convergence 
point of multiple pathways. To further explore other possibly involved signaling, 
Iinvestigated the effects of cholesterol remover MβCD and PKC activator PMA on 
the morphological and cytoskeletal changes induced by KAI1/CD82. Ifound that 
both reagents could not override the changes induced by KAI1/CD82 (our 
unpublished data).  
      Surprisingly, Irealized that KAI1/CD82-induced morphological and 
cytoskeletal changes became alleviated when cell-cell contacts were formed 
(Figure 3.3B). Namely, stress fibers and cortical actin meshwork were partially or 
largely restored, respectively, in the KAI1/CD82-expressing cells when they were  
placed in a cell-cell contact microenvironment. This observation suggests that the 
signaling resulting from cell-cell adhesion acts against KAI1/CD82 signaling by 
rescuing actin polymerization probably through either the downstream of 
KAI1/CD82’s signaling target or a pathway parallel to KAI1/CD82 signaling. HGF 
was reported to override the motility-inhibitory effect of KAI1/CD82 in YTS1  
bladder cancer cells (Todeschini et al., 2007). However, Idid not observe a 
similar effect on cell migration for HGF in Du145-KAI1/CD82 cells (Figure 2.2).  
The method to calculate relative F-actin intensity of the membrane protrusion is 
illustrated in Figure 3.1.  
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Figure 3.3   Effects of cell-ECM adhesion, cell-cell adhesion, chemokine, 
and growth factor on KAI1/CD82-induced cytoskeletal changes 
 
A. Du145-Mock or -KAI1/CD82 transfectant cells were spread on FN-coated 
plates in complete DMEM and treated with integrin β1 activating mAb A1A5 (8 
µg/ml), EGF (100 ng/ml), HGF (100 ng/ml), or SDF-1 (100 ng/ml) at 37oC for 4-6 
h. Cells were then fixed, permeabilized, and incubated with Texas Red-
conjugated α-phalloidin. Digital images were captured under a fluorescent 
microscope. Scale bar, 20 µM. B. Quantitative analysis. The cortical F-actin 
intensity was quantitated as described in Experimental Procedures.  Bars denote 
the average intensity of 50~95 cells from three individual experiments. The 
differences between Mock and all CD82 groups are statistically significant (p 
values < 0.05), while the differences between untreated CD82 and each treated 
CD82 group are not statistically significant (p values > 0.05).  C. Effect of cell-cell 
contact on actin polymerization in Du145-Mock and -KAI1/CD82 cells. Scale 
bars, 100 µM in Du145-Mock cells and 20 µM in Du145-CD82 cells. Arrows 
indicate the well-developed actin cortical meshwork seen in the KAI1/CD82-
expressing cells with cell-cell contacts. Arrowheads indicate that no well-
developed cortical network was found in KAI1/CD82-expressing cells without 
cell-cell contacts. D. Quantitative analysis. The cortical F-actin intensity was 
quantitated as described in Experimental Procedures.  Bars denote the average 
intensity of 32-40 cells from three individual experiments. The differences 
between the Mock and the KAI1/CD82 cells without cell-cell contacts and 
between the KAI1/CD82 cells with and without cell-cell contacts are statistically 
significant (p values < 0.05), while the differences between the groups of Mock 
and KAI1/CD82 cells containing cell-cell contacts are not statistically significant 
(p values > 0.05). 
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3.4.4   KAI1/CD82 regulates Rac1 and RhoA activities  
      Since a previous study found that Rho GTPases are involved in KAI1/CD82-
mediated signaling in T cells (Delaguillaumie et al., 2002) and Rho GTPases are 
the key regulators of actin cytoskeleton organization (Nobes and Hall, 1995;  
Nimnual et al., 2003), Ianalyzed the Cdc42, Rac, and Rho activities in Du145-
Mock and -KAI1/CD82 cells. By the effector domain pull-down experiments, 
Ifound that Rac1 activity was significantly downregulated by KAI1/CD82 while 
RhoA activity was markedly upregulated by KAI1/CD82. Cdc42 activity remained 
unchanged upon the overexpression of KAI1/CD82 (Figure 3.4).  
      Since Rac1 and RhoA play crucial roles in actin polymerization and cell 
migration as described above, Inext determined whether Rac1 activity is  
essential for KAI1/CD82-induced morphological and cytoskeletal changes, 
Iexpressed the constitutively activated form of Rac1, i.e., Rac1 L61 mutant, in 
Du145-KAI1/CD82 cells. Rac1 L61 mutant could not induce the cortical 
meshwork formation (Figure 3.5A), lamellipodia formation (Figure 3.7D), and cell 
migration (Figure 3.5C) in Du145-KAI1/CD82 cells. Surprisingly, in Du145-Mock 
cells, the dominant negative form of Rac1, i.e., Rac1 N17 mutant could not inhibit 
the formations of cortical meshwork (Figure 3.5A), lamellipodia formation (Figure  
3.5A), and cell migration (Figure 3.5C) either. In addition, inhibition of Rac1 
activity by a Rac1 specific inhibitor 23766 (Gao et al., 2004) can’t suppress the  
lamillapodia formation of Du145 cells (Figure 3.5B).  Thus, Rac1 appears not to 
be required for lamellipodia formation in Du145 cells. Moreover, the inhibition of  
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Figure 3.4   KAI1/CD82 regulates the activities of Rho GTPases   
 
Upper panel, KAI1/CD82 inhibits Rac1 activity. Du145-Mock or -KAI1/CD82 
transfectant cells were lysed in a lysis buffer containing 1% NP-40 and 0.2% 
SDS detergents. Cell lysates were subjected to the affinity precipitation using 
GST-PAK1, which only binds to the activated or GTP-bound Rac. The co-
precipitated, GTP-bound Rac GTPase was detected by Rac mAb. The intact cell 
lysates were blotted with Rac mAb to demonstrate equivalent levels of total Rac 
proteins between Mock and KAI1/CD82 transfectant cells. Blots show results 
from a single representative experiment;  the graph represents the relative 
density of the Rac band summarized from four individual experiments (mean ± 
SD), based on the densitometric analyses. P value between Mock and 
KAI1/CD82 is < 0.05. Middle panel, KAI1/CD82 enhances RhoA activity.  Du145 
transfectants were pretreated as described above. GTP-bound RhoA was pulled 
down by GST-Rhotekin and detected by RhoA mAb. The picture shows the 
results from a single representative experiment; the graph represents the relative 
density of the RhoA bands summarized from four individual experiments (mean ± 
SD), based on the densitometric analyses. P value between Mock and 
KAI1/CD82 is < 0.05.  Lower panel, KAI1/CD82 does not significantly alter Cdc42 
activity.  GTP-bound Cdc42 was pulled down by GST-PAK1 and detected by 
Cdc42 mAb. The picture shows the results from a single representative 
experiment; the graph represents the relative density of the Cdc42 bands 
summarized from four individual experiments, based on the densitometric 
analyses. P value between Mock and KAI1/CD82 is < 0.05.  In all experiments, 
tubulin protein levels in cell lysates were detected via Western blot and served as 
protein loading controls. 
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Figure 3.5   Rac1 cannot rescue KAI1/CD82-altered cellular morphology and 
actin cytoskeletal organization  
 
A. Du145-Mock cells expressing GFP or Rac1 N17-GFP and Du145-KAI1/CD82 
cells expressing GFP or Rac1 L61-GFP were spread on FN-coated coverslips at 
37oC, 5% CO2 for 3-6 min. Cell morphology images were captured using a digital 
camera at magnification of 60X, and F-actin were stained and photographed as 
described in Experimental Procedures, Bar = 20 um. B. Effect of Rac1 inhibition 
on lamellipodia formation in Du145 cells. Rac1 specific inhibitor 23766, no-
activity control 23766, and DMSO control were add to DMEM media to treat 
Du145 cell overnight. Cell morphology images were captured using a digital 
camera at magnification of 60X. C. Rac 1 activities in the cells expressing Rac1 
N17 or L61 and treated with 23766. (D) Cell migration of Du145 transfectants 
were measured on FN-coated substratum.   
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RhoA activity in Du145-KAI1/CD82 cells by C3 toxin cannot rescue KAI1/CD82-
induced morphological and cytoskeletal alterations (Figure 3.6).  
 
3.4.5   KAI1/CD82 blocks cofilin translocation  
      Cofilin is a downstream effector of both Rac and Rho and promotes actin 
reorganization (Raftopoulou and Hall, 2004). Despite that the levels of total, 
inactive (phosphorylated), and active (= total - phosphorylated) cofilin proteins  
remain unchanged in KAI1/CD82-overexpressing cells (Figure 3.7A), cofilin was 
concentrated in membrane protrusions such as lamellipodia (Figure 3.7B and D, 
arrow) as well as in nuclei in Du145-Mock cells (Figure 3.7B), resulting in 
relatively less cofilin within the cytoplasm (Figure 3.7B and D, arrow head). In 
contrast to Du145-Mock cells, cofilin was distributed across the cytoplasm but not 
enriched at the cell periphery in Du145-KAI1/CD82 cells (Figure 3.7B). The 
phosphorylated or inactivated cofilin was present in the perinuclear cytoplasm, 
and there was no difference in subcellular distribution of phosphorylated or 
inactivated cofilin between Mock and KAI1/CD82 cells (Figure 3.7C). Thus, 
although cofilin was still translocated to peripheral cytoplasm in Du145-
KAI1/CD82 cells, KAI1/CD82 expression inhibits the translocation of cofilin to or 
the enrichment of cofilin at the cell periphery, implying a putative mechanism by 
which Du145-KAI1/CD82 cells fails to form lamellipodia. Moreover, this blockage 
of cofilin translocation was not overturned by the increased activity of Rac1 
(Figure 3.7D), which activates cofilin, promotes cofilin translocation to membrane 
ruffles, and initiates the lamellipodia formation (Suzuki et al.,1995; Nagaishi et  
 123  
 
 
Figure 3.6   RhoA specific inhibtor – C3 transferase’s effect on actin 
reorganization 
 
Du145-Mock and Du145-CD82 cells were spread on 10 µg/ml FN-coated Mak-
Tek chamber and treated with either glycerol control or C3 (2.5 ug/ml) for 4-6 
hours according to manufacturer’s manual. Cells were then fixed with 3% 
paraformaldehyde, permeabilized by 0.1% Brij 98. F-actin werewas stained with 
Texas Red-conjugated phalloidin and analyzed using confocal microscopy. Scale 
bar, 50 µm 
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Figure 3.7   KAI1/CD82 blocked the translocation of cofilin  
 
A. The levels of total and phosphorylated cofilin proteins in Du145-Mock and -
KAI1/CD82 cells were assessed by Western blot using pAbs against cofilin and 
phosphorylated cofilin, respectively, as described in Experimental Procedures. 
Tubulin blot is used a control for protein loading. B. KAI1/CD82 prevents cofilin 
from being targeted to the cell periphery. Du145 transfectant cells were spread 
on FN-coated coverslips in complete DMEM for 3-6 h. The cells were fixed, 
permeabilized, and incubated with cofilin pAb and TRITC-conjugated α-
phalloidin, followed by the FITC-conjugated 2nd Ab staining. Digital images were 
captured under a confocal microscope and each image represents a single XY 
section. Arrow indicates the translocation of cofilin into lamellipodia, while 
arrowhead indicates the relatively transparent zone beneath the actin cortical 
meshwork and within the cytoplasm. Scale bar, 20 µm. C. Comparison of the 
subcellular distribution of phosphorylated cofilin between Du145-Mock and -
KAI1/CD82 cells. The experiment was performed as described in B except that 
the pAb against phosphorylated cofilin was used as the primary Ab. Scale bar, 20 
µm.  D. Du145-Mock cells expressing GFP or Rac1 N17-GFP and Du145-
KAI1/CD82 cells expressing GFP or Rac1 L61-GFP were spread on FN-coated 
coverslips at 37oC, 5% CO2 for 3 ~ 6 h. Cofilin was visualized using 
immunofluorescence as described above. The digital images were captured 
under a confocal microscope. Scale bar, 20 µm.      
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al., 1999; Nagata-Ohashi et al., 2004; Verdijk et al., 2004). Neither can the 
inhibition of Rac1 by dominant negative N17 suppress the translocation of cofilin 
in Du145-mock cell (Figure 3.7D).  
      To further elucidate how important cofilin is in the KAI1/CD82 signaling 
pathway, Ioverexpressed GFP-cofilin into both Du145-Mock and Du145-CD82 
transfectants (Figure 3.8). Upon cofilin overexpresion, Du145-Mock cells were 
still able to form lamellipodia (Figure 3.8 upper panel), whereas Du145-CD82 
cells still failed to form membrane protrusion effectively (Figure 3.8 lower panel). 
Although cofilin still actively participated in membrane protrusion in both Du145-
Mock and Du145-CD82 cells, Icouldn’t determine whether cofilin is the primary 
driven force for membrane protrusion formation or not in this spectacular 
experiment. This is not a surprise to us as overexpression of cofilin may impair 
the actin cytoskeleton rearrangement and cell migration (Lee et al., 2005) or 
enhance the same process (Dang et al., 2006).  
      As Imentioned above in Chapter 1, PIP2 binds to cofilin and restricts its 
activation. It is thus worthwhile to determine if there are any difference regarding 
to the sub-cellular localization of PIP2 within Du145-Mock and Du145-CD82 
cells, as it might give us some useful hints on why there are less cofilin present in 
the leading edge of Du145-CD82 cells. As shown in Figure 3.9, PIP2 subcellular  
distribution, more accurately, the plama membrane PIP2 distribution has not 
been altered by KAI1/CD82. 
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Figure 3.8   GFP-cofilin overexpression cannot overturn the inhibited 
lamellipodia formation by CD82 in Du145 cells  
 
The pEGFP-Cofilin construct was transiently transfected into Du145-Mock and 
Du145-CD82 transfectants. 48 h after transfection, the cells were spread on 10 
µg/ml FN-coated plates in complete DMEM at 37oC for 4-6 h. Cells were then 
photographed using time-lapse confocal videomicroscopy for 30 minutes. 
Representative pictures from 0, 5,10,15,20,25,30 minutes are shown.  Green 
color stands for the expression and localization of GFP-cofilin. Images were 
taken at a magnification of 60X. Scale bar, 20 µm 
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Figure 3.9   No alteration in PIP2 level upon KAI1/CD82 expression  
 
The pEGFP and pEGFP-PLCδ PH domain constructs were transiently 
transfected into Du145-Mock and Du145-CD82 transfectants. At the 48 h after 
transfection, the cells were spread on 10 µg/ml FN-coated Mak-Tek chamber and 
analyzed using confocal microscopy. A Z-stack of digital images was captured as 
described above. Representative images of different transfectants were shown.  
Green color stands for the expression and localization of either pEGFP or 
pEGFP-PLCδ PH domain. 
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3.4.6   Effect of KAI1/CD82 expression on Rac effector Arp2/3 
      Arp2/3 complex is a downstream effector of Cdc42 and Rac1 and plays 
pivotal roles in nucleation and polymerization of actin (Pollard and Borisy, 2003), 
especially for the branched cortical actin network (Mullins et al., 1998) at the 
leading edge of lamellipodia (Svitkina and Borisy, 1999). By analyzing p34, a 
component of Arp2/3 complex, Ifound that Arp2/3 complex remains unchanged in 
both subcellular localization and protein level between Du145-Mock and -
KAI1/CD82 cells (Figure 3.10).  
 
3.4.7   KAI1/CD82 inhibiting actin polymerization can’t be overturned by N-
WASp or jasplakinolide  
      N-WASp and jasplakinolide are potent actin polymerization inducers. N-
WASp promotes actin polymerization via Arp2/3 (Kozma et al., 1995;  Nobes and 
Hall, 1995;  Raftopoulou and Hall, 2004). Jasplakinolide is a cyclic peptide 
isolated from the marine sponge, Jaspis johnstoni.  It has been shown to bind to, 
de novo nucleate, and stabilize actin filaments (Bubb et al., 1994b;  Bubb et al., 
2000). Neither overexpression of GFP-N-WASp nor treatment of jasplakinolide 
(50nM), can rescue the defective actin polymerization induced by KAI1/CD82 
(Figures 3.11 and 3.12) 
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Figure 3.10 KAI1/CD82 doesn’t alter the protein level and subcellular 
localization of the p34 protein in Arp2/3 complex  
 
A. The level of p34 proteins in the Arp2/3 complex in Du145-Mock and -
KAI1/CD82 cells was assessed by Western blot using pAbs against p34 protein 
as described in Experimental Procedures. Tubulin blot is used a control for 
protein loading.  B. Du145 transfectant cells were spread on FN-coated 
coverslips in complete DMEM for 3-6 h. The cells were fixed, permeabilized, and 
incubated with p34 pAb and TRITC-conjugated α-phalloidin, followed by the 
FITC-conjugated 2nd Ab staining. Digital images were captured under a confocal 
microscope, and each image represents a single XY section. Scale bar, 20 µm.   
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Figure 3.11 Effect of N-Wasp on actin polymerization in Du145 
transfectants  
 
The pEGFP and pEGFP-N-WASp constructs were transiently transfected into 
Du145-Mock and Du145-CD82 transfectants. At the 48 h after transfection, the 
cells were spread on 10 µg/ml FN-coated Mak-Tek chamber. Cells were then 
fixed. F actin was stained with Rhodamine-labeled Phalloidin, and analyzed 
using confocal microscopy. Representative images of different transfectants were 
shown.  Green color stands for the expression and localization of either pEGFP 
or pEGFP-N-WASp. Images were taken at a magnification of 60X. Scale bar, 50 
µm 
 133  
 
 134  
 
 
 
Figure 3.12 Jasplakinolide cannot overturn the actin polymerization defect 
in Du145-CD82 cells  
 
It has been reported that Jasplakinolide  (Molecular probe, J7473) can induce 
actin polymerization (Bubb et al., 1994a). Jasplakinolide’s effect on actin 
polymerization that was suppressed by CD82 was determined. Du145-Mock and 
Du145-CD82 transfectants cells were spread on 10 µg/ml FN-coated Mak-Tek 
chamber and treated with 50nM Jasplakinolide in full DMEM containing 10% FCS 
for 24 hours, Cell were then fixed, stained with Rhodamine-labeled Phalloidin, 
and visualized by fluorescence microscopy.  Images were taken at a 
magnification of 60X. Scale bar, 50 µm 
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3.5 Discussion 
 
3.5.1   Alterations in cellular morphology upon KAI1/CD82 expression 
reflect the deficiencies in protrusion and retraction - the motility-inhibitory 
mechanism at the cellular level 
      KAI1/CD82 expression alters the cellular morphology in various aspects. 
These alterations can be attributed to both diminished protrusive activities such 
as the lack of formation of lamellipodia and cellular protrusion and attenuated 
retraction of cellular extension and trailing edge. Since migrating cells typically 
display these motility-related morphological events, loss and disruption of these 
events are therefore predicted to be important for the cell movement-inhibitory 
activity of KAI1/CD82.   
      In Du145 prostate cancer cells, KAI1/CD82 expression abolishes the 
lamellipodia formation on fibronectin-coated, laminin-coated, or regular cell 
culture flasks. Only on laminin 5-coated substratum KAI1/CD82-expressing cells 
underwent cell flattening, a symmetric cell spreading process. In PC3 prostate 
cancer cells, KAI1/CD82 grossly inhibits the lamellipodia formation on fibronectin 
but partially inhibits it on laminin. Because PC3 cells could form fan-like, well-
developed lamellipodia on laminin, KAI1/CD82 more likely inhibits the 
development or prevailing of fan-like lamellipodia. Of note, the definition of 
lamellipodia referred herein covers both subdomains of recently designated 
lamellipodia and lamella (Ponti et al., 2004). Since both Du145 and PC3 cells 
form lamellipodia during cell migration, the lack or disruption of lamellipodia 
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formation or development is very likely to be crucial for the motility-inhibitory 
activity of KAI1/CD82 though some PC3-KAI1/CD82 cells can still form 
incomplete lamellipodia on laminin.  
      The presence of elongated cellular extensions is another genuine effect of 
KAI1/CD82 overexpression in Du145 and PC3 cells. The elongated cellular 
extensions could be the consequence of excessive protrusive activity, but they 
could also reflect the retraction deficiency. Our study clearly demonstrated that 
various cellular extensions in KAI1/CD82-expressing Du145 and PC3 cells are 
caused by deficiency in retraction processes. Earlier studies showed that the 
immobilized-KAI1/CD82 mAbs induce profound dendritic extensions in 
hematopoetic cells (Nojima et al., 1993;  Lagaudriere et al., 1998), 
morphologically reminiscent of some types of cellular extensions seen in 
KAI1/CD82-expressing Du145 and PC3 cells. Despite the differences between 
overexpression and Ab engagement and between adherent and suspension 
cells, these dendritic extensions more likely represent the phenotype of less 
retraction if the motility-inhibitory activity of KAI1/CD82 is taken into 
consideration. 
      MTOC is important for promoting cell polarization at the front edge of a 
migrating cell (Etienne and Hall, 2002;  Ridley et al., 2003;  Rodriguez et al., 
2003). The diminished MTOC in Du145-CD82 may play a role in indicating a 
potential mechanism;   however, the major regulator of the MTOC, Cdc42 
activity, has not been changed by KAI1/CDC42 (Figure 3.4). 
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      KAI1/CD82 not only blocked the cellular protrusion and retraction processes 
that were induced by the integrin-ECM engagement but also blocked these 
events stimulated by growth factors or serum (Figure 3.2), For example, 
KAI1/CD82-caused deficiency in real tail retraction is manifested in the presence 
of HGF. These observations indicate that KAI1/CD82 inhibits both integrin and 
growth factor signaling. Another novel observation in this study is that the effect 
of KAI1/CD82 on these motility-required cellular processes appears to be 
independent of cell-cell contacts. In other words, KAI1/CD82 can induce these 
morphological changes without directly engaging a cellular receptor from 
adjacent cells because those morphological effects are pronounced when cells 
do not form cell-cell contacts. On the contrary, the cell-cell contacts alleviate 
KAI1/CD82 effects on the actin cytoskeleton, the foundation of morphological 
changes.     
 
3.5.2   KAI1/CD82-induced deficiencies in protrusion and retraction 
processes are caused by the aberrant actin polymerization 
      The profound morphological changes induced by KAI1/CD82 apparently 
result from the aberrant organization and/or reorganization of cellular 
cytoskeleton networks. Actin is the cytoskeletal system that plays a central role in 
cell movement-related subcellular events including protrusion, traction, and 
retraction (Horwitz and Parsons, 1999;  Parent and Devreotes, 1999;  Horwitz 
and Webb, 2003;  Ridley et al., 2003;  Van Haastert and Devreotes, 2004;  
Vicente-Manzanares et al., 2005). As predicted, the actin cytoskeleton becomes 
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globally aberrant upon KAI1/CD82 expression. The lack of or defect in cortical 
meshwork and stress fibers is evident in KAI1/CD82-expressing cells, suggesting 
the aberrancy in actin polymerization. Indeed, KAI1/CD82 overexpression in 
Du145 cells results in the attenuation of actin polymerization, which is likely 
caused by the disregulated activities and/or localization of Rac, Rho, and their 
effectors. 
      The development of the cortical actin network generates protrusive force, 
morphologically evidenced by lamellipodia formation (Ridley et al., 2003). In 
addition, actin reorganization drives the extension of lamellipodia at the leading 
edge and creates the traction force (Ridley et al., 2003). Cell movement needs 
both protrusion and traction forces (Ridley et al., 2003). Therefore, the formation 
of the actin cortical meshwork and simultaneous extension of leading 
lamellipodia are the major subcellular morphological features of many migrating 
cells. In KAI1/CD82-overexpressing Du145 cells, the losses of these 
morphological characteristics are apparently caused by the aberrant actin 
polymerization, particularly the polymerization of the branched actin network. 
      In parallel, the retraction process is also essential for the movement of many 
cells (Ridley et al., 2003). The defects in retraction upon KAI1/CD82 expression 
are displayed either as elongated trailing tails when Du145-KAI1/CD82 cells were 
treated with HGF, or as long cellular extensions in cells with bipolar-or dumbbell-
shape, or simply as persistent vertices in cells with polygonal shape. 
Mechanistically, the deficiency in retraction could result from either functional 
and/or structural abnormality of actin-myosin retraction machinery. For example, 
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loss of ROCK activity will cause functional incompetence of this machinery while 
disrupted actin fibers due to the suppressed actin polymerization will make the 
retraction process lose the structural base in Du145-KAI1/CD82 cells.    
 
3.5.3   Aberrant actin polymerization in KAI1/CD82-expressing cells results 
from the deregulations of Rac, Rho, and their effectors - the molecular 
mechanism 
      Rho small GTPases are the master regulators of actin reorganization. Rac 
activation stimulates membrane ruffling through polymerization of cortical actin 
around the cell periphery, while Rho activation stimulates cell contractility through 
assembly of mainly radial-oriented actin stress fibers (Hall, 1998; Raftopoulou 
and Hall, 2004). In many cell types, Rac activation negatively regulates Rho 
activity through generating reactive oxygen species and subsequently activating 
p190RhoGAP (Nimnual et al., 2003). The delicate balance between the 
antagonistic activities of Rac and Rho is crucial for proper cell movement and 
also specifies cell morphology (Sander et al., 1999; Nimnual et al., 2003). The 
aberrant cytoskeleton reorganization upon KAI1/CD82 expression very likely 
results from the imbalance of Rho GTPase activities, namely, increased RhoA 
and decreased Rac1 activities. Iextrapolate that this imbalance ultimately leads 
to the defect in actin polymerization, aberrant cellular morphology, and 
diminished cell motility.  
      Consistent with the current understanding of the roles of Rac in cell 
morphology and movement, the suppressed lamellipodia and cell movement 
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caused by KAI1/CD82 expression correlate well with the diminished Rac1 activity 
in Du145 cells. However, Rac1 activity is, unexpectedly, not required for the 
lamellipodia formation in Du145 cells and the dominant-active mutant of Rac1 did 
not enhance the movement of Du145 cells either. Hence, departing from the 
doctrine, our finding in Du145 cells underlines a Rac1-independent mechanism 
for lamellipodia formation. In fact, Rac-independent lamellipodia formation has 
been sporadically reported elsewhere (Spaargaren and Bos, 1999; West et al., 
2000), though the underlying mechanism remains obscure.  In Rac1-/- mouse 
embryonic fibroblasts, lamellipodia formation is abolished (Guo et al., 2006; 
Vidali et al., 2006), but the cells are still able to migrate in a lamellipodia-
independent manner (Vidali et al., 2006). Du145 cells were isolated from the 
brain metastatic lesion of a prostate cancer patient and may not behave like 
fibroblasts. The mechanism responsible for lamellipodia formation in Du145 cells 
could vary from the one for fibroblasts. Notably, cell migration appears to be 
driven by, at least partially, lamellipodia in both PC3 and Du145 cells though 
lamellipodia are not essential for cell migration in fibroblasts (Vidali et al., 2006).   
      As expected, a lower Rac1 activity is accompanied with a higher RhoA 
activity in Du145 cells expressing KAI1/CD82 because Rac and Rho are mutually 
antagonistic in a variety of cells (Sander et al., 1999; Caron, 2003; Nimnual et al., 
2003). Based on the Bar-Sagi pathway (Nimnual et al., 2003), Ipredict that the 
decreased Rac1 activity results in the enhanced RhoA activity through a less 
p190RhoGAP activity at the plasma membrane. If so, KAI1/CD82-expressing 
Du145 cells may not experience the defect in retraction because an enhanced 
 141  
RhoA activity typically promotes cellular retraction (Nobes and Hall, 1995; Alblas 
et al., 2001; Raftopoulou and Hall, 2004).  
      Meanwhile, an enhanced RhoA activity will promote stress fiber formation, 
which is apparently attenuated upon KAI1/CD82 expression. Alternatively, the 
enhanced RhoA activity in KAI1/CD82-expressing Du145 cells plays a 
compensatory role in reacting to the suppressions of downstream events such as 
ROCK or cofilin. If so, cells are unable to retract even with the enhanced RhoA 
activity. More likely, both possibilities coexist in KAI1/CD82-expressing Du145 
cells and the elevated RhoA per se is probably a combinatory effect.  
      The third possibility is that KAI1/CD82 activates RhoA at the leading edge of 
migrating cells.  Since an increased RhoA activity at the leading edge of 
migrating cells inhibits membrane protrusion, RhoA is suppressed in lamellipodia 
probably through the local enrichment of Rac1(Raftopoulou and Hall, 2004).  
Because KAI1/CD82 inhibits membrane protrusive events such as lamellipodia, 
the upregulation of RhoA by KAI1/CD82 in the leading edge leads to an 
increased local activity of RhoA that inhibits lamellipodia formaiton. Surprisingly, 
our observation is not unique. When cells lose stress fibers and focal adhesions, 
such as cell rounding up by entering mitosis or experimental manipulation, Rho 
activity are higher instead of lower (Ren et al., 1999; Maddox and Burridge, 
2003). According to Rho’s role in promoting focal adhesion and stress fiber 
formation, the logical consequence of round up cell should be a decreasing in 
Rho activity. Why? The answer may be that the presence of high Rho activity 
would disassemble stress fibers (Burridge and Wennerberg, 2004) 
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      KAI1/CD82 expression did not alter Cdc42 activity in Du145 cells, in contrast 
to an earlier report that Cdc42 activity was upregulated during the transient 
overexpression of KAI1/CD82 (Schoenfeld et al., 2003). The enhanced Cdc42 
activity was reported to serve as a mechanism for a mass scale of apoptosis 
induced by KAI1/CD82 (Schoenfeld et al., 2003). In KAI1/CD82 stable 
transfectants, apoptosis is apparently not a major phenotype though KAI1/CD82-
expressing Du145 or PC3 cells are more prone to apoptosis (our unpublished 
data). As mentioned above, Ido realize that KAI1/CD82-expressing Du145 cells 
exhibit more symmetric morphology and are less polarized on laminin 5. Since 
Cdc42 regulates polarity, one may expect KAI1/CD82 to down-regulate Cdc42 
activity. However, Cdc42 is not the sole controller for cell polarity because Cdc42 
null fibroblasts still retain polarity. Thus, the connection between Cdc42 and 
KAI1/CD82-induced morphological effects may not be immediate.    
      As a key effector of both Rac and Rho, cofilin plays an important role in 
membrane ruffling (Aizawa et al., 1996) or lamellipodia formation (Chan et al., 
2000; Zebda et al., 2000; DesMarais et al., 2004; Ghosh et al., 2004; 
Raftopoulou and Hall, 2004; Cai et al., 2007) and in cell migration and invasion 
(Bamburg et al., 1999; Raftopoulou and Hall, 2004; Wang et al., 2006; Cai et al., 
2007; Iwasa and Mullins, 2007).  
      Driven by the activated Rac, LIM kinase (LIMK) phosphorylates or inactivates 
cofilin. The net effect of PAK-LIM kinase activation is to stabilize actin filaments 
and filament bundles. This is somewhat paradoxical, as the stabilization of F-
actin may slow down the turnover rate of actin filaments, which will at some 
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extent retard the formation of lamellipodia or ruffles. During cell migration, 
lamellipodia formation demand active cofilin and rapid actin recycling between 
polymer and monomer to sustain the actin treadmilling (Blanchoin et al., 2000a; 
Zebda et al., 2000). How to explain such a discrepancy? One possible 
explanation would be that cofilin activation and inactivation are under elegant 
spatial or temporal control. During the active cell migration stage, active cofilin 
was found more distally in a lamellipodium / ruffle to promote polymerization in 
cooperation with the Arp2/3 complex at the leading edge of a protrusion.  
      In contrast to the active cofilin, inactive cofilin phosphorylated by PAK-LIM 
kinase phosphorylation may be concentrated further back from the leading edge 
of lamellipodia. This subtle difference may allow cofilin to promote 
polymerization, synergizing with the Arp2/3 complex at the leading edge of 
lamellipodia, while simultaneously the inactive confilin distributes further back in 
the body of the lamellipodium or ruffle to stabilize the newly formed actin 
filaments within the dendritic actin mesh network (Burridge and Wennerberg, 
2004). Consequently, activated cofilin is translocated to the plasma membrane 
(Suzuki et al., 1995; Nagaishi et al., 1999; Nagata-Ohashi et al., 2004; Verdijk et 
al., 2004) where it interacts with the actin cytoskeleton and promotes actin 
cortical meshwork formation, actin recycling, and lamellipodia formation 
(Raftopoulou and Hall, 2004).  
      Translocation of cofilin to the plasma membrane is considered as an indicator 
of the cofilin activation (Suzuki et al., 1995; Nagaishi et al., 1999; Nagata-Ohashi 
et al., 2004; Verdijk et al., 2004). For example, in T leukemia cells and NIH3T3 
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cells, phosphorylated cofilin undergoes the translocation to lamellipodia upon 
activation or dephosphorylation (Verdijk et al., 2004). In resting cells, cofilin is 
distributed evenly throughout cytosol. Once the cells are activated, cofilin 
becomes accumulated at the plasma membranes (Suzuki et al., 1995; Nagaishi 
et al., 1999; Nagata-Ohashi et al., 2004; Verdijk et al., 2004).  
      Interestingly, the subcellular localizations of total and inactivated cofilin in 
Du145-Mock and -KAI1/CD82 cells display similar distribution patterns as the 
ones in migrating and non-migrating fibroblasts cell (Dawe et al., 2003), 
respectively. The novel observation made from this study is that, upon 
KAI1/CD82 expression, cofilin is no longer enriched at the cell periphery though it 
can be translocated to the peripheral cytoplasm. This observation strongly 
suggests that KAI1/CD82 expression block the translocation and therefore 
activation of cofilin, underlining a putative mechanism by which KAI1/CD82 
impairs lamellipodia formation. If so, one would expect more phosphorylated or 
inactive cofilin in Du145-KAI1/CD82 cells. In fact, the level of phosphorylated 
cofilin proteins remains unchanged upon KAI1/CD82 expression. This could be 
explained by the fact that, in Du145-KAI1/CD82 cells, more cofilin 
dephosphorylation due to the enhanced RhoA activity offsets less cofilin 
dephosphorylation due to the decreased Rac activity. Alternatively, cofilin 
underwent dephosphorylation during the translocation to the peripheral 
cytoplasm in Du145-KAI1/CD82 cells, as it did during the translocation to the cell 
periphery in Mock cells.            
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      Interestingly, cofilin is still able to translocate to lamellipodia in the Du145 
cells expressing dominant-negative Rac1, implying a Rac1-independent 
translocation mechanism. Surprisingly, the overexpression of GFP-cofilin (Figure 
3.8), N-WASP (Figure 3.11) or or treatment of actin polymerization inducer 
jasplakinolide (Figure 3.12) in Du145-CD82 cells can’t rescue KAI1/CD82-caused 
defects in actin cytoskeleton rearrangements such as cortical ring, stress fiber, 
and/or lamellipodia.  
      Another key player in cortical actin polymerization is the Arp2/3 complex, 
which is localized at the leading edge of the lamellipodia in Xenopus laevis 
keratocytes and fibroblasts (Svitkina and Borisy, 1999). However, Ididn’t observe 
the expected localization of P34, a component of Arp2/3 complex, in lamellipodia 
in Du145 prostate cancer cells (Figure 3.10B), probably due to the partial 
overlapping in subcellular distribution between P34 and Arp2/3, a seven-protein-
complex. 
 
3.5.4   KAI1/CD82 intercepts multiple signaling pathways: cell-cell adhesion 
stands out     
      KAI1/CD82 can initiate outside-in signaling. For example, KAI1/CD82 
engagement by the immobilized KAI1/CD82 mAb in T cells leads to the tyrosine 
phosphorylations of adaptor protein SLP76 and Rac guanosine exchange factor 
Vav1(Delaguillaumie et al., 2002) and actin reorganization (Lagaudriere et al., 
1998; Delaguillaumie et al., 2002; Delaguillaumie et al., 2004). This signaling 
may intercept the pro-migration signaling derived from integrin and growth factor 
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receptor. In parallel, since KAI1/CD82 physically interacts with β1 integrin and 
EGFR and down-regulates their function, KAI1/CD82 can directly inhibit the pro-
migration signaling at the very upstream. If the complexity of TEM constituents is 
taken into the consideration, there are multiple signaling pathways susceptible for 
KAI1/CD82 inhibition. Indeed, Ifound in this study that KAI1/CD82-induced 
morphological and cytoskeletal changes cannot simply be overridden by one or 
two signaling mechanisms. For example, the signaling originated from β1 integrin 
(Ridley et al., 2003) ,EGFR (Yarden and Sliwkowski, 2001), C-Met (Matsumoto et 
al., 1994; Dugina et al., 1995; Guasch et al., 1998; Sridhar and Miranti, 2006; 
Todeschini et al., 2007), and CXCR4 (Lapidot, 2001; Kayali et al., 2003; 
Bartolome et al., 2004; Marchesi et al., 2004; Tan et al., 2006) promote cell 
migration and actin reorganization through Rho small GTPases.  Activation of 
these signaling pathways, however, cannot override KAI1/CD82-exerted 
signaling and reverse the morphological and cytoskeletal effects. Iunderline this 
finding as a major advent of the molecular mechanism of KAI1/CD82.  
      Interestingly and also surprisingly, cell-cell adhesion significantly alleviates 
the morphological and cytoskeletal effects of KAI1/CD82. Although KAI1/CD82 
has been reported to upregulate cell-cell adhesion or aggregation (Lagaudriere-
Gesbert et al., 1997b; Shibagaki et al., 1998; Shibagaki et al., 1999; Jee et al., 
2003), associate with E-cadherin in colon cancer cell (Lee et al., 2003b), and 
bind to the counter-receptor DARC, the interplay between KAI1/CD82 and cell-
cell adhesion remains to be understood. Likely, cell-cell adhesion corrects, to 
some degree, the imbalanced Rac and Rho activities in Du145-KAI1/CD82 cells 
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as cell-cell contacts typically promote Rac but suppress Rho activities.  In 
contrast to the notion that KAI1/CD82 inhibits cell migration by engaging DARC 
through cell-cell adhesion, it appears that KAI1/CD82 only exerts the cell 
movement-related morphological and cytoskeletal impacts on cells when cell-cell 
adhesion falls apart.    
      In conclusion, Idemonstrated in this study that KAI1/CD82 likely intercepts 
multiple signaling events and/or common steps of various signaling pathways, 
resulting in the imbalance of Rac and Rho activities. Consequently, actin 
organization and reorganization become aberrant. The cytoskeletal changes in 
KAI1/CD82-expressing cancer cells cause the inhibitions of both cellular 
protrusion and retraction processes, which ultimately leads to the suppression of 
cell movement.  
      It has been reported that CD82 can induce apoptosis through reducing 
Redox species, and thus raising the ROS (Ono et al., 2000; Schoenfeld et al., 
2003). Here, Ifound that CD82 can also inhibit migration through impairing actin 
cytoskeleton reorganization. Interestingly, disruption of cytoskeleton can trigger 
and accompany apoptosis (Rao et al., 1999). So far, whether CD82 inhibit cancer 
cell metastasis and trigger apoptosis through common pathway or different 
pathway remain unclear. In our study, Idiscovered that CD82 can downregulated 
Rac1, which also contribute to the reduction of the Redox.  Finally, this study on 
actin cytoskeleton rearrangement will definitely shed lights on how CD82 
suppress cancer metastasis.   
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CHAPTER 4.  DISCUSSION 
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4.1 Summary: how KAI1/CD82 regulates cytoskeleton rearrangement and 
cell migration at molecular and cellular level 
 
 4.1.1   Molecular level: KAI1/CD82 inhibits cell migration by inhibiting actin 
polymerization and lamellipodia formation  
      KAI1/CD82 impairs the actin cytoskeleton rearrangement through four 
possible mechanisms (Figure 4.1):  
      In the absence of KAI1/CD82, such as cancer cells that lose their KAI1/CD82 
expression due to epigenetic events, stimulation of motogenic signaling 
pathways such as integrin, cMet, and EGFR will activate small RhoGTPases 
through DOCK/Crk-p130CAS or PI-3K-Akt axis (Hasegawa et al., 1996; Klemke 
et al., 1998; Buday et al., 2002; Hood and Cheresh, 2002) (Figure 1.5). In turn, 
as one of the downstream effector of RhoGTPases, cofilin is phosphorylated and 
stabilizes newly synthesized actin filaments.  In addition, activation of those cell 
surface receptors by stimuli might also couple (Nishita et al., 2005a) or uncouple 
(Song et al., 2006a)  with the the dephosphorylation activation of cofilin. Cofilin 
then undergoes translocation to the plasma membrane at the leading edge of 
migrating cells to sever actin filaments (Suzuki et al., 1995; Nagaishi et al., 1999; 
Nagata-Ohashi et al., 2004; Verdijk et al., 2004).  The consequence of cofilin 
activation is to generate more barbed ends fo actin filaments (Bamburg et al., 
1999; Condeelis et al., 2001; Ono, 2003; Pollard and Borisy, 2003; Wang et al., 
2007). On the other hand, small GTPase activation will also activate Arp2/3 
(Raftopoulou and Hall, 2004). The synergic effects of Arp2/3 and cofilin  
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Figure 4.1   Summarization of how KAI1/CD82 inhibits cell migration at 
molecular level  
 
Detail of how KAI1/CD82 impairs actin cytoskeleton rearrangement by inhibiting 
actin polymerization and lamellipodia formation. A. In the abesenceabsence of 
KAI1/CD82, as in cancer cells which lose their KAI1/CD82 expression due to 
epigenetic events, multiple pro-migration signalingssignals including integrin, 
cMet, and EGFR will activate small RhoGTPases. In addition, those stimuli might 
also promote the dephosphorylation and thus activation of the cofilin. Cofilin then 
undergoes translocation beneath the plasma membrane to sever actin filaments 
to generate more barbed ends. Small GTPases then activate Arp2/3. 
Subsequentially Arp2/3 and active cofilin work synergistically to promote actin 
polymerization and in turn form those pro-migration morphology such as dendritic 
actin mesh network and lamellipiodia.  B. The presence of KAI1/CD82 will inhibit 
multiple signaling pathways: (1).Accelerate the internalization of cell surface pro-
adhesiveness and pro-migration proteins, such as integrin and EGFR; (2). Inhibit 
Rac1 activity and disrupt the balance among individual small RhoGTPases, (3) 
inhibit the activation of Arp2/3 and thus actin polymerization and generates less F 
actin fiber, less dendritic actin mesh network and less or no lamellipodia; (4). 
Inhibit cofilin translocation to membrane protrusion and lamellipodia. 
 
 151  
 152  
activations are to induce actin polymerization, increase F-actin level, and 
consequently promote pro-migration events such as the formation of dendritic 
actin mesh network and lamellipoidia (Bamburg et al., 1999; Condeelis et al., 
2001; Ono, 2003; Pollard and Borisy, 2003; Wang et al., 2007) (Figure 4.1A).   
      In the presence of KAI1/CD82, multiple signaling pathways crucial for actin 
cytoskeletal rearrangement and cell migration are interrupted (Figure 4.2) (Liu 
and Zhang, 2006): First, KAI1/CD82 can accelerate the internalization of cell 
surface pro-adhesion and pro-migration proteins, such as integrin and EGFR (Liu 
and Zhang, 2006), and subsequently attenuate their responses to external and 
internal stimuli. The outcomes of this attenuation are that cytoskeleton 
rearrangement is slowed down and cells become less motile; KAI1/CD82 might 
also directly or indirectly inhibit Rac1 activation and disrupt the delicate balance 
between individual small RhoGTPases, such as the Rac1 / RhoA ratio (Figure 
3.4). Rac1 and RhoA are important for proper initiation and maintenance of cell 
migration (Etienne and Hall, 2002; Hood and Cheresh, 2002; Ridley et al., 2003; 
Burridge and Wennerberg, 2004; Raftopoulou and Hall, 2004;). Rac1 promotes 
actin polymerization and lamellipodia formation, whereas RhoA  isRhoA is 
responsible for stress fiber formation to provide the cell a transient firm 
attachment on the substratum during membrane protrusion and rear 
contratilecontractility to finish the final step of cell migration.  Rac1 and RhoA 
activities are under tightly temperaltemporal and spatial control so that Rac1 and 
RhoA cooperate with each other during cell migration (Etienne and Hall, 2002; 
Hood and Cheresh, 2002; Ridley et al., 2003; Burridge and Wennerberg; 2004;  
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Figure 4.2   Summarization of how KAI1/CD82 inhibits cell migration at 
cellular level  
 
Cell migration contains three distinct steps. They are polarization, protrusion 
formation and rear retraction. In this dissertation, Ilearned that KAI1/CD82 may 
intercept all of those three processes, and thus suppress cell migration. During 
polarization, KAI1/CD82 might disturb the MTOC organization.  Although Cdc42 
activity remain equal in the present or absent of KAI1/CD82 in Du145 cells, other 
regulatory mechanisms importantsimportant for cell polarization may be affected 
by KAI1/CD82 (Also see Figure 1.4). . During protrusion formation, KAI1/CD82 
profoundly inhibits the membrane protrusion and lamellipodia formation, probably 
through disturbing actin cytoskeletal rearrangement as discussed in Figure 5.1. 
Iconclude that unbalancing Rho GTPases, especially Rac1 / RhoA and blockage 
of cofilin translocation to leading edge induced by KAI1/CD82, account for those 
defects. During rear retraction, KAI1/CD82 induces an exceptionally prolonged 
cell morphology that can be exaggerated by pro-migratory stimuli such as HGF.  
These defects strongly imply dysfunction of rear retraction during cell migration. 
RhoA upregulation and Rac1/RhoA unbalancing may be important for this defect.  
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Raftopoulou and Hall, 2004). In our study,  I found that this balance is disrupted 
as Rac1 is downregulated and RhoA is upregulated upon overexpression of 
KAI1/CD82 (Figure 3.4). This imbalance may account for the declined actin 
polymerization, dendritic actin cortical mesh network formation, lamellipoidia 
formation and cell motility (Figure 4.1B).  
      As downstream effectors of small Rho GTPases, Arp2/3 and cofilin might 
also be affected in function when KAI1/CD82 overexpression causes the 
imbalance of Rac1 and RhoA. As described above, the downregulated Arp2/3 
and coflilin activities will lead to decreased actin polymerization, less F actin fiber, 
less dendritic actin mesh network formation and less or no lamellipodia (Figures 
2.3, 2.4, 3.2- 3.12);  Although MTOC became obscure upon KAI1/CD82 
overexpression, RhoGTPase member Cdc42, which is responsible for cell 
polarization (Ridley et al., 2003),  was unchanged. Cofilin translocation to the 
leading edge of membrane protrusion is important for membrane protrusion or 
lamellipodia formation (Bamburg et al., 1999; Condeelis et al., 2001; Ono, 2003; 
Pollard and Borisy, 2003; Wang et al., 2007). In this study, Iobserved an 
interesting phenominanphenomenon: KAI1/CD82 can block cofilin translocation 
to the cell periphery (Figure 3.7). Overexpression of cofilin, dominant negative 
Rac1, or constitutively active Rac1 cannot rescue this inhibitory effect (Figures 
3.7, 3.8).  
      The inhibition of actin cytoskeletal rearrangement by KAI1/CD82 is strong. 
Overexpression of an Arp2/3 activator, N-WASp, or stimulation with an actin 
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polymerization inducer, Jasplakinolide, cannot overturn the inhibition by 
KAI1/CD82 (Figures 3.11, 3.12).  
      In short, these evidences strongly indicate that KAI1/CD82 inhibits multiple 
pro-migratory signaling pathways rather than just one or two specific pathways 
(Liu and Zhang, 2006). 
 
4.1.2   How KAI1/CD82 inhibits cell migration at cellular level  
      Cell migration can be divided into three distinct steps: polarization, protrusion 
formation and rear retraction. In this dissertation study, Ilearned that KAI1/CD82 
might have impacts on all three steps to suppress cell migration (Figure 4.2). 1). 
Polarization. In Figure 3.2A, MTOC in Du145-CD82 became vague as compared 
to a strong present in the Du145-Mock cells.  Although Cdc42 activity is not 
altered by KAI1/CD82 in Du145 cells, other regulatory mechanisms 
importantsimportant for cell polarization may be affected by KAI1/CD82 (Figure 
1.4). 2). Protrusion formation. KAI1/CD82 can profoundly inhibit the membrane 
protrusion and lamellipodia formation (Figures 3.1, 3.2, 3.3, 3.5, 3.7, 3.8, 3.11, 
and 3.12). Ipropose that deregulation of Rho GTPases, especially Rac1and 
RhoA and blockage of cofilin translocation to leading edge account for those 
defects. 3) Rear retraction. As shown in Figure 3.1 and Figure 3.3A, cells 
overexpressing KAI1/CD82 exhibit an elongated cell morphology that can be 
substaintiated by pro-migratory stimuli such as HGF.  This defect strongly 
suggests a malfunction of rear retraction during cell migration. RhoA upregulation 
may be important for this defect since loss of focal adhesion and stress fiber 
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usually accompany by the upregulated RhoA activity (Ren et al., 1999; Maddox 
and Burridge, 2003). In addition, transiently decreased Rho activity may facilitate 
the transition of actin network from a rigid cortex to a more dynamic actin cortex 
that allows cell spreading and cell migration (Ren et al., 1999).  
 
4.2 Summary: a historic perspective of KAI1/CD82 
      Based on the current understanding, a summary of the mechanisms by which 
KAI1/CD82 inhibits cell migration and cancer invasion is illustrated in Figure 1.2. 
In the effort to delineate these mechanisms, there are a list of intriguing 
questions remain to address, and some of them have been long-standing since 
the first paper about KAI1/CD82 was published 14 year ago. For example, 
KAI1/CD82 appears to be functionally versatile as shown in Figure 1. If so, is 
there really a master or major mechanism for KAI1/CD82 to inhibit cell migration 
and caner invasiveness? Or does KAI1/CD82 inhibit migration and invasion by 
regulating a specific signaling pathway? If such mechanism(s) indeed exist, can 
the migration- and invasion-inhibitory mechanism of KAI1/CD82 be applied to its 
suppression of metastasis? Some early studies found that KAI1/CD82 
expression in leukemia and lymphoma cells was actually upregulated (Lebel-
Binay et al., 1995; Shibagaki et al., 1998; Shibagaki et al., 1999; Delaguillaumie 
et al., 2002; Delaguillaumie et al., 2004), which is distinctive from what Ilearned 
from solid tumors. Does KAI1/CD82 behave differently in solid tumor and 
hematopoetic malignancy? With the emergence of other metastasis suppressors, 
are there any mechanistic links between KAI1/CD82 and other cancer metastasis 
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suppressors such as BRMS1, KISS1, CD44, and NM-23 (Welch et al., 2000)? In 
contrast to KAI1/CD82, some tetraspanins like CO-029 and CD151 promote cell 
migration and cancer metastasis. What are the structural bases responsible for 
the functional differences between KAI1/CD82 and these motility-promoting 
tetraspanins? Since most of KAI1/CD82-associated proteins are residents in the 
Tetraspanin-enriched microdomain, what is the role of Tetraspanin-enriched 
microdomain in KAI1/CD82-mediated suppression of cell migration, cancer 
invasion and metastasis? Although Ihave focused on the cell-extracellular matrix 
adhesion mediated by KAI1/CD82-associated integrins, several studies indicated 
that KAI1/CD82 regulates calcium-independent cell-cell adhesion. How does 
KAI1/CD82 regulate cell-cell adhesion? Is the altered cell-cell adhesion a part of 
mechanism for KAI1/CD82’s metastasis-suppressive activity? As Idiscussed 
earlier, KAI1/CD82 likely takes part in development and immune response. Do 
the physiological functions of KAI1/CD82 share the same mechanism with its 
suppression of cancer metastasis? Ibelieve the answers to these questions will 
elaborate the understanding of the nature of KAI1/CD82 as well as the general 
mechanism of cancer progression.  
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